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SUMMARY 
SUMMARY 
The adherence of enteropathogenic Escherichia coli (EPEC) to human intestinal cells triggers 
the formation of actin-rich pedestals. This process requires the translocation of the bacterial 
translocated intimin receptor (Tir) into host cells through a type III secretion system. The 
insertion of Tir into the plasma membrane and its tyrosine-phosphorylation leads to the 
recruitment of the host cell adaptor Nck, following Tir interaction with its ligand -the EPEC 
intimin surface protein. Nck in turn activates the neural Wiskott-Aldrich syndrome protein 
(N-WASP) initiating actin polymerisation mediated by the actin-related (Arp)2/3 complex. 
Interestingly, the host cortactin protein activates the Arp2/3 complex and N-WASP 
promoting actin polymerisation by two different mechanisms.  
 
Here, we interrogate a suggested role for cortactin in Tir-mediated actin nucleation events 
and reveal a critical role. We propose that cortactin binds Tir through its N-terminal part in 
a phosphorylation independent manner. On the other hand, the SH3 domain binding and 
activation of N-WASP is regulated by tyrosine and serine mediated phosphorylation of 
cortactin. Moreover, Tir-cortactin interaction promotes Arp2/3 complex-mediated actin 
polymerisation in vitro. Therefore, cortactin could act on Tir:Nck:N-WASP signalling pathway 
and control a possible cycling activity of N-WASP underlying pedestal formation.  
 
We also demonstrate that Crk family adaptor proteins have a redundant inhibitory role in 
regulating actin polymerisation in actin pedestals. Furthermore, we have observed that Nck-
deficient mouse embryonic fibroblasts (MEFs) have significantly reduced amounts of Tir 
whereas the levels of other translocated effectors, EspF and EspB, are normal. In addition, 
the levels of Map effector are also reduced in these cells. Importantly, we establish that the 
absence of Tir in Nck-deficient cells implies a decrease in pedestal formation and bacterial 
attachment to these cells. We investigated whether the drastic reduction in the amount of 
Tir in the absence of Nck is due to protein degradation or to a defective delivery process. 
Interestingly, the treatment with TSA, a known deacetylase and autophagy inhibitor, results 
in a significant increase in the amount of Tir in Nck-deficient cells. Although our results 
point to a selective defective delivery of Tir and Map proteins, the only two effectors whose 
efficient translocation is dependent on the chaperone CesT, we cannot discard a possible 
degradation of both effectors inside the host cell.  
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ABBREVIATIONS 
ABBREVIATIONS AND ACRONYMS 
A/E: Attaching and effacing  
Ab: Antibody 
Abl: Tyrosine kinase: Abelson tyrosine kinase  
ABR: Actin-binding region 
ADF: Actin depolymerising factor 
ADP: Adenosine diphosphate 
ARF: ADP-ribosylation factor 
Arp: Actin-related protein  
ATEC: Atypical enteropathogenic E. coli  
ATP: Adenosine triphosphate 
BFP: Bundle-forming pili 
CBD: Chaperone-binding domain 
Cdc42: Cell division cycle 42 
CML: Chronic myelogenous leukaemia 
CR: Citrobacter rodentium  
CRIB domain: Cdc42/Rac-interactive binding domain 
Crk: CT10 (chicken tumour virus no. 10) regulator of kinase 
CrkL: Crk-like 
C-terminal: Carboxyl-terminal 
DAEC: Diffusely adhering E. coli  
dS mutant: ptirS434/463A 
dY mutant: ptirY474F/Y454F  
EAEC: Enteroaggregative E. coli  
EGF: Epidermal growth factor  
EHEC: Enterohaemorrhagic E. coli  
EIEC: Enteroinvasive E. coli  
EPEC: Enteropathogenic E. coli  
Erk: Extracellular signal-regulated kinase  
Esc: E. coli secretion component  
Esp: E. coli secretion protein 
ETEC: Enterotoxigenic E. coli  
Etk: Epithelial and endothelial tyrosine kinase 
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ABBREVIATIONS 
FA: Focal adhesion  
F-actin: Filamentous actin  
FAK: Focal adhesion kinase 
Fer tyrosine kinase: Feline sarcoma-related tyrosine kinase 
FGF: Fibroblast growth factor 
FL: Full-length 
G-actin: Globular monomeric form  
GBD: GTPase-binding domain 
GEF: Guanine exchange factor 
GST: Glutathione S-transferase 
GTP: Guanosine triphosphate 
GTPase: Guanosine triphosphatase 
HDAC6: Histone deacetylase 6  
HDACi: Histone deacetylase inhibitor 
HS1: Haematopoetic-specific protein 1  
I-BAR: Inverse Bin-amphiphysin-Rvs167 
IF: Immunofluorescence  
IRSp53: Insulin receptor tyrosine kinase substrate p53  
IRTKS: Insulin receptor tyrosine kinase substrate 
IVOC: In vitro organ cultures 
LA: Localised adherence  
LEE: Locus of enterocyte effacement  
Map: Mitochondrial-associated protein 
MEFs: Mouse embryonic fibroblasts 
Mo Ab: Monoclonal antibody 
MOI: Multiplicity of infection 
NC: Needle complex 
Nck-/-: Nck-deficient MEFs 
Nck: Non-catalytic tyrosine kinase 
NF-kB: Nuclear factor kB 
Nle: Non-LEE effectors 
NMR: Nuclear magnetic resonance 
NPF: Nucleation-promoting factor  
NPY motif: Asn-Pro-Tyr motif 
NSD domain: N-terminal signal domain  
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ABBREVIATIONS 
NTA: N-terminal acidic domain 
N-WASP-/-: N-WASP-deficient MEFs 
N-WASP: Neural Wiskott Aldrich Syndrome Protein 
p130Cas: p130 Crk-associated substrate   
Pak: p21 activated kinase 1 
PCAF: Histone acetyltransferase p300/CBP-associated factor  
PDGF (R): Platelet-derived growth factor (receptor) 
PI3K: Phosphoinositide 3-kinase 
PIP2: Phosphatidylinositol 4,5-bisphosphate 
PKA: Protein kinase A 
Poly Ab: Polyclonal antibody 
PRD: Proline-rich domain  
ptir: pACYC184 based plasmid carrying the 3´map, tir and cesT 
quad: ptirY474F/Y454F S434/463A   
REPEC: Rabbit-specific enteropathogenic E. coli  
S405,418A (2A) mutant: Erk non-phosphorylatable mutant 
S405,418D (SD) mutant: Erk-phosphorylation-mimicking mutant 
SEM: Scanning electron micrograph 
Sep: Secreted E. coli proteins  
SGTL-1: Sodium-dependent glucose co-transporter 
SH2 domain: Src homology-2 domain 
SH3 domain: Src homology-3 domain 
siRNA: Small interference RNA 
SNX9: Sortin nexin 9 
Src tyrosine kinase: Sarcoma tyrosine kinase 
Tccp: Tir cytoskeleton coupling protein (also known as EspFu) 
TCR: T-cell receptor 
Tir: Translocated intimin receptor  
TJ: Tight-junction 
TNF- α: Tumor necrosis factor-α 
TTSS: Type III secretion system 
VCA domain: Verprolin homology, central hydrophobic and acidic regions 
W22A mutant: Arp2/3 activation mutant (W22A)  
W525K mutant: SH3 domain mutant 
WASPs: Wiskott-Aldrich syndrome family of proteins  
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ABBREVIATIONS 
WAVE: WASP-family verprolin homologue  
WB: Western blot 
WCA domain: see VCA domain 
WH1 domain: WASP-homology 1 domain 
WIP: WASP-interacting protein 
WT: Wild type 
Y421,466,482D (3D) mutant: Src-phosphorylation-mimicking mutant  
Y421,466,482F (3F) mutant: Src non-phosphorylatable mutant  
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1. Actin polymerisation promoted by the Arp 2/3 complex 
 
The actin cytoskeleton is a dynamic network composed of actin filaments that remodels 
to accomplish many cellular processes and therefore exhibits significant changes during 
cell migration, adhesion, endocytosis and bacterial invasion. Actin polymerisation 
occurs when the globular monomeric form (G-actin) undergoes cycles of self-assembly 
into filamentous actin (F-actin) in a tightly regulated process. Actin filaments are polar 
structures that contain fast-growing barbed ends and less active pointed ends. The 
initial formation of a dimeric or a trimeric nucleus is kinetically unfavourable being 
promoted and controlled by proteins that facilitate the process, such as the actin-
related protein (Arp) 2/3 complex and formin proteins. The Arp2/3 complex has the 
ability to organise the actin filaments into branched networks (Figure 1A) (reviewed in 
(Pantaloni et al., 2001)) whereas formins produce unbranched actin filaments (Figure 
1B). Apart of the novo nucleation of monomers, cells initiate actin assembly creating 
free barbed ends by uncapping or severing pre-existing filaments. Cells need to 
maintain a high concentration of monomeric actin to support the rapid and constant 
actin polymerisation at their leading edge. Proteins of the cofilin/ADF (actin 
depolymerising factor) family play a major role in this process by disassembling the 
actin network. It has been proposed that ADF acts by severing actin filaments (reviewed 
in (Pollard and Cooper, 2009)) or by increasing the dissociation rate of monomers at 
the pointed end of actin filaments (reviewed in (Pantaloni et al., 2001)). 
 
The Arp2/3 complex is comprised of seven subunits, including the two actin-related 
proteins 2 and 3. This complex is able to add a ‘branch’ to the side of a pre-existing 
actin filament, giving rise to branched filaments with a characteristic 70-degree angle 
(Pollard and Cooper, 2009) (Figure 1A). By itself, the Arp2/3 complex is inactive and 
requires the action of the so-called nucleation-promoting factors (NPFs) to efficiently 
nucleate filaments.  
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The first described activators of the Arp2/3 complex are the Wiskott-Aldrich syndrome 
family of proteins (WASPs) (Marchand et al., 2001). The representative member of the 
family, WASP, which is expressed exclusively in the immune system, is mutated in the 
immune deficiency called Wiskott-Aldrich syndrome (WAS) (Derry et al., 1994). Neural 
WASP (N-WASP), first discovered in brain, is more ubiquitous than WASP and is 
coexpressed with this protein in some cell types, such as macrophages and dendritic 
cells (Miki et al., 1996). WASPs proteins belong to a group of NPFs called Class I that 
promotes actin polymerisation through the binding to G-actin and activating the 
Arp2/3 complex through a conserved carboxyl terminal VCA domain (or WCA domain) 
named for its three sub-elements, the Verprolin homology (also called WASP homology 
2), Central hydrophobic (previously known as cofilin-homology) and Acidic regions 
(Machesky and Insall, 1998) (reviewed in (Kurisu and Takenawa, 2009)).  
 
 
 
In addition to Class I NPFs, many animals possess a second type of Arp2/3 activator, 
termed Class II activators. This category includes cortactin and the haematopoetic-
specific protein 1 (HS1). These proteins have Arp2/3-binding acidic motifs and 
Figure 1. (A) Model of Arp2/3-dependent actin polymerisation. 1. The WCA domains of 
Class I NPFs, such as N-WASP, recruit the Arp2/3 complex. 2. The collective activities of WCA 
domain serve for bringing Arp2/3 together with the first actin subunit in the new filament to 
generate a 70º branch on the side of a pre-existing filament. 3. Arp2/3 branch points can be 
stabilised by filamentous actin (F-actin)-binding class II NPFs, such as cortactin. 
(Abbreviations used: G-actin, globular actin; W, WASP homology 2 domain; C, central 
hydrophobic region; A, acidic region; R, repeat). (B) Model of formin-mediated actin 
polymerisation. In contrast to the Arp2/3 complex, formins nucleate formation of 
unbranched actin filaments. The formin closed conformation prevents capping by other 
factors. Figure adapted from (Campellone and Welch, 2010). 
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repetitive sequences that interact with F-actin influencing the stability of F-actin branch 
points (Weaver et al., 2001) (Figure 1A). 
 
WASP family proteins 
 
WASP family proteins are categorised into two groups: (1) WASP and N-WASP, and (2) 
three WASP-family verprolin homologue (WAVE; also known as SCAR) isoforms. All of 
them have a modular organisation. WASP and N-WASP present an N-terminal WASP 
homology 1 domain (WH1) followed by a basic region, a GTPase-binding domain (GBD) 
and a proline-rich domain (PRD). In the C-terminus they have the conserved VCA 
domain that directly binds to and activates the Arp2/3 complex.  
 
WASP and N-WASP present an inactive conformation because its VCA region is 
inhibited by intramolecular interactions with the autoinhibitory portion of the GBD (Kim 
et al., 2000; Padrick and Rosen, 2010), and require the interaction with other proteins 
and possibly post-translational modifications to be fully active. Thus, the complex 
regulation of N-WASP implies the interaction of multiple cellular proteins with its GBD 
or PRD domains. For example, the autoinhibition is released by the competitive binding 
of the small GTPase cell division cycle 42 (Cdc42) to the GBD domain. This activation 
mechanism is enhanced by phosphatidylinositol 4,5-biphosphate (PIP2) binding to the 
basic region amino-terminal to the GBD domain that synergises with cdc42 to activate 
WASPs and N-WASPs (Rohatgi et al., 2001). In addition, Src homology 3 (SH3)-domain 
containing proteins such as Nck (Rivero-Lezcano et al., 1995) or Grb2 (She et al., 1997) 
binds to the numerous proline motifs in the PRD and also activates N-WASP by 
destabilising the inhibitory interactions. It is currently thought that the activation of N-
WASP occurs in a cooperative way; therefore WASPs proteins are able to integrate 
multiple signalling inputs that promote their maximal activity. 
 
The inactive conformation is stabilised by the binding of WASP-interacting protein 
(WIP) to WH1 domain of WASP and N-WASP. Although the role of WIP in vivo requires 
further investigations (reviewed in (Noy et al., 2012)), in vitro WIP inhibits N-WASP 
(Martinez-Quiles et al., 2001). 
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2. Cortactin, a cytoskeletal oncoprotein targeted by pathogens 
 
Cortactin was originally described as a substrate of the sarcoma (Src) kinase located 
primarily at the cell cortex (Wu et al., 1991). Almost simultaneously, cortactin was 
cloned as the product of the CTTN gene (formerly EMS1), located in chromosomal 
region 11q13, which is frequently amplified in different human carcinomas (Schuuring 
et al., 1993). Today, cortactin is considered an oncoprotein and a bona fide marker of 
actin-rich protusions of the cell membrane that degrade the extracellular matrix, called 
invadopodia (Weaver, 2008) (Caldieri et al., 2009).  
 
Cortactin is a key regulator of the actin cytoskeleton that participates in many cellular 
functions emerging as an important node in the network regulating the cytoskeleton 
during numerous biological processes (Daly, 2004; Ren et al., 2009). Thus, cortactin is 
involved in several pathogenic processes, such as actin-based motility of Listeria 
monocytogenes, Shigella flexneri and vaccinia virus (Frischknecht and Way, 2001), cell 
scattering induced by Helicobacter pylori (Selbach et al., 2003), invasion of Shigella 
flexneri (Dehio et al., 1995) and others (Neisseria meningitides (Hoffmann et al., 2001), 
Rickettsia conorii (Martinez and Cossart, 2004) etc.) and pedestal formation of 
enteropathogenic E. coli (EPEC) and enterohaemorrhagic E. coli (EHEC) (Cantarelli et al., 
2006). Hence, it was called by our collaborators the Achilles´ heel of the actin 
cytoskeleton targeted by pathogens (Selbach and Backert, 2005).  
 
2.1. Structure of cortactin 
 
Cortactin is composed of several domains. It contains an N-terminal acidic domain 
(NTA) which harbours a 20DDW22 motif that directly binds and activates the Arp2/3 
complex, thereby behaving as a nucleation-promoting factor (NPF) as previously 
mentioned. The NTA domain is followed by six and a half amino acids repeats which 
bind to filamentous actin and define the actin-binding region (ABR) (Weed and 
Parsons, 2001). The ABR is followed by a helical, proline-rich region, and a final C-
terminal SH3 domain (Figure 2). 
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Cortactin only weakly activates the Arp2/3 complex in vitro (Uruno et al., 2001), 
therefore it is unclear whether cortactin requires post-translational modifications to be 
fully active. On the other hand, cortactin and N-WASP can be found as components of 
molecular complexes in cells as first described by (Mizutani et al., 2002). In addition, it 
was demonstrated that in vitro cortactin binds directly to N-WASP through its SH3 
domain and activates it (Martinez-Quiles et al., 2004). Thus, cortactin can promote actin 
nucleation in two different ways, firstly by activating the Arp2/3 complex and secondly 
by activating N-WASP. 
 
Moreover, cortactin binds various proteins through its SH3 domain, such as WIP 
[(Kinley et al., 2003) and (Martinez-Quiles et al., unpublished results)] and Nck 
(Okamura and Resh, 1995) (Figure 2) that are also implicated in actin dynamics. 
 
 
 
Figure 2. Cortactin and its binding partners. Schematic of cortactin domains 
(Abbreviations used: NTA, N-terminal acidic domain; SH3, Src homology 3 domain). Amino 
acids that are essential for the interaction with cortactin binding proteins are shown (W22 in 
the NTA domain and W525 within SH3 domain). Interacting proteins are shown in the same 
colour as the domain on cortactin. Proteins in yellow bind the amino terminus of cortactin. 
The kinases known to phosphorylate cortactin are shown above the respective sites they 
have been shown to phosphorylate. Figure adapted from (Kirkbride et al., 2011). 
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2.2. Regulation of cortactin 
 
The understanding of the regulation of cortactin is far from clear (reviewed in (Ammer 
and Weed, 2008)). Although cortactin has been described as a substrate of Src family 
kinases (Wu et al., 1991), it can also be phosphorylated by other tyrosine kinases such 
as feline sarcoma-related protein (Fer) (Sangrar et al., 2007) and Abelson (Abl)-family 
kinases Abl and Abl-related gene (Arg) (Boyle et al., 2007) (Figure 2). Interestingly, it is 
thought that Src family kinases act upstream of Arg in phosphorylating cortactin 
(Mader et al., 2011). Tyrosine phosphorylation of cortactin by Src occurs at residues 
421, 466 and 482 (Huang et al., 1998) during numerous physiological conditions, such 
as integrin-mediated cell adhesion, fibroblast growth factor (FGF) 1-mediated cell 
migration and others (reviewed in (Lua and Low, 2005)). 
 
The effects of tyrosine phosphorylation on cortactin structure and function remain 
largely unknown. One group described that tyrosine phosphorylation of cortactin 
decreases its F-actin binding and cross-linking activity in vitro (Huang et al., 1997). 
Moreover the binding of cortactin to F-actin is required for cortactin activation of the 
Arp2/3 complex (Weaver et al., 2001). By using tyrosine non-phosphorylatable cortactin 
mutants, it was shown that Src-mediated phosphorylation of cortactin is involved in 
endothelial cell migration (Huang et al., 1998). Similarly, tyrosine phosphorylation of 
cortactin is also required for inducing bone metastasis of breast cancer cells in nude 
mice (Li et al., 2001).  
 
Studies have demonstrated that tyrosine phosphorylation of cortactin is essential for 
generation of free barbed ends to promote actin polymerisation in invadopodia 
(Bowden et al., 1999; Oser et al., 2009) and for efficient extracellular matrix degradation 
(Clark et al., 2007). Moreover, it has been described that the tyrosine kinase Arg 
mediates epidermal growth factor (EGF)–induced cortactin phosphorylation in 
invadopodia, promoting actin polymerisation. Notably, it was suggested that Src 
indirectly regulates the process through Arg activation. Hence, they propose that the 
EGFR–Src–Arg–cortactin pathway is responsible for mediating functional maturation of 
invadopodia and breast cancer cell invasion (Mader et al., 2011).  
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Considering the many molecular complexes that must be formed in vivo, cortactin 
actions are difficult to analyse in vitro. Thus, it was proposed that the tyrosine 
phosphorylation of cortactin promotes the efficient actin polymerisation in vitro by 
facilitating the assembly of an Nck1–N-WASP–WIP–Arp2/3 signalling complex (Tehrani 
et al., 2007). 
 
Hence, tyrosine phosphorylation of cortactin has to be tightly regulated since tyrosine 
phosphorylation-dephosphorylation of cortactin may regulate its ability to form 
complexes with other proteins. In fact, protein phosphatase 1B (PTP-1B) 
dephosphorylates cortactin (Mertins et al., 2008; Stuible et al., 2008), suggesting a 
reversible regulation.  
 
On the other hand, tyrosine-phosphorylated cortactin is involved in bacterial invasion 
of cells. The entry of Shigella flexneri (Dehio et al., 1995) is accompanied by an increase 
in the phosphorylation of cortactin. In contrast, Helicobacter pylori infection induces the 
tyrosine-dephosphorylation of cortactin (Selbach et al., 2003). Many other pathogens 
have been shown to alter the tyrosine phosphorylation of cortactin (reviewed in 
(Selbach and Backert, 2005)).  
 
Cortactin is also the target for serine-threonine kinases, including extracellular signal-
regulated kinase (Erk) that phosphorylates cortactin at serine residues 405 and 418 
(Campbell et al., 1999). The stimulation with epidermal growth factor (EGF) of tumour 
cells leads to phosphorylation of these sites and induces a shift in cortactin 
electrophoretic mobility from 80 kDa to 85 kDa in SDS-PAGE. The member of the p21 
activated kinase family (Pak) 1 also phosphorylates cortactin at residues 405 and 418. In 
addition, Pak3 phosphorylates cortactin at serine residue 113 (Grassart et al., 2010; 
Webb et al., 2006). Phosphorylation of serine residues of cortactin enhances binding of 
the cortactin SH3 domain to N-WASP, stimulating Arp2/3-mediated actin 
polymerisation in vitro (Martinez-Quiles et al., 2004) (see below). 
 
Besides the previously mentioned sites, phosphoproteomic analysis of cortactin has 
revealed numerous new phosphorylation sites, most of which are serines and 
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threonines (Martin et al., 2006). However, the functional implications of these sites need 
to be studied. 
 
Adding another level of complexity to cortactin regulation, studies have shown that the 
protein is also regulated by reversible acetylation. The protein can be acetylated by 
histone acetyltransferase p300/CBP-associated factor (PCAF) and deacetylated mainly 
by Histone Deacetylase 6 (HDAC6) and SIRT1 (Zhang et al., 2007; Zhang et al., 2009). 
Acetylation of lysine residues in the ABR of cortactin was shown to reduce binding to F-
actin, which inhibits cell migration (Zhang et al., 2007). 
 
Our group has recently described a competition between acetylation and tyrosine 
phosphorylation of cortactin and that tyrosine phosphorylation inhibits cell spreading. 
Furthermore, we demonstrated that cell spreading promotes the association of 
cortactin and focal adhesion kinase (FAK) and that tyrosine phosphorylation of cortactin 
disrupts this interaction, which may explain how it inhibits cell spreading (Meiler et al., 
2012). This will be the subject of the Ph.D. dissertation from Eugenia Meiler. In 
accordance with our results it has been demonstrated that focal adhesion (FA) 
remodelling may occur through the formation of a FAK-cortactin complex and cortactin 
tyrosine phosphorylation results in FAK-cortactin complex dissociation associated with 
FA turnover (Tomar et al., 2012). 
 
2.3. Cortactin as a cytoskeletal switch 
 
As previously mentioned, Src kinase targets tyrosine residues 421, 466 and 482 of 
cortactin while Erk phosphorylates serines 405 and 418 (Campbell et al., 1999), which lie 
in a proline rich area. Cortactin promotes actin polymerisation through two pathways: 
directly, by activating the Arp2/3 complex; and indirectly, when the SH3 domain binds 
and activates N-WASP (Martinez-Quiles et al., 2004). The interaction between cortactin 
and N-WASP was studied using in vitro actin polymerisation assays involving both 
phosphomimetic mutants and non-phosphorylatable mutants of cortactin, as well as 
recombinant cortactin phosphorylated in vitro. Erk phosphorylation of cortactin or the 
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double mutation S405,418D in cortactin that mimics this phosphorylation enhance the 
binding and activation of N-WASP. Conversely, Src phosphorylation inhibits the ability 
of both Erk-phosphorylated cortactin and that doubly mutated S405,418D cortactin, to 
activate N-WASP. Furthermore, phospho-mimetic mutation of the three tyrosine 
residues targeted by Src (Y421,Y466, and Y482) inhibited the ability of S405,418D 
cortactin to activate N-WASP. Thus, cortactin binds and activates N-WASP only when 
phosphorylated on serines by Erk, whereas phosphorylation by Src terminates cortactin 
activation of N-WASP, which suggests that phosphorylation indeed affects cortactin 
structure. Based on these studies by the P.I. of our group (Martinez-Quiles et al., 2004) 
and previous studies (Campbell et al., 1999), it was proposed a model in which 
serine/tyrosine phosphorylation of cortactin controls the ability of cortactin to activate 
N-WASP (Figure 3). 
 
 
 
This model was subsequently reviewed by Lua and Low, who renamed it as the ‘S-Y 
Switch’ model (Lua and Low, 2005). Until that moment the study by Campbell and 
colleagues (Campbell et al., 1999) was the sole report on cortactin phosphorylation by 
Erk that was brought to light by the study of Martinez-Quiles et al. Interestingly, the 
Figure 3. Coupled cortactin-N-WASP activation according to the ‘S-Y Switch’ model 
proposed by (Martinez-Quiles et al., 2004). In non-phosphorylated cortactin, the SH3 
domain folds back and binds the repeats region (Cowieson et al., 2008). The phosphorylation 
of serine residues by Erk could interrupt the intramolecular interaction and induce a 
conformational change. This could liberate the SH3 domain for binding N-WASP, which can 
stimulate the activity of the Arp2/3 complex. Phosphorylation on tyrosines residues by Src 
induces another conformational change and the interaction of the cortactin SH3 domain with 
N-WASP is terminated. Taken together, Erk and Src phosphorylation of cortactin might act as 
a ‘switch on/off’ mechanism that controls the activity of cortactin via its ability to bind F-actin 
and activate N-WASP. Figure adapted from (Nieto-Pelegrin et al., 2010). 
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former report was the first one using the expression of phospho-mimetic cortactin 
tyrosine and serine mutants, not only the non-phosphorylatable cortactin forms. 
 
One of the most important prediction of the model is that cortactin can be regulated 
by a conformational change, that would liberate the SH3 domain from intramolecular 
interactions. Soon after the proposal of the model, the structure of unmodified 
cortactin using circular dichroism revealed a closed, globular conformation achieved 
mainly through interactions between the SH3 domain and the ABR region (Cowieson et 
al., 2008). This study is in contrast to the previously described elongated monomeric 
form of cortactin (Weaver et al., 2002). Currently both conformations are accepted to 
exist (reviewed in (Ammer and Weed, 2008)). 
 
As an immediate consequence of the proposal of cortactin mode of regulation and of 
the use of the phospho-mimetic mutants, many studies were carried out to understand 
the functional consequences of serine and tyrosine phosphorylation of cortactin.  
 
Indeed, Kruchten and colleagues proposed that different cortactin phosphoforms have 
distinct cellular functions (Kruchten et al., 2008). In this study, tyrosine-
phosphocortactin mainly regulates FA turnover and leads to stress fiber disassembly, 
whereas serine-phosphocortactin promotes the assembly of branched actin networks. 
More recently, antibodies specific for phospho-serine cortactin have been used to 
study the implications of serine phosphorylation in regulating lamellipodia actin 
dynamics (Kelley et al., 2010). The production of planar protrusive extensions of the 
plasma membrane at the leading edge of the cell named lamellipodia is essential for 
carcinoma cell migration (Small et al., 2002). Lamellipodia extension drives cell 
migration through cycles of actin polymerisation and depolymerisation and cortactin, 
that it is highly enriched in lamellipodia, regulates the actin dynamics in these 
structures (reviewed in (Cosen-Binker and Kapus, 2006)). Kelley and colleagues have 
shown that serine phosphorylation of cortactin is implicated in carcinoma motility and 
adhesion and is also essential for lamellipodial persistence (Kelley et al., 2010).  
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Finally, the importance of studying the different states of cortactin phosphorylation 
during bacterial invasion has been highlighted (Selbach and Backert, 2005). A recent 
study to which our group has contributed has demonstrated the importance of serine 
phosphorylation of cortactin in cell scattering induced by Helicobacter pylori 
(Tegtmeyer et al., 2011). Thus, phosphorylation of cortactin at serine residue 405 is 
required for the interaction of cortactin and FAK whose activity is involved in regulating 
cell adhesion processes. 
 
3. Nck family adaptor proteins 
 
Non-catalytic tyrosine kinases (Nck) 1 and 2 are ubiquitously expressed adaptor 
proteins that regulate a variety of cellular processes linking phosphotyrosine signals to 
actin cytoskeletal reorganisation. Nck1 and Nck2 (collectively termed “Nck”) bind to 
specific phosphotyrosine-containing sites on activated receptors and scaffolds proteins, 
through its SH2 domain, and to proline-rich motifs in downstream effectors, through its 
SH3 domain (Buday et al., 2002). 
 
The two isoproteins possess one SH2 domain and three SH3 domains (Buday et al., 
2002). They represent the prototype of regulatory proteins called adaptors, composed 
of SH2 and SH3 domains separated by linker sequences that act as building blocks to 
assemble multiprotein complexes (Figure 4). SH2 domain recognises targets in a 
phosphotyrosine-dependent manner, binding phosphorylated tyrosine with the 
consensus pTyr-X-X-Pro (where X is any amino acid) (Songyang et al., 1993). SH3 
domains bind to proline-rich sequences (Cicchetti et al., 1992) and also have specific 
preferences for arginine and leucine residues (Yu et al., 1994).  
 
 
Figure 4. Schematic of Nck adaptor proteins. Nck1 and Nck2 are composed of three SH3 
domains followed by one SH2 domain. 
  
 
50 
 
INTRODUCTION 
Nck1 and Nck2 are thought to be functionally redundant in many aspects (Bladt et al., 
2003). Notably, both proteins display 68% identitiy at the amino acid level, and the 
largest differences are mainly located in the linker regions between the interaction 
domains. In like manner, neither Nck1 nor Nck2 knockout mice exhibit an apparent 
phenotype whereas double knockout mice have profound defects in the development 
of mesodermal structures causing embryonic lethality (Bladt et al., 2003). 
 
The SH3 domains of Nck bind many proteins functionally associated with the regulation 
of actin cytoskeleton, including N-WASP (Rivero-Lezcano et al., 1995) and WIP (Anton 
et al., 1998). 
 
Rohatgi and colleagues demostrated that the SH3 domains of Nck stimulate the rate of 
Arp2/3-dependent actin nucleation by purified N-WASP (Rohatgi et al., 2001). Several 
Nck ligands bind to more than one SH3 domain suggesting that a cooperative 
interaction is necessary for the formation of complexes (Wunderlich et al., 1999). 
Accordingly, each SH3 domain can bind and activate N-WASP individually, but their 
native tandem configuration results in cooperative N-WASP activation, leading to high 
levels of actin polymerisation in vitro (Rohatgi et al., 2001). Interestingly, artificially 
clustering of the SH3 domains of Nck at the plasma membrane, using an antibody-
based system, triggers actin polymerisation in cultured cells (Rivera et al., 2004). 
 
The isolated SH2 domain of Nck was shown to bind cortactin in pull-down assays with 
cell lysates (Okamura and Resh, 1995). In addition, the SH2 domain of Nck has been 
shown to associate with activated receptor-tyrosine kinases such as the EGF receptor 
(EGFR), PDGF receptor (PDGFR) and with the Ephrin receptor EphB1. In T lymphocytes, 
Nck mediates a role in the T cell receptor (TCR)-induced reorganisation of the actin 
cytoskeleton and the formation of the immunological synapse (reviewed in (Lettau et 
al., 2009)). Moreover, via binding to phosphorylated transmembrane adhesion protein 
nephrin, Nck promotes the reorganisation of the actin cytoskeleton in protusions 
known as podocytes of kidney epithelial cells (Jones et al., 2006). This signalling 
pathway to induce actin polymerisation targeting Nck, has been hijacked by pathogenic 
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microorganism, such as EPEC and vaccinia virus, which have evolved a similar strategy 
to promote their infection (Frischknecht et al., 1999; Gruenheid et al., 2001). 
 
4. Crk family adaptor proteins 
 
The CT10 regulator of kinase (Crk) protein was originally identified as a product of the 
oncogene v-crk in a CT10 chicken retrovirus system (Mayer et al., 1988a; Mayer et al., 
1988b). v-Crk and its cellular homologous, CrkI, CrkII, and the paralog Crk-like (CrkL) 
are adaptor proteins. CrkII and CrkL consist of one SH2 domain followed by two SH3 
domains while CrkI lacks the carboxyl-terminal SH3 domain (Figure 5) (reviewed in 
(Birge et al., 2009)). CrkI and CrkII are derived from alternative splicing from a single 
gene locus (Matsuda et al., 1992) in chromosome 17p13 (Fioretos et al., 1993), whereas 
the CrkL protein is expressed by a distinct gene in chromosome 22q11 (ten Hoeve et 
al., 1993).   
 
This ubiquitously expressed family of proteins plays an important role in intracellular 
signal transduction integrating signals from a wide variety of sources, including growth 
factors, extracellular matrix molecules and bacterial pathogens. Crk proteins are 
involved in cell spreading, actin reorganisation and cell migration (reviewed in (Birge et 
al., 2009)). In fact, Crk proteins are required for remodelling of actin cytoskeleton 
induced by PDGF and for the formation and turnover of focal adhesions (Antoku and 
Mayer, 2009). Some of the key partners of Crk include the p130 Crk-associated 
substrate (p130Cas) and paxillin, both of which are FA proteins (Birge et al., 1993; Sakai 
et al., 1994). Crk proteins are also dysregulated in several human malignancies 
(reviewed in (Sriram and Birge, 2010)).  
 
CrkL shares high sequence identity with CrkII, and the two proteins have been shown to 
compensate to each having overlapping functions in certain cases. However, several 
studies have demonstrated that they also have distinct physiological roles. In fact, the 
study of knockout mouse models indicates that these proteins have non-overlapping 
roles during embryonic development. Crk knockout mice, which lack both CrkI and 
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CrkII, die perinatally due to defects in cardiac and craniofacial development (Park et al., 
2006). CrkL knockout mice exhibit defects in multiple cranial and cardiac neural crest 
derivatives, and they do not survive embryogenesis. Interestingly, mice homozygous for 
a null mutation of CrkL provide a model for studying the congenital birth defects seen 
in the DiGeorge syndrome (Guris et al., 2001).  
 
4.1. Regulation of Crk proteins 
 
Crk signalling acts through the assembly of protein-protein complexes and requires 
both SH2 and SH3 domains (Matsuda et al., 1991). As mentioned before, SH2 domain 
recognises phosphotyrosine-containing targets. The consensus sequence for the N-
terminal SH3 (designated hereafter as nSH3) domain was determined to be Pro-X-Leu-
Pro-X-Lys (where X is any amino acid) (Wu et al., 1995). In contrast, the C-terminal SH3 
domain (cSH3) of CrkII and CrkL is atypical lacking the binding determinants of 
polyproline type II binding SH3 domains (Muralidharan et al., 2006). Indeed, it is 
thought that the cSH3 domain of CrkII functions as an autoregulatory element 
(Kobashigawa et al., 2007). 
 
Both CrkII and CrkL are regulated by phosphorylation on tyrosine residue Y221 in CrkII 
(or Y207 in CrkL) (Figure 5) via the activity of the tyrosine kinase Abl (de Jong et al., 
1997; Feller et al., 1994). It has been described that the phosphorylation of Y221 in CrkII 
and Y207 in CrkL causes intramolecular binding of the linker region to the SH2 domain, 
preventing SH2 and nSH3 from binding target proteins, determined by the binding 
affinities (Kobashigawa et al., 2007; Rosen et al., 1995). However, a recent nuclear 
magnetic resonance (NMR) spectroscopy study has revealed that the SH2 and SH3 
domains of CrkL are organised in a different architecture from that in CrkII. They 
corroborate that upon phosphorylation of Y207 in CrkL, the linker region interacts with 
the SH2 domain, inhibiting the binding of phosphotyrosine effectors. However, this 
intramolecular interaction has little effect on the nSH3 domain of CrkL, which is fully 
accessible, in contrast to CrkII, when phosphorylation of Y221 results in nSH3 
autoinhibition (Jankowski et al., 2012).  
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The authors also show differences in the assembled structure between the 
unphosphorylated forms of CrkL and CrkII. Moreover, they demonstrate that CrkL forms 
a constitutive complex with Bcr-Abl, the oncogenic kinase that causes chronic 
myelogenous leukaemia (CML), independently of phosphorylation (Colicelli, 2010). In 
contrast, the association of CrkII with the kinase is repressed in various conformational 
states of the protein (Jankowski et al., 2012; Kobashigawa and Inagaki, 2012). Thus, the 
differences in the structural organisation of the two adaptors confer specific functions 
of both proteins. However, CrkL is thought to bind many or all of the same partners of 
CrkII, pointing to overlapping functions of both proteins in certain processes.   
 
The C-terminus of CrkI ends prior to the regulatory Y221 site and lacks the carboxyl-
terminal SH3 domain (Matsuda et al., 1992) (Figure 5). Thus, CrkI signalling cannot be 
regulated by tyrosine phosphorylation (Kobashigawa et al., 2007), a possible 
explanation for the greater transforming activity of this protein (Feller et al., 1994). 
 
 
 
4.2. Crk adaptor proteins contribute to bacterial pathogenesis 
 
Many studies suggest that Crk may contribute to bacterial pathogenesis by 
participating in bacterial internalisation or being a target for bacterial virulence factors.  
 
A role for Crk in bacterial uptake was demonstrated in Yersinia pseudoturbeculosis 
infection into epithelial cells. The binding of Yersinia to β1 integrin receptor initiates a 
Figure 5. Schematic of CrkI, CrkII and CrkL proteins. CrkII and CrkL are composed of one 
SH2 domain followed by two SH3 domains. CrkI lacks the carboxyl-terminal SH3 domain 
(cSH3). Phosphotyrosine residues Y221 in CrkII and Y207 in CrkL are shown. 
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cascade of signalling events involving tyrosine phosphorylation of p130Cas and the 
subsequent formation of p130Cas-Crk complexes (Weidow et al., 2000).  
 
Crk is also involved in Shigella flexneri infection as a target for Abl kinases. Thus, it was 
shown that a phosphorylation-deficient Crk mutant significantly inhibits bacterial 
uptake (Burton et al., 2003). Moreover, in a subsequent study Bougneres et al. 
demonstrated that Shigella uptake promotes the interaction of Crk with tyrosine 
phosphorylated cortactin which was necessary for cortactin-dependent actin 
polymerisation required for bacterial uptake (Bougneres et al., 2004).  
 
A role for Crk as a target for a bacterial factor is exemplified by the interaction of Crk 
with CagA, a major virulence factor from Helicobacter pylori (Suzuki et al., 2005). As 
mentioned before, cortactin phosphorylation is also implicated in H. pylori infection. It 
has been demonstrated that H. pylori induces cortactin tyrosine dephosphorylation in a 
CagA-dependent manner (Selbach et al., 2003) followed by serine phosphorylation in a 
CagA-independent manner (Tegtmeyer et al., 2011). 
 
In the case of enteropathogenic E. coli (EPEC), the focus of our study, is a single report 
where immunofluorescence analysis suggested that CrkII localised to actin pedestals 
induced by EPEC (Goosney et al., 2001) (Figure 6). 
 
 
 
 
Figure 6. Immunofluorescence analysis of CrkII in EPEC pedestal formed in HeLa cells 
infected with EPEC. Right panel represent a merger of Tir (green), CrkII (red), and DAPI-
stained EPEC (blue). Bars, 5 µm. Figure from (Goosney et al., 2001).  
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5. Enteropathogenic Escherichia coli manipulates the actin cytoskeleton 
5.1. Pathogenic Escherichia coli 
 
Escherichia coli was first isolated from the faeces of newborns in 1885 by Theodor 
Escherich and was then named Bacterium coli commune. It was later renamed 
Escherichia coli, and for many years the bacterium was simply considered to be a 
commensal organism of the large intestine. In the 1940s E. coli was characterised as a 
cause of diarrhoea for the first time in United Kingdom, based on epidemiological 
investigations of infantile gastroenteritis outbreaks (Bray, 1945).   
 
E. coli belongs to the large family of enteric bacteria -Enterobacteriacea- which are 
facultatively anaerobic gram-negative rods that live in the intestinal tracts of animals. 
The family Enterobacteriaceae is among the most important bacteria medically having a 
great number of human intestinal pathogens within the family (e.g. Salmonella, 
Shigella, Yersinia). Several others are normal commensal of the human gastrointestinal 
tract (e.g., Klebsiella, Enterobacter, Escherichia) but may occasionally be associated with 
diseases of humans. Thus, several E. coli strains have acquired specific virulence factors, 
which confer abilities to cause a broad range of diseases in human (reviewed in (Kaper 
et al., 2004)).  
 
Pathovar is a group of strains of a single specie defined based on common virulence 
factors and its characteristics of pathogenicity. The various species of E. coli tend to be 
clonal groups that are characterised by shared O (lipopolysaccharide, LPS) and H 
(flagellar) antigens that define serogroups (O antigen only) or serotypes (O and H 
antigens) (Nataro and Kaper, 1998). 
 
Intestinal pathogenic (or diarrhoeagenic) E. coli is categorised into seven pathovars: 
enteropathogenic E. coli (EPEC), enterohaemorrhagic E. coli (EHEC), enterotoxigenic E. 
coli (ETEC), enteroinvasive E. coli (EIEC), enteroaggregative E. coli (EAEC), atypical 
enteropathogenic E. coli (ATEC) and diffusely adhering E. coli (DAEC) (reviewed in 
(Kaper et al., 2004)). In addition, there are other human pathovars, such as adherent 
  
 
56 
 
INTRODUCTION 
invasive E. coli (AIEC) and others not yet well defined, like the novel strain of E. coli 
O104:H4 bacteria that caused a serious outbreak of foodborne illness in northern 
Germany in 2011. EHEC was the first suspected cause of the outbreak, but it was later 
shown that the causative agent was an EAEC strain that had acquired the genes to 
produce Shiga toxins. This fact highlights the high plasticity of the genome of E. coli 
facilitating the emergence of new pathotypes. 
 
5.2.  Enteropathogenic E. coli, an attaching and effacing (A/E) bacterial 
pathogen 
 
The term enteropathogenic E. coli (EPEC) was first used in 1955 to describe strains 
associated with infantile gastroenteritis (Neter, 1955). In 1978, studies with human 
volunteers using the EPEC O127:H6 strain E2348/69 clearly demonstrated the 
pathogenic potential of EPEC. Based on these studies, EPEC E2348/69 became the 
prototype EPEC strain (Levine et al., 1978) and the one used in this study.  
 
Today, EPEC is one of the leading causes of diarrhoea worldwide, contributing to an 
overall burden of two million annual deaths in children in developing countries (Bryce 
et al., 2005). EPEC primarily cause prolonged watery diarrhoea, which is usually self-
limited, but can be chronic, often accompanied by low-grade fever, dehydration and 
vomiting. EPEC is transmitted person-to-person via the fecal-oral route being an 
important agent of water and food contamination. Although this bacterium is not a 
major concern in developed nations, outbreaks of EPEC-related pathogens infections, 
as the one occurred last year in Europe, demonstrate the importance of studying the 
pathogenic mechanisms of this family of bacteria. 
 
EPEC is the prototypic member of a closely related family of pathogens that induce the 
formation of characteristic attaching and effacing (A/E) lesions on the apical surface of 
intestinal epithelial cells. The members of this family of non-invasive extracellular 
pathogens are so called A/E pathogens, and include the human pathogen EHEC and a 
number of animal pathogens such as the mouse-specific Citrobacter rodentium (CR) 
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and rabbit-specific enteropathogenic E. coli (REPEC). Attaching and effacing lesions are 
characterised by a localised loss of epithelium microvilli (Figure 7A), close adherence of 
the bacteria to the host cell membrane and the generation of filamentous (F)-actin-rich 
structures beneath these bacteria called pedestals (Figure 7B and 7C) ((Knutton et al., 
1989), reviewed in (Croxen and Finlay, 2010; Hayward et al., 2006)). 
 
 
 
Pedestal structures are dynamic, promoting bacterial motility along the surface of the 
cultured cells. The dynamic polymerisation and breakdown of F-actin beneath the cell 
surface induced by EPEC permit the movement of the bacteria across the surface of the 
cell and perhaps cell to cell spread (Sanger et al., 1996). Though the biological purpose 
of these pedestals still remains unclear, the ability of EPEC to form pedestals has been 
correlated with the extent of the diarrhoea that was induced in human volunteers 
(Donnenberg et al., 1993a). In addition, the disruption of genes critical for the 
formation of these structures, such as genes that encode bacterial proteins intimin and 
the translocated intimin receptor (Tir), has been shown to diminish colonisation and 
disease in experimental animals (Donnenberg et al., 1993b; Marches et al., 2000; 
Schauer and Falkow, 1993; Tzipori et al., 1995).  
 
The pedestals may provide an advantage for EPEC growth and residence inside the 
intestine, by allowing the bacteria to remain attached to the epithelium during 
Figure 7. (A) Scanning electron micrograph (SEM) of extensive loss of microvilli of Caco-2 
cell surface around EPEC infection site (taken from (Dean et al., 2006)). (B) SEM of pedestals 
formed by EPEC on the surface of HeLa cells (taken from (Finlay and Cossart, 1997)). (C) 
Immunofluorescence image of pedestals formed by EPEC on murine embryonic fibroblast. 
Actin is stained with TRITC-phalloidin (in red) and bacteria and cell nuclei are stained with 
DAPI (in blue). 
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peristalsis and during the host response to infection (Hecht, 1999). An additional view is 
that pedestals formation is an antiphagocytosis mechanism. The authors Darkoh and 
DuPont have proposed, based on recent results (Lin et al., 2011), that internalisation is 
blocked by hijacking the host endocytosis-associated proteins to remain extracellular 
and to avoid the host defense mechanism (Darkoh and Dupont, 2011). These and other 
hypotheses await future experimental work. 
 
5.3. The locus of enterocyte effacement (LEE) 
 
Pathogenic bacteria have large clusters of virulence genes called pathogenicity islands 
integrated in the chromosome. Hence, the capacity for A/E lesions formation is 
encoded mainly on the 35 Kb-pathogenicity island termed the locus of enterocyte 
effacement (LEE) that was identified in 1995. The overall organisation and the gene 
content of the LEE are highly conserved among different A/E pathogens (McDaniel et 
al., 1995).  
 
The regulation of LEE gene expression is complex, controlled through complicated 
regulatory cascades involving quorum sensing, host and environmental factors and 
several regulators (Hughes and Sperandio, 2008). The LEE contains 41 genes, most of 
which are organised in 5 operons that encode (Figure 8):  
 
 The outer membrane adhesin, intimin (Jerse et al., 1990). 
 Structural components of the type III secretion system (TTSS) (Jarvis et al., 1995).  
 Several secreted proteins, including the translocated intimin receptor (Tir) 
(Kenny et al., 1997), secreted translocators (Elliott et al., 1999) and 
transcriptional regulators (Elliott et al., 2000). 
 Type-III specific chaperones (Abe et al., 1999). 
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5.3.1. Intimin 
The outer membrane adhesin intimin, encoded by the LEE-eae gene, is essential for 
colonisation by A/E pathogens (Donnenberg et al., 1993a; Ritchie et al., 2003). The 
principal function of intimin is to interact with the extracellular region of Tir protein that 
is exposed on the surface of the cell. In this way, the bacteria inject its own receptor to 
achieve a “lock and key” adhesion mechanism. 
 
The N-terminus of the protein promotes intimin localisation in the bacterial outer 
membrane, forming a β-barrel-like structure, and mediates dimerisation (Touze et al., 
2004) (see figure 10 in section 5.5), whereas the intimin C-terminus interacts with 
receptors in the host cell plasma membrane (Batchelor et al., 2000; Frankel et al., 1995).  
 
It has been postulated that in addition to binding Tir, intimin can bind one or more 
host receptors to promote bacterial adhesion. On the other hand, results also suggest 
the contribution of intimin to the disruption of epithelial barrier function (Dean and 
Kenny, 2004). The epithelial barrier is achieved by cell–cell contact through the tight 
junctions. Tight junctions are dynamic structures composed of many different proteins, 
which enable regulation of this intestinal barrier function. Disruption of tight junction 
integrity enhances the diarrhoea phenotype and, accordingly, is a mechanism used by 
several bacteria (Balkovetz and Katz, 2003). 
 
5.3.2. Type III Secretion System (TTSS) 
EPEC modulates cell traits by translocating proteins directly into the interior of host 
cells through the type III secretion system (TTSS). The TTSS is found among gram-
Figure 8. Diagram of the genetic organization of the locus of enterocyte effacement 
region (LEE). This image has been reproduced from (Wong et al., 2011). 
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negative bacteria and is responsible for the transport of proteins, termed effectors, into 
the host cell cytoplasm. The bacterial effectors modify signalling pathways within the 
host cell contributing to the pathogenicity of EPEC.  
 
The TTSS is a multiprotein apparatus assembled from the products of approximately 20 
genes. Most of these 20 structural components are highly conserved among several 
pathogens and are also evolutionarily related to proteins of the flagellar system 
(reviewed in (Cornelis, 2006)). The TTSS apparatus of A/E pathogens is made up of a 
needle complex (NC, composed of a basal body that spans the inner and outer 
membranes and a needle that projects from the bacterial surface) and a filamentous 
extension of the NC that interacts with the host cell plasma membrane (reviewed in 
(Garmendia et al., 2005)) (Figure 9).  
 
Figure 9. Schematic representation of the EPEC type III secretion system (TTSS). The 
basal body of the TTSS is mainly composed of EscC and EscV, and the EscJ lipoprotein that 
spans the periplasm forming a cylindrical structure. EscF constitutes a short needle structure 
that forms a projection channel that is extended by a long filament formed by EspA subunits. 
EspA filament is a hollow tube through which proteins are delivered form the bacteria to the 
cell being also an important adhesion factor. The translocator proteins EspB and EspD form 
the pore in the host cell plasma membrane, connecting the bacteria with the cell. The 
cytoplasmic ATPase EscN provides the energy to the system by hydrolysing ATP into ADP. 
The functional switch from secreting components of the translocator apparatus (EspA, B and 
D) to secreting effector proteins is regulated by two proteins, SepD and L, which sense 
environmental conditions, such as Ca
+2
 concentration. Image from (Garmendia et al., 2005). 
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5.3.3. LEE effectors 
Historically, the LEE effectors were the first to be identified and until now a total of 
seven proteins delivered into the host cell have been characterised, namely Tir, Map, 
EspF, EspG, EspZ, EspH and EspB. More recently, many effectors encoded outside the 
LEE region, which utilise the TTSS for delivery into host cells, have been found and 
recent functional studies on these “non-LEE” effectors have started to ascribe cellular 
functions to these proteins. Although the list of known type III secreted effectors 
proteins continues to expand, currently EPEC is predicted to encode 21 effector 
proteins (Iguchi et al., 2009). 
 
5.4. The four-stage model for EPEC lesion formation 
 
The pathogenesis of EPEC infection has been proposed to occur in four different stages 
(Donnenberg et al., 1997; Nougayrede et al., 2003). In the first step, EPEC adheres non-
intimately to the host epithelium in discrete microcolonies, the so-called localised-
adherence (LA) phenotype that is mediated by the fimbriae named “bundle-forming 
pili” (BFP). Apart of BFP, this first stage of adherence is supported by multiple other 
adhesins, including the fimbrial E. coli common pilus, flagella and the EspA filament and 
intimin (reviewed in (Humphries and Armstrong, 2010)).  
 
In the second stage, EPEC injects Tir and others effector proteins into the host cells via 
the TTSS. These effector proteins induce cytoskeletal restructuring leading to 
depolymerisation of the apical host cell actin cytoskeleton and the effacing of the 
epithelium microvilli. Tir is modified by the action of host kinases and inserted into the 
membrane.  
 
In the third stage, following effector translocation, EspA filaments and the type III 
secretion organelles are eliminated from the bacteria cell surface. This is necessary for 
the intimate attachment to the host cell through intimin-Tir interactions (Frankel et al., 
1998; Knutton et al., 1998).  
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The fourth and final step involves the intimate adherence of EPEC and the massive 
accumulation of cytoskeletal proteins at the site of bacterial attachment resulting in the 
actin polymerisation and formation of the pedestal-like structure. 
 
5.5. Translocated intimin receptor (Tir) 
 
Translocated intimin receptor (Tir) is the most studied and the best characterised LEE 
effector. Tir contains two transmembrane domains and upon injection is inserted in the 
plasma membrane in a hairpin-loop conformation, with both its C and N termini 
located within the host cell and the region between the two transmembrane domains 
forming an extracellular loop (Figure 10).  
 
The extracellular portion of Tir is exposed on the surface of the cell and interacts with 
intimin (Kenny, 1999). Intimin forms a dimer within the bacterial outer membrane 
(Touze et al., 2004), as occurs with Tir in the plasma membrane (Luo et al., 2000). Each 
of the two Tir-binding domains of the intimin dimer interacts with Tir molecules of 
different Tir dimers (Figure 10). This binding pattern generates a reticular conformation 
resulting in the clustering of Tir in the plasma membrane beneath adherent bacteria. 
The interaction between intimin and Tir appears to trigger downstream signalling 
events leading to the formation of actin-rich pedestals (Kenny and Finlay, 1997) in a 
manner dependent on Tir tyrosine phosphorylation (Kenny et al., 1997). However, 
tyrosine phosphorylation of Tir occurs in cells infected with an EPEC strain lacking 
intimin (Kenny and Finlay, 1997) (Kenny et al., 1997). Hence, is not clear whether the 
phosphorylation of Tir is directly related to intimin–Tir interaction (reviewed in (Frankel 
et al., 1998)). 
 
The currently accepted major pathway for actin polymerisation in EPEC pedestals takes 
place as follows. Tir becomes phosphorylated on tyrosine residue 474 (Y474) within the 
C-terminal cytoplasmic domain (Kenny, 1999) by redundant mammalian tyrosine 
kinases including c-Fyn (Phillips et al., 2004), Abl, Arg and epithelial and endothelial 
tyrosine kinase (Etk) (Swimm et al., 2004a). This phosphotyrosine is the binding site for 
  
63 
 
INTRODUCTION 
the SH2 domain-containing host cell adaptor proteins Nck1 and Nck2 (hereafter 
referred to collectively as Nck) (Gruenheid et al., 2001). Nck in turns recruits N-WASP, 
which initiates actin polymerisation by binding and activating the Arp2/3 complex 
(Kalman et al., 1999; Lommel et al., 2001) (Figure 10).  
 
 
 
Although the predominant site of tyrosine phosphorylation is Y474, a second tyrosine 
residue Y454 can also be phosphorylated. This residue Y454 forms part of a conserved 
Asn-Pro-Tyr (NPY) motif (Campellone and Leong, 2005), which has been recently 
demostrated to recruit the insulin receptor tyrosine kinase substrate p53 (IRSp53) 
(Weiss et al., 2009) and insulin receptor tyrosine kinase substrate (IRTKS, a homologue 
of IRSp53) (Vingadassalom et al., 2009), promoting weak Nck-independent actin 
polymerisation.  
Figure 10. Major pathway for actin polymerisation in EPEC pedestals. Intimin (in green) 
is localised in the bacterial outer membrane (OM). Tir (in red) is shown as a dimer inserted in 
the host plasma membrane (PM). Tir is composed of the extracellular intimin binding domain 
(IBD) and the two transmembrane (TM) domains. The model for intimin-Tir interaction is 
adapted from (Luo et al., 2000; Touze et al., 2004). The phosphorylation of Tir in Y474 by host 
kinases recruits the adaptor protein Nck that activates N-WASP, which initiates actin 
polymerisation mediated by the Arp2/3 complex.  
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In addition, the bacterial effector Tir is also phosphorylated at serine residues S434 and 
S463 by a host cell kinase (Warawa and Kenny, 2001)(see below) and has intimin-
independent functionality (Dean et al., 2010; Ruchaud-Sparagano et al., 2011). 
 
Phosphorylation of Tir 
 
As mentioned before, tyrosine phosphorylation of Tir by host cell tyrosine kinases 
represents a crucial step leading to actin polymerisation and pedestal formation 
(Kenny, 1999). The identity of the cell kinases implicated in this process has been 
controversial. The Src-family tyrosine kinase c-Fyn has been reported to associate 
transiently with Tir within minutes of Tir clustering (Phillips et al., 2004). However, 
evidences suggest that c-Fyn is not sufficient for pedestal formation (Swimm et al., 
2004a; Swimm et al., 2004b).  
 
Interestingly, the Abl-family kinases Abl and Arg, and the Tec-family kinase Etk have 
also been shown to phosphorylate Tir (Bommarius et al., 2007; Swimm et al., 2004a). 
Unlike c-Fyn, these kinases appear to endure in the pedestal as a result of their ability 
to associate with an N-terminal proline-rich peptide of Tir using their SH3 domains 
(Bommarius et al., 2007). Collectively, these studies suggest a molecular mechanism 
that helps to maintain long-term Tir signalling by ensuring that it is persistently 
phosphorylated.  
 
The bacterial effector Tir is also phosphorylated at serine residues that are also required 
for efficient pedestal formation. The phosphorylation at serine residues of Tir in vitro 
has been linked to the observed shift in the apparent molecular mass of the protein 
(Kenny, 2001; Kenny and Finlay, 1997). This shift can be mimicked by in vitro protein 
kinase A (PKA)-mediated phosphorylation of two serine residues, 434 and 463 (Warawa 
and Kenny, 2001).  It has been proposed that these serine residues may induce changes 
in the three-dimensional structure of Tir. These changes might aid additional kinase-
dependent modification and/or promote Tir insertion into the plasma membrane (Race 
et al., 2007; Warawa and Kenny, 2001).  
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Co-infections experiments with H.pylori and EPEC demonstrated a function for protein 
kinase A (PKA)-mediated phosphorylation of Tir at serine residues 434 and 463. It was 
shown that EPEC infection activates PKA which phosphorylates the Rho GTPase 
member Rac1 inactivating it. The authors proposed that the phosphorylation of Rac1 by 
PKA during EPEC infection could contribute to the formation of A/E lesions and 
subsequently disruption of epithelial cell-cell interactions (Brandt et al., 2009). 
 
5.6. Nck-mediated actin assembly stimulated by Tir 
 
Once clustered and phosphorylated, a 12-residue Tir peptide that harbours the tyrosine 
residue Y474, binds to Nck (Campellone et al., 2004a; Gruenheid et al., 2001). In 
addition, Tir is phosphorylated to a lesser extent at tryosine residue Y454 (Campellone 
and Leong, 2005).  
 
Nck is crucial for recruiting N-WASP whose localisation diminishes drastically in the 
absence of this protein (Gruenheid et al., 2001). Although Nck binds directly to the PRD 
domain of N-WASP through it SH3 domain (Rohatgi et al., 2001), it is not completely 
clear whether N-WASP is recruited to Tir via direct binding of Nck to N-WASP or 
indirectly through another cell host protein. Lommel and colleagues observed that the 
PRD of N-WASP is dispensable, while the WASP-homology 1 (WH1) domain of N-
WASP is essential for EPEC pedestal formation (Lommel et al., 2001). However, recently 
it has been demonstrated that both PRD domain and WH1 domain are important 
regions for pedestal formation (Wong et al., 2012).  
 
N-WASP is absolutely required for actin pedestal formation by EPEC, as demostrated by 
the absence of pedestal formation on N-WASP-deficient murine embryonic fibroblasts 
(Lommel et al., 2001). The genetically modified murine fibroblast-like cells (FLCs) that 
lack N-WASP (Snapper et al., 2001) used in the present study, have been also assessed 
for the deficiency of EPEC-induced pedestals (Mousnier et al., 2008; Vingadassalom et 
al., 2010). The required role of N-WASP in pedestal formation lies in its ability to 
promote the actin nucleation activity of the Arp2/3 complex.  
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Moreover, the clustering of Tir in the host cell membrane initiates the recruitment of a 
large number of cytoskeletal-related proteins. These proteins include focal adhesion (α-
actinin, vinculin, talin and ezrin), cytoskeletal (actin and cytokeratins 8 and 18) (reviewed 
in (Caron et al., 2006)), endocytic (dynamin 2, clathrin, adaptor protein-2, epsin1 and 
Eps15) (reviewed in (Darkoh and Dupont, 2011)) and actin assembly-regulating proteins 
that include cortactin (Cantarelli et al., 2000), apart from the two previously mentioned 
N-WASP and the Arp2/3 complex.  
 
5.7. Nck-independent functions of Tir 
 
Several activities of Tir aside from Nck recruitment might modulate actin pedestal 
formation. In like manner, the N-terminus of Tir can interact with the SH3 domain of 
tyrosine kinases (Bommarius et al., 2007). In addition, the second phosphotyrosine Y454 
of Tir stimulates low levels of actin assembly independent of Y474 and Nck recruitment 
(Campellone and Leong, 2005). The mutation of tyrosine residue 474 results in an 
approximately 95% reduction in the frequency of pedestal formation, establishing the 
signalling pathway Y474:Nck:N-WASP as the primary mechanism by which EPEC 
triggers actin assembly in cultured cells (reviewed in (Hayward et al., 2006)).  
 
Interestingly, the phosphotyrosine 454 was recently shown to bind to the SH3 domain 
of phosphoinositide 3-kinase (PI3K) (Sason et al., 2009). In addition, there is increasing 
evidence that additional Tir residues can coordinate actin signalling pathways 
modulated by phosphoinositide metabolism (Sason et al., 2009; Selbach et al., 2009). As 
mentioned before, the tyrosine residue 454 is also involved in the recruitment of  
IRSp53/IRTKS (Vingadassalom et al., 2009; Weiss et al., 2009), promoting weak Nck-
independent actin polymerisation.  
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5.8. Contribution of cortactin to pedestal formation by EPEC 
 
At the start point of our study it was known that cortactin localises to actin pedestals 
induced by EPEC (Cantarelli et al., 2000) and that the overexpression of a truncated 
form of cortactin that lacks the NTA domain blocks pedestal formation (Cantarelli et al., 
2002). Furthermore, it was also shown by immunoprecipitations assays that complexes 
of Tir contain cortactin (Cantarelli et al., 2002). However, the direct interaction between 
Tir and cortactin was not demonstrated since it could be mediated by others proteins, 
such as N-WASP. In conclusion, although it was clear that cortactin could play an 
important role in pedestal actin dynamics, the underlying mechanism was not well 
understood.  
 
5.9. Formation of pedestals by enterohaemorrhagic E. coli (EHEC) 
 
Enterohaemorrhagic E. coli (EHEC) is a A/E pathogen that causes bloody diarrhoea, 
haemorrhagic colitis and haemolytic uremic syndrome. EHEC generates pedestals by a 
mechanism distinct from EPEC, because TirEHEC does not recruit or require Nck for actin 
assembly (Gruenheid et al., 2001) and is not tyrosine phosphorylated (Deibel et al., 
1998; DeVinney et al., 1999; Kenny, 1999). Instead, utilises the conserved Asn-Pro-Tyr 
(NPY458) motif to recruit the host factors IRSp53 and IRTKS. These two factors are 
members of the inverse Bin-amphiphysin-Rvs167 (I-BAR) family, a group of proteins 
that possesses an I-BAR domain that binds membranes to induce membrane 
protrusion, and contains also an SH3 domain (reviewed in (Scita et al., 2008)).  
 
EHEC requires a second translocated effector, EspFu (also known as Tir cytoskeleton 
coupling protein, Tccp) (Campellone et al., 2004b; Garmendia et al., 2004), which 
contains multiple almost identical 47-amino-acid proline-rich repeats that bind 
IRTKS/IRSp53 (Vingadassalom et al., 2009) and the GBD of N-WASP (Campellone et al., 
2004b; Garmendia et al., 2004). Rather than mimicking cdc42 activation, each EspFu 
repeat mimics an auto-inhibitory element within the GBD, thus competitively binding to 
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the GBD to relieve N-WASP autoinhibition, triggering actin polymerisation via the 
Arp2/3 complex (Cheng et al., 2008; Sallee et al., 2008).  
 
Notably, IRTKS/IRSp53 might have additional functions in actin pedestal formation as I-
BAR domains may be important for deforming the membrane during pedestal 
protusion. 
 
5.10. Role of Tir:Nck and Tir:IRTKS/IRSp53 signalling pathways in vivo 
 
Tir is essential for A/E lesion formation on mucosal surfaces, and in vitro cultured cells 
appear to be a selective pressure for the preservation of the Tir Y474 or Y454 signalling 
pathways responsible for actin polymerisation. However, neither the Tir:Nck nor 
Tir:IRTKS/IRSp53 signalling complexes are necessary for A/E lesion formation or N-
WASP recruitment during Citrobacter rodentium (CR) infection of mice (Crepin et al., 
2010) or EPEC infection of human intestinal in vitro organ cultures (IVOC)(Crepin et al., 
2010; Schuller et al., 2007). Although not essential, Tir residues Y454 (Y451 in CR) and 
Y474 (Y471 in CR) play an important role, and these signalling pathways provide the 
bacterium with competitive advantage and fitness in vivo (Crepin et al., 2010).  
 
Cortactin is recruited to the sites of EHEC bacterial adhesion in human IVOC via an 
EspFu- and N-WASP-independent pathway, in contrast to the EspFu dependent 
recruitment of cortactin in cultured cells (Mousnier et al., 2008). These results indicate 
that cortactin might have a more influential role during EHEC infection of mucosal 
surfaces than of cultured cells in vitro, and its role in mediating A/E lesion formation 
needs further investigation. 
 
Collectively, all these data are suggestive of important signalling differences between in 
vitro and in vivo conditions. 
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5.11. Other LEE-effectors 
 
Map (mitochondrial-associated protein) is targeted to the mitochondria where it 
disrupts the mitochondrial membrane potential, triggering mitochondrial damage 
(Kenny and Jepson, 2000). At the initial stages of EPEC infection, Map induces the 
formation of finger-like protrusive structures that contain actin bundles called filopodia 
at the bacterial attachment sites (Kenny and Jepson, 2000). Moreover, Map is essential 
for disruption of intestinal barrier function and alteration of tight junctions, and 
inactivates the sodium-dependent glucose co-transporter 1 (SGTL-1) affecting 
enterocyte fluid uptake (Dean and Kenny, 2004; Dean et al., 2006).  
 
EspH represses the formation of filopodia and is involved in promoting the formation 
and elongation of actin pedestals (Tu et al., 2003). Recently, it has been demonstrated 
that EspH promotes the recruitment of N-WASP and the Arp2/3 complex 
independently of the Tir:Nck and Tir:IRTKS/IRSp53 signalling pathways (Wong et al., 
2012). On the other hand, EspH blocks the activation of Rho GTPases by inactivating 
endogenous Rho guanine exchange factors (GEFs) to inhibit phagocytosis (Dong et al., 
2010).  
 
EspB is a translocon component that spans the cytoplasmic membranes of host cells to 
form pores through which effectors are translocated (Wolff et al., 1998). In addition, 
EspB has an effector activity. Cytosolic EspB localises to the region of bacterial 
attachment (Taylor et al., 1998), and when expressed in host cells, EspB induces a 
dramatic loss of actin stress fibers altering the morphology of the cells (Taylor et al., 
1999). EspB binds to myosin inhibiting its function and facilitates microvillus effacing 
and antiphagocytosis (Iizumi et al., 2007).  
 
EspZ promotes cell survival and the maintenance of the epithelium and it has been 
identified as essential for virulence of the murine A/E pathogen CR (Deng et al., 2004; 
Kanack et al., 2005). Moreover, EspZ localises to host mitochondria and its role may be 
to stabilise the epithelium during bacterial colonisation, thereby reducing the cytotoxic 
effect of the infection (Shames et al., 2010). Thus, EspZ and the anti-apoptotic non-LEE 
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effector H (NleH) (Hemrajani et al., 2010), would promote cell adherence and epithelial 
integrity.  
 
The two effectors EspG and EspG2 (EspG2 is encoded outside of the LEE) belong to a 
class of proteins involved in microtubule network disruption underneath adherent 
bacteria during EPEC infection (Hardwidge et al., 2005; Matsuzawa et al., 2004). 
However, it has been recently described that EspG appears to possess a dual function 
where it forms a GTPase-kinase signalling complex with ADP-ribosylation factor (ARF) 
GTPases ARF1 and 6 and Pak family members. EspG inhibits GTPase signalling and 
stimulates PAK being a regulator of endomembrane trafficking (Germane and Spiller, 
2011; Selyunin et al., 2011). Moreover, EspG and EspG2 induce a detaching phenotype 
in host cell by activating the host cysteine protease calpain, process that is maintained 
in check by Tir protein (Dean et al., 2010).  
 
EspF is a proline-rich effector protein that have the greatest number of reported 
functions among the A/E pathogens effectors known (reviewed in (Holmes et al., 2010)). 
EspF plays a role in antiphagocytosis and mitochondrial disruption, induces tight 
junction breakdown and promotes degradation of anti-apoptotic proteins playing a 
direct role in apoptosis (McNamara et al., 2001; Nougayrede and Donnenberg, 2004). 
Moreover, EspF coordinates membrane remodelling and F-actin polymerisation by 
binding to the SH3 domain of the host protein sorting nexin 9 (SNX9). In addition, EspF 
binds to the Cdc42/Rac-interactive binding (CRIB) domain of N-WASP contributing to 
its activation (Alto et al., 2007). 
 
5.12. Type III secretion chaperones 
 
The efficient secretion and translocation of many secreted proteins is often dependent 
of a specific family of type III chaperones (Hueck, 1998; Wattiau et al., 1996). A typical 
effector contains two regions required for its translocation: the N-terminal signal 
domain (NSD) and the chaperone-binding domain (CBD) (reviewed in (Ghosh, 2004)). 
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Chaperones are low molecular mass proteins, cytosolic or membrane-associated, that 
bind to the N-terminal CBD of effectors and remain in the bacterial cell following 
translocation of effectors into the host cell. Many chaperones show structural similarity, 
even in the absence of primary sequence homology (Delahay and Frankel, 2002; 
Wattiau et al., 1996). Chaperones promote translocation by stabilising the effectors, 
maintaining them in a secretion-competent conformation, and by targeting the bound 
effector to the TTSS (summarised in (Ghosh, 2004)). The effector-chaperone interaction 
is required for efficient translocation.  
 
Two classes of TTS chaperones have been distinguished according to whether they 
associate with a single effector (class I) or two translocators (class II). Class I is 
subdivided on the basis if the chaperone binds one effector (class IA) or several 
effectors (class IB) (Parsot et al., 2003). In the case of EPEC, five TTS chaperones have 
been identified. One example is CesT, a class IA chaperone that binds and enhances the 
translocation of Tir and Map (Creasey et al., 2003; Elliott et al., 1999) and probably also 
influences the translocation of EspH, EspZ, and some non-LEE efectors (Thomas et al., 
2005). One class IB chaperone is CesF, which binds to EspF and enhances its 
translocation (Elliott et al., 2002).  
 
5.13. Non-LEE effectors 
 
The effector repertoire of A/E pathogens is much larger than previously thought as it is 
not restricted to LEE-encoded proteins, however EPEC appears to have a much smaller 
non-LEE effector repertoire than its related pathogen EHEC. The non-LEE effector genes 
are clustered in six pathogenicity islands. Due to the more recently discovery of non-
LEE effectors (Nle), their cellular functions are beginning to be elucidated. NleA is 
reported to inhibit protein secretion and tight-junction disruption (Kim et al., 2007; 
Thanabalasuriar et al., 2010), EspJ inhibits phagocytosis (Marches et al., 2008), whilst 
NleE and NleH activate innate inmune responses (Hemrajani et al., 2008; Zurawski et al., 
2008). The antagonism of pro-apoptotic effects by EPEC is mediated by the 
translocation of a set of anti-apoptotic effectors such as NleH1/2 and NleD. NleD may 
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complement the activities of NleH to promote overall cell survival protecting infected 
cells form the activation of pro-death pathways. The concerted activity of the effectors 
NleE, NleB, NleC, NleD and NleH, prevents host cells from mounting an effective 
inflammatory respone (reviewed in (Wong et al., 2011)).  
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OBJECTIVES 
Our first goal was to determine the contribution of the protein cortactin in the actin 
polymerisation process during pedestal formation by enteropathogenic E. coli (EPEC). 
This aim takes into account the new prism of the ‘S-Y Switch’ model for regulation of 
cortactin, that proposes that serine and tyrosine phosphorylation modulates cortactin 
activity in vitro. The knowledge over the contribution of cortactin to pedestal formation 
at the start point of the thesis was solely based on the publications of one group. In 
2000, Cantarelli and colleagues demonstrated by confocal microscopy studies, that 
cortactin is accumulated at the sites of EPEC infection in cultured HeLa cells (Cantarelli 
et al., 2000). In 2002, the same group reported that the overexpression of a truncated 
form of cortactin lacking the NTA domain blocks pedestal formation suggesting that 
cortactin was necessary for pedestal formation. Furthermore, they also showed by 
immunoprecipitation assays that complexes of Tir contain cortactin (Cantarelli et al., 
2002). Based on these data our initial hypothesis was that cortactin plays a role in 
the Tir:Nck:NWASP signalling pathway for actin polymerisation in pedestal 
formation by EPEC. 
 
EPEC recruits a large number of host cell proteins although their specific function in the 
process of pedestal formation has not been yet clarified. That it is the case for the 
adaptor protein Crk, which despite being localised in EPEC pedestals (Goosney et al., 
2001), its function is completely unknown. Moreover, it was shown that Crk is involved 
in Shigella entry by interacting with tyrosine phosphorylated cortactin, which is 
necessary for cortactin-dependent actin polymerisation required for bacterial uptake. 
Taking into consideration the former data, we intended to investigate the role of Crk 
during pedestal formation by EPEC aiming to understand the significance of its 
EPEC-induced recruitment.  
 
Murine embryonic fibroblasts that lack Nck were used as basis to study the role of 
cortactin in EPEC-induced pedestal formation. Our experimental results demonstrated 
that unexpectedly reduced amounts of the bacterial effector Tir were present in 
Nck-deficient infected cells. Due to the importance of Tir:Nck:N-WASP pathway in 
actin polymerisation by EPEC, we decided to study in depth this phenomenon.  
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OBJECTIVES 
 
Part I 
 
 Study the role of cortactin and its regulation by protein kinases Erk and Src in 
pedestal formation induced by enteropathogenic Escherichia coli. 
 Analysis of the contribution of cortactin to the activation of Arp2/3-mediated 
polymerisation in pedestals. 
 
 
Part II 
 
 Analysis of the role of the host adaptor proteins Crk in pedestal formation 
induced by enteropathogenic Escherichia coli. 
 
 
Part III 
 
 Study of the role of the host adaptor protein Nck in the injection or stability of 
the bacterial effector protein Tir. 
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MATERIALS AND METHODS 
 
1. Cell culture 
 
The human cervical epithelial cancer cell line HeLa was obtained from American Type 
Culture Collection (ATCC). Wild type (WT) mouse embryonic fibroblasts (MEFs), N-
WASP-deficient MEFs and N-WASP-deficient MEFs that were retrovirally reconstituted 
with N-WASP (Rescued N-WASP) (Snapper et al., 2001) were obtained from Dr. Scott B. 
Snapper (Massachusetts General Hospital, Boston, USA). Nck1/2-deficient MEFs and 
Nck1/2-deficient MEFs that were retrovirally reconstituted with EGFP-Myc-tagged Nck1 
vector (Rescued Nck) (Bladt et al., 2003) were obtained from Dr. Tony Pawson (Mount 
Sinai Hospital, Toronto, Canada). CrkI/II-deficient MEFs and the corresponding WT 
MEFs (Park et al., 2006) were obtained from Dr. Thomas Curran (The Children's Hospital 
of Philadelphia, Pennsylvania, USA). CrkL-deficient MEFs, the corresponding WT MEFs 
and CrkL-deficient MEFs reconstituted with CrkL (Guris et al., 2001) were obtained from 
Dr. Akira Imamoto (The University of Chicago, USA). Calpain 4-deficient MEFs, Calpain 
4-deficient MEFs that were transduced with lentiviruses encoding calpain 4 and the 
corresponding WT MEFs (Tan et al., 2006) were obtained from Dr. Peter Greer (Queen´s 
University. Ontario. Canada). 
All cell lines were maintained in Iscove´s Modified Dulbecco´s medium (IMDM, 
Invitrogen) supplemented with 10% heat-inactivated foetal bovine serum (FBS, Lonza 
BioWhittaker, FisherScientific), antibiotics (penicillin 100 U/ml and streptomycin 100 
µg/ml, Invitrogen) at 37 ºC in a humidified atmosphere with 5% CO2. Cell lines were 
routinely subcultured twice a week by detaching the monolayer with 0.25% trypsin-
0.03% ethylenediaminetetraacetic acid (EDTA) solution. The cell passage was recorded 
and cells were discarded after about 25 passages. Frozen cell stocks were stored in 
liquid nitrogen using a freezing solution containing 20% of dimethyl sulfoxide (DMSO) 
as a cryoprotectant. 
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2. Bacterial strains 
 
Strains used in this study were E. coli BL21 (DE3) (Genotype: hsdS, gal (λcIts857 ind1 
Sam7 nin5 lacUV5-T7 gene 1); E. coli DH5α (Genotype: supE44 ΔlacU169 
(Φ80lacZΔM15) hsdR17 recA1 endA1 gyrA96 thi-1 relA1).  
Enteropathogenic E. coli strains used were WT EPEC 0127:H6 strain E2348/69 (Levine et 
al., 1978) (provided by Dr. Brett B. Finlay. University of British Columbia, Vancouver, 
Canada), Δtir mutant (strain E2348/69 with in frame deletion within tir gene (Kenny et 
al., 1997) and the Δeae (intimin) mutant CVD206 (Donnenberg and Kaper, 1991) that 
were provided by Dr. Brendan Kenny (University of Newcastle. Newcastle-upon-Tyne. 
England). Δeae and Δtir mutant were nalidixic acid-resistant strains. All strains were 
cultured in Luria-Bertani (LB) broth at 37 ºC with shaking at 200 r.p.m. 
 
3. Molecular methods 
 
3.1. Preparation of DH5α competent cells using rubidium chloride method 
 
A single fresh colony of E. coli DH5α was inoculated into 5 ml of LB medium and 
incubated at 37 ºC with shaking for 16 hrs. A volume of 5 ml of this overnight culture 
was inoculated into 500 ml of LB medium and incubated at 37 ºC with shaking to an 
optical density of 0.5 at a wavelength of 600 nm (O.D. 600). 250 ml of the bacterial 
culture were transferred to pre-chilled tubes and kept on ice for 15 min, the cells were 
then pelleted at 1,500 x g for 15 min at 4 ºC. The supernatant was completely drained 
and the pellet was gently resuspended in 80 ml of ice cold buffer R1 (100 mM RbCl, 50 
mM MnCl2.4H2O, 30 mM potassium acetate, 10 mM CaCl2.2H2O, 15% glycerol) and 
incubated on ice for 15 min. The cells were then pelleted at 1,500 x g for 10 min at 4 ºC 
and the pellet was gently resuspended in 20 ml of ice cold buffer R2 (10mM 4-
morpholinopropanesulfonic acid (MOPS), 10 mM RbCl, 75 mM CaCl2.2H2O, 15% 
glycerol) and incubated on ice for 15 min. The competent cells were then distributed 
into pre-chilled 1.5 ml tubes in 500 µl aliquots, quick frozen in liquid nitrogen and 
stored at -80 ºC.  
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3.2. Transformation of bacteria using heat-shock procedure 
 
After thawing DH5α competent bacteria on ice, 20 ng of purified plasmid DNA were 
added to 50 µL competent cells in a pre-chilled 1.5 mL tube (for BL21 competent cells 
β-mercaptoethanol was added to a final concentration of 0.287 mM). Then competent 
bacteria were mixed gently with the DNA and kept on ice for 30 min. The bacteria were 
then heat-shocked at 37 °C for 45 seconds, incubated on ice for 1 min and 200 µL of LB 
medium were added. The bacteria were incubated at 37 °C with shaking for 60 min. 
Selection of transformed bacteria by the desired plasmid was done by plating 100 µL of 
the bacterial suspension on antibiotic-containing LB agar plates that were allowed to 
grow at 37 ºC for 16-20 h. A single colony was then grown in 4 ml of LB medium with 
antibiotics and used for preparing frozen glycerol stock cultures, DNA preparation or 
protein production. For storage of bacteria, a glycerol stock culture was prepared by 
adding sterile glycerol to a final concentration of 15% and subsequently frozen at -80 
ºC. 
 
3.3. Preparation of electrocompetent EPEC cells and electroporation 
 
The following protocol was kindly provided by Brendan Kenny (University of Newcastle. 
Newcastle-upon-Tyne. England). 100 ml of LB medium were inoculated with 100 µl of 
an overnight culture of EPEC strain and grown at 37 °C with shaking till the O.D. 600 
reached 0.4-0.6. Then, 50 ml of bacterial culture were pelleted by centrifugation at 
1,200 x g for 15 min at 4 ºC and the pellet was washed three times with 50 ml of cold 
sterile water. The pellet was finally resuspended in 100 µl of cold sterile water. 40 µl of 
these competent bacteria were transfected with 3 µl of DNA plasmid by electroporation 
at 2KV in 1 mm-gap electroporation cuvettes (Cell Project) using a BTX Electro Cell 
Manipulator 600. As soon as the electroporation was completed, the electroporated 
bacteria were kept on ice and 1 ml of SOC media (2% tryptone, 0.5% yeast extract, 10 
mM sodium chloride, 2.5 mM potassium chloride, 10 mM magnesium chloride, 20 mM 
glucose, p.H=7) was added by mixing gently. Selection of bacteria that have taken up 
the desired plasmid was done by plating 50 µL and 500 µL of electroporated bacteria 
on antibiotic-containing LB agar plates incubating at 37 ºC for 16-20 h.  
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3.4. DNA constructs 
 
Plasmid DNAs were purified with the High Pure Plasmid Isolation Kit for mini 
preparation (Roche) according to the manufacture’s instruction. 
Murine wild type cortactin construct and selected mutants (Martinez-Quiles et al., 2004) 
were subcloned in frame with GFP at the N-terminus into the pC2-EGFP vector 
(Invitrogen) by Narcisa Martinez Quiles and verified by sequencing in the UCM facility. 
The constructs used in this study were full-length wild type cortactin (FL), and the 
following derivatives: the single point mutants W22A and W525K; the double mutant 
S405,418D; the triple mutant Y421,466,482D; an N-terminal fragment of cortactin (NH2) 
containing residues 1-333, and a cortactin fragment (residues 458-546) containing the 
SH3 domain (SH3). Two new cortactin mutants: S405,418A and Y421,466,482F were 
generated by PCR with QuikChange site-directed mutagenesis kit (Stratagene) with 
glutathione S-transferase (GST)-FL as the template. PCR products were cloned into 
pC2-EGFP vector by Narcisa Martinez Quiles and verified by sequencing. pC2-EGFP 
plasmids were selected with kanamycin (30 µg/ml, final concentration). 
pCAGGS-myc-CrkII encodes myc-tagged rat CrkII protein and pCAGGS-myc-CrkII-R38V 
encodes myc-tagged rat CrkII protein with a single amino acid substitution in the SH2 
domain (Hashimoto et al., 1998). Both DNA plasmids were obtained from Dr. Michiyuki 
Matsuda (Osaka University, Japan). pCAGGS plasmids were selected with ampicillin (100 
µg/ml, final concentration). 
pGEMT-tir DNA was obtained from Dr. Isabel Rodriguez Escudero (Dpto. Microbiología 
II. Facultad de Farmacia. Universidad Complutense, Madrid) and tir was sub-cloned into 
the pcDNA3.1HisB. The pcDNA3.1HisB-tirY474D mutant was produced using the 
QuikChange kit according to the manufacture’s instruction. Both pcDNA3.1HisB-tir and 
tirY474D were produced by Narcisa Martinez Quiles and verified by sequencing. 
The EPEC strains were transformed by electroporation (see section 3.3) with different 
DNA plasmids, ptir is a pACYC184 based plasmid, which is low-copy-number plasmid 
carrying the 3´map, tir and cesT (Kenny and Warawa, 2001). ptirY474F/Y454F (referred 
as dY) is a ptir plasmid harbouring a double substitution converting tyrosine residues 
474 and 454 to phenylalanine residues. ptirS434/463A (referred as dS) is a ptir plasmid 
harbouring a double substitution converting serine residues 434 and 463 to alanine 
  
83 
 
METHODS 
residues. ptirY474F/Y454F S434/463A (referred as quad) is a ptir plasmid containing 
four substitutions at described residues. Strains carrying pACYC184 based plasmids 
were selected with chloramphenicol (25 µg/ml, final concentration). pSK-T7mapHA 
[pBluescript (pSK) plasmid (Stratagene)] was selected with carbenicillin (100 µg/ml). All 
these DNA plasmids were obtained from Dr. Brendan Kenny (University of Newcastle. 
Newcastle-upon-Tyne. England). 
 
3.5. Purification and elution of GST fusion proteins 
 
A volume of 200 mL of LB medium was inoculated with 2 ml of an overnight culture of 
E. coli BL21 transformed with the expression vector pGEX-6P2/cortactin constructs, and 
grown at 37 °C with shaking till the O.D. 600 reached 0.6-0.7. GST-fusion protein 
expression was induced by the addition of isopropyl-β-D-thiogalactopyranoside (IPTG) 
to a final concentration of 1 mM. After 2 h of incubation, the culture was harvested by 
centrifugation at 5,000 × g for 10 min. The pellet was resuspended in 10 ml of 1X PBS 
(phosphate buffer saline, BD Bioscience) containing phenylmethylsulfonyl fluoride 
(PMSF) to a final concentration of 1 mM. Lysozyme was added to a final concentration 
of 0.1 mg/ml and incubated 5 min on ice. Triton X-100 was added to a final 
concentration of 1% and the sample was sonicated (3 × 30 s) on ice. The sample was 
then centrifuged for 20 min at 10,000 × g at 4 °C. The supernatant was filtered through 
a 0.45 µm filter and incubated with 200 µl of pre-washed Glutathione-Sepharose 4 Fast 
Flow beads (GSH, Amersham Bioscience) for 4 h at 4 °C with gentle rotation. After that, 
centrifugation for 5 min at 3,000 × g and 4 °C and the supernatant was discarded. The 
beads were washed three times with 1X PBS containing 0.1% Tween-20 and three times 
with 1X PBS. Finally, beads were stored at 4 ºC in 1 ml of 1X PBS. GST fusion proteins 
with GSH-Sepharose beads were used in pull down assays.  
For actin polymerisation assays the bound GST-cortactin was eluted with elution buffer 
(16 mM glutathione, 100 mM NaCl [pH 7.6]). The eluates containing the protein were 
collected and further purified using a column with a cutt-off of 50 ± 10 KDa (Centricon 
YM-50, Millipore) and dialysed using Slide-A-Lyzer Dialysis Cassettes 10K MWCO 
(PIERCE) according to the manufacture’s instruction.  
When necessary, the GST was cleavaged from cortactin construct. The bound GST-
cortactin was washed with PreScission Cleavage Buffer (50 mM Tris-HCl, 150 mM NaCl, 
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1 mM EDTA, 1 mM dithiothreitol [pH 7.0]) and the residual buffer was removed. The 
PreScission protease (GE Healthcare) was added to the fusion protein-bound matrix in 
Cleavage Buffer and the reaction proceeded at 4 °C for 16 h. The samples were dialysed 
using Slide-A-Lyzer Dialysis Cassettes (PIERCE) according to the manufacture’s 
instruction. 
 
4. Antibodies 
 
All primary antibodies (Ab) used in western blotting (WB) and immunofluorescence (IF) 
are listed in Table 1. Antibodies for bacterial proteins are marked in grey. All secondary 
antibodies are listed in Table 2. 
 
Table 1 
Primary antibody Species Dilution used in 
        WB                   IF 
Source 
Anti-acetylated-lysine  Rabbit Poly Ab 1:300 - Cell Signalling 
(#9441) 
Anti-actin clone C4 Mouse Mo Ab 1:3000 (for ECL) 
1:150,000 (for 
Odyssey) 
_ MP Biomedicals 
(#69100) 
Anti-cortactin (EP1922Y) Rabbit Mo Ab 1:1500 - Novus Biological 
NB110-55723 
Anti-cortactin 4F11 
1 mg/ml 
Mouse Mo Ab 1:1,000 _ Millipore  
(#05-180) 
Anti-Crk (clone 22) 
250 µg/ml 
 
Mouse Mo Ab 1:500 _ BD Biosciences 
Pharmingen (No. 
610035) 
Anti-CrkII H-53 
200 µg/ml 
Rabbit poly Ab 1:250 _ Santa Cruz 
Biotechnology (sc-
9004) 
Anti-CrKL (C-20) 
200 µg/ml 
Rabbit poly Ab 1:350 _ Santa Cruz 
Biotechnology (sc-
319) 
Anti-HA High Affinity 
(clone 3F10) 
100 µg/ml 
Rat Mo Ab 1:100 - Roche (No. 
11867423001) 
Anti-Myc tag  
(clone 4A6) 
1 mg/ml 
Mouse Mo Ab 1:500 _ Millipore  
(#05-724) 
Anti-Nck (clone 108) 
250 µg/ml 
Mouse Mo Ab 1:500 _ BD Biosciences 
Pharmingen (No. 
610099) 
Anti-N-WASP  Rabbit Poly 
Antiserum 
1:2,000 _ (Miki et al., 1998) 
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Anti-p44/42 
MAP Kinase  
Rabbit Poly Ab 1:1,000 - Cell Signalling 
(#9101) 
Anti-phospho-p44/42 
(T202/Y204) 
(clone E10) 
Mouse Mo Ab 1:500 - Cell Signalling 
(#9106) 
Anti-phospho-tyrosine 
(p-tyr-100) 
Mouse Mo Ab 1:750 - Cell Signalling 
(#9411) 
Anti-phosphoY207-CrkL Rabbit poly Ab 1:250 _ Cell Signalling 
(#3181) 
Anti-phosphoY221-CrkII Rabbit poly Ab 1:200 _ Cell Signalling 
(#3491) 
Anti-phosphoY416-Src  Rabbit poly Ab 1:1,000 _ Upstate 
Anti-phosphoY466-
cortactin 
1 mg/ml 
Rabbit Poly Ab 1:500 _ Abcam (ab51073) 
Anti-phosphoY466-
cortactin 
100 µg/ml 
Rabbit Poly Ab 1:1,000 _ Santa Cruz 
Biotechnology (sc-
101661) 
anti-Src (clone GD11) 
1 mg/ml 
Mouse Mo Ab 1:500 _ Millipore  
(#05-184) 
Anti-tubulin alpha 
(clone YOL1/34) 
1 mg/ml 
Rat Mo Ab 1:15,000 _ AbD Serotec (No. 
MCA78G) 
Mouse IgG1, Myeloma 
1 mg/ml 
Mouse Mo Ab This Ab was 
used as a 
control for 
inmuno-
precipitations. 
_ Calbiochem (No. 
401122) 
Anti-E.coli DnaK 
(clone 8E2/2) 
Mouse Mo Ab 1:2,000 - Enzo Life Sciences 
(No. ADI-SPA-880) 
Anti-E.coli LPS  
(clone 2D7/1) 
0.5 mg/ml 
Mouse Mo Ab - 
 
1:100 Abcam (ab35654) 
Anti-EspB Rabbit poly Ab 1:4,000 - Laboratory of B. 
Kenny 
Anti-EspF Rabbit poly Ab 1:4,000 - Laboratory of B. 
Kenny 
Anti-EspF Rabbit poly Ab 1:500 - Laboratory of C. 
Sasakawa 
Anti-Tir Rabbit poly Ab 1:12,000 - Laboratory of B. 
Kenny 
Anti-Tir2A5  
(N-terminal) 
Mouse Mo Ab 1:1,000 
 
1:100 Laboratory of B. 
Finlay 
Anti-Tir2C3  
(C-terminal) 
Mouse Mo Ab 1:1,000 - Laboratory of B. 
Finlay 
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Table 2 
Secondary antibody Species Dilution used in 
  WB                  IF 
Source 
Alexa Fluor 405-labeled 
anti-mouse IgG (H+L) 
2 mg/ml 
Goat - 1:750 Invitrogen 
(Molecular Probes) 
Alexa Fluor 488-labeled 
anti-mouse IgG (H+L) 
2 mg/ml 
Goat - 1:1,000 Invitrogen 
(Molecular Probes) 
Alexa Fluor 488-labeled 
anti-rabbit IgG (H+L) 
2 mg/ml 
Goat Poly Ab _ 1:1,500 Invitrogen 
(Molecular Probes) 
Alexa Fluor 680-labeled 
anti-mouse  IgG (H+L) 
2 mg/ml 
Goat Poly Ab 1:7,000 _ Invitrogen 
(Molecular Probes) 
Horseradish peroxidase-
linked anti-mouse IgG  
Sheep Poly Ab 1:3,000 _ Amersham 
Biosciences  
(GE Healthcare) 
Horseradish peroxidase-
linked anti-rabbit IgG 
Donkey Poly Ab 1:2,000 _ Amersham 
Biosciences  
(GE Healthcare) 
IRDye 800CW-labeled 
anti-mouse IgG (H+L) 
highly cross adsorbed. 
1 mg/ml 
Goat 1:5,000 _ Li-cor Biosciences 
(Fisher Scientific) 
IRDye 800CW-labeled 
anti-rabbit IgG (H+L) 
highly cross adsorbed. 
1 mg/ml 
Goat Poly Ab 1:5,000 _ Li-cor Biosciences 
(Fisher Scientific) 
IRDye 800CW-labeled 
anti-rat IgG (H+L) highly 
cross adsorbed. 
1 mg/ml 
Goat 1:5,000 _ Li-cor Biosciences 
(Fisher Scientific) 
 
5. Cell transfection 
 
Plasmid DNAs for cell transfection were purified with endotoxin-free, transfection-
grade JetStart Maxi columns as per manufacturer´s instructions. Cell transfection was 
carried out using LipofectamineTM 2000 reagent (Invitrogen). Cells were grown to 60-
70% confluence in 6-well or 100 mm-plates and transfected with 5 µg or 24 µg, 
respectively, of the indicated plasmid. Transfected cells were incubated for 
approximately 16 hours in medium containing 10% FBS but no antibiotics. Western 
blotting was carried out on cells from a single well or from a 100 mm-plate. Cell 
monolayers were washed once with cold 1X D-PBS that contains calcium and 
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magnesium (Dulbecco's Phosphate-Buffered Saline, Invitrogen) and scraped into 200 µl 
of 2X Laemmli sample buffer (24 mM Tris-HCl pH 6.8, 10% Glycerol, 0.8% sodium 
dodecyl sulphate (SDS), 6 mM β-mercaptoethanol and 0.04% bromophenol blue) in the 
case of a single well. Samples were homogenised by six passages through a syringe 
with a 25-gauge needle, followed by centrifugation at 21,000 x g (14,000 r.p.m. in a 
standard table centrifuge) for 15 min at 4 ºC and boiled for 5 min.  
 
6. SDS-PAGE and western immunoblot analysis 
 
Twenty to thirty microliters of samples were resolved by 10% (or 12% when indicated) 
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). Molecular 
weight (MW) of the proteins was estimated by extrapolating from a commercial protein 
molecular weight marker (Invitrogen or BioRad). Electrophoresis was performed in 
running buffer (25 mM Tris, 192 mM Glycine and 0.1% SDS, pH 8.3) at a constant 
voltage (150V) for 80 min. After SDS-PAGE the proteins were transferred to 
nitrocellulose membranes (Amersham) using a Biorad transfer system at 300 mA for 90 
min. The electrotransfer solution contained 25 mM Tris Base, 192 mM Glycine and 20% 
methanol (pH 8.3).  
Membranes were developed using enhanced chemiluminiscence system (ECL, 
Amersham) or Odyssey Infrared System (LI-COR, Fisher Scientific) as follows.  
 
6.1. Chemiluminiscence system 
 
Blots were blocked for 1 hour at room temperature with 5% skim milk in Tris-buffered 
saline with Tween-20 (TBS-T; 150 mM NaCl and 10 mM Tris-HCl, 0.1% Tween-20 pH 
7.5) and incubated overnight with the primary antibody diluted in TBS-T with 2% skim 
milk. Blots were washed three times for 10 min with TBS-T, and then incubated for 1 
hour with the horseradish peroxidase (HRP)-conjugate secondary antibody (see Table 
2). Blots were washed three times for 10 min with TBS-T and once with PBS and 
developed using ECL. When required, membranes were stripped for 30 min at 50 ºC in 
stripping buffer (100 mM β-mercaptoethanol, 2% SDS, 625 mM Tris-HCl pH 6.7) and 
reprobed with a different antibody. Quantification of bands was done by densitometry 
using NIH Image J software. Normalisation for each experiment was done by 
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normalising for actin or for the unphosphorylated form of the protein as indicated. 
Results were reported as the average from at least three independent experiments ± 
standard deviations (SD). 
 
6.2. Odyssey Infrared system 
 
Blots were blocked for 1 hour with Odyssey blocking buffer (Fisher Scientific) and 
incubated overnight with primary antibody diluted in blocking buffer containing 0.1% 
Tween-20. Blots were washed four times for 5 min with PBS containing 0.1% Tween-20 
(PBS-T), then incubated for 1 hour with the appropriate secondary antibody. 
Membranes were washed four times for 5 min with PBS-T and scanned using the red 
(700nm) and green (800 nm) channels. When significantly different intensities were 
observed between the two colour signals, we performed sequential antibody 
incubations. Membranes were stripped using NewBlot Nitro Stripping buffer (LI-COR) 
during 20 min at room temperature (RT) and incubated first with secondary Ab alone, 
and scanned them to confirm the efficiency of the stripping process before incubating 
them with a different primary Ab. The protein molecular weight marker was detected 
using the red channel (700 nm); therefore the real bands were shown in certain figures. 
When not detected, the marker is represented by a short black line to the right of the 
panel. Quantification of the bands was performed on the scanned images with the 
Odyssey Scan band tool. Statistical analyses were carried out using the two-tailed 
Student's t-test and displayed graphically using GraphPad Prism software (version 5.0). 
Graphs represent mean ± SD. 
  
7. EPEC infections 
 
Cells were grown in 6-well-plate to 70-80% confluency. Overnight bacterial cultures 
were grown in LB broth at 37 ºC with shaking at 200 r.p.m. In initial infection 
experiments of HeLa cells, bacteria from overnight cultures were directly added to 
wells, as indicated. For preactivation experiments, overnight bacterial cultures were 
diluted 1:100 in IMDM medium containing 10% FBS but no antibiotics and grown at 37 
ºC with 5% CO2 to enhance type III-dependent secretion. After 2 hours of preactivation, 
the O.D. of the suspension was measured at 600 nm to adjust to 0.2 and 12.5 μl were 
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added to each well referred to as X EPEC. The Multiplicity of Infection (MOI) is the 
number of bacteria added per cell at the beginning of the infection. The MOI was 
calculated by colony forming assay of serial bacterial dilutions in triplicate and 
assuming that the number of cells is approximately 1x106 cells per well of a 6-well plate 
at the confluence used. We determined that X EPEC is equivalent to a MOI of 3. This 
result was corroborated considering that 1 O.D. 600 unit is equivalent to 109 bacteria 
per ml (Current Protocols in Molecular Biology. Vol. 1). When indicated, the cells were 
infected at higher MOIs referred to as 10X, 50X or 100X. Cells were infected for 
indicated times (1, 2 or 3 hours) in medium containing 10% FBS but no antibiotics at 37 
ºC in a humidified atmosphere with 5% CO2.  
 
8. siRNA treatment 
 
Inhibition of the expression of human cortactin and CrkI/II including a scrambled 
nucleotide was done using Santa Cruz siRNA kits, as per manufacture instructions. 
Briefly, HeLa cells were grown to 60% confluency in 6-well-plate and transfected with 4 
to 8 µl of siRNA duplex and 1:1 siRNA Transfection Reagent (Santa Cruz) in 1 ml of 
serum-free medium. After the 6-h transfection period, 1 ml of 20% FBS medium was 
added to the cells to achieve a final serum concentration of 10%, and cells were further 
cultured for 16-20 hours prior to EPEC infection.  
siRNA treatment for the inhibition of Mus musculus CrkL was carried out using Silencer 
Pre-designed siRNA (Ambion. Life Technologies). MEFs were grown to 50-60% 
confluency in 6-well-plate and transfected with 20 nM of siRNA plus 3 µl of 
lipofectamineTM RNAiMAX (Invitrogen) per well. Cells were incubated for 20 hours prior 
to EPEC infection.  
siRNA treatment for the inhibition of Nck1/Nck2 in HeLa cells was carried out using 
Silencer Pre-designed siRNA (Ambion. Life Technologies). HeLa cells were grown to 50 - 
60% confluency in 6-well-plate and transfected with 40 nM of siRNA plus 6 µl of 
lipofectamineTM RNAiMAX (Invitrogen) per well. Afterwards, the cells were incubated for 
20 hours prior to EPEC infection.  
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9. Actin polymerisation assays 
 
Tir and Tir D (explain latter) recombinant proteins from pcDNA3.1HisB-Tir and 
pcDNA3.1HisB-TirY474D respectively were generated by in vitro transcription coupled 
to translation (TNT translation kit, Promega) according to the manufacture’s instruction. 
The following protocol and the Arp2/3 complex and actin protein were kindly provided 
by Marie-France Carlier and Christophe LeClainche (CNRS. Gif-sur-Yvette. France). 
Carboxilate microspheres (1 μm; Polysciences Inc.) were washed three times with Xb 
buffer (10 mM HEPES pH 7.8, 100 mM KCl, 0.1 mM CaCl2, 1 mM MgCl2, 1 mM ATP). A 
volume of 5 μl of microspheres was incubated with 500 nM of Tir/TirD proteins in Xb 
buffer for 1 hour at 4 ºC with gentle rotation. Control microspheres were incubated 
only with Xb buffer. The microspheres were washed once with Xb buffer and twice with 
Xb buffer containing 1% of bovine serum albumin (BSA) to block non-specific 
interactions. An eighth of the microspheres was then incubated with purified actin (2.5 
μM) and Arp2/3 complex (300 nM), and with cortactin and its mutants (500 nM) to a 
final volume of 25 μl of Xb buffer. As a control the microspheres were incubated with 
actin and Arp in the absence of cortactin protein. After 1h-incubation at RT, TRITC-
phalloidin was added to a final concentration of 3.3 μM. The solution containing the 
beads was placed on a slide and sealed with melted paraffin. Pictures were acquired at 
600x magnification keeping all relevant parameters fixed (gain, exposure time) to allow 
for fluorescence intensity comparison. Experiments were performed at least three times.  
We briefly modified the above protocol to use it with GST-cortactin coupled to GSH 
beads. A volume of 15 μl of GSH beads (of a total of 1 ml of GSH beads resuspended in 
1 ml of 1X PBS) was washed once with Xb buffer and twice with Xb buffer containing 
1% BSA with Xb buffer. Then, a third of the beads were incubated with purified actin 
(2.5 μM), Arp2/3 complex (300 nM) and Tir/TirD proteins (500nM) to a final volume of 
50 μl of Xb buffer and the same steps were followed as described above. 
 
10. Membrane enrichment procedure 
 
EPEC-infected MEFs were fractionated as previously described (Patel et al., 2006) with 
some modifications. MEFs were grown to 70-80% confluency in 150 mm-plates and 
infected with preactivated EPEC. After 3 hours of infection, cells were washed once with 
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ice-cold D-PBS and rapidly lysed at 4 ºC by overlaying the cell monolayer for 10 min 
with 1 ml of imidazole lysis buffer (3 mM imidazole pH 7.4, 250 mM sucrose, 1 mM 
sodium orthovanadate (Na3OV4), 1 mM sodium fluoride (NaF), one tablet of protease-
phosphatase inhibitor cocktail [CompleteTM-mini EDTA-free, Roche] and a half of a 
tablet of phosphatase inhibitor [PhosStop, Amersham] per 50 ml of buffer). The cells 
were then collected using a cell scraper (Sarstedt) and disrupted by six passages 
through a syringe with a 25-gauge needle, followed by centrifugation at 3,000 x g for 
15 min at 4 ºC to remove cellular debris, bacteria and nuclei. Clarified lysates were 
centrifuged again for 1 hour at 21,000 x g at 4 ºC to separate the membrane (pellet) 
from the cytoplasmic fraction (supernatant). Both of these final fractions were stored at 
-80 ºC until further use. The pellets (membrane fraction) were resuspended in 400 µl of 
imidazole lysis buffer containing 0.1% Triton X-100. 
 
11. GST pull-down assays 
 
For pull-down experiments equivalent amounts (10-25 µL) of GST fusion proteins 
estimated from Coomassie-stained SDS-PAGE were used for each sample. GST was 
used as a negative control. For pull-downs with GST fusion cortactin constructs, a 
volume of 100 µl of resuspended pellets (membrane fraction) was used for each pull-
down assay. The sepharose bound GST proteins were incubated with the membrane 
fraction with tumbling for 3 hours at 4 ºC and were then washed three times with 100 
µl of imidazole lysis buffer diluted 1:10 in PBS containing 0.05% Tween-20.  
Pull-down assays with in vitro expressed Tir/TirD proteins were performed. A volume of 
10 µl of resuspended sepharose bound GST fusion proteins was incubated with Tir or 
TirD (250 nM) in PBS containing 0.5% Tween-20 with tumbling for 4 h at 4 ºC. Pull-
downs were washed three times with 100 µl of PBS containing 0.05% Tween-20 and 
eluted by boiling in 2X Laemmli buffer for 5 min. The samples were separated by SDS-
PAGE and analysed by WB. In parallel, one fiftieth of each recombinant protein that was 
used in each pull down was loaded and the gel was stained with Coomassie blue 
staining solution (0.25% Coomassie Brilliant Blue R-250, 45% methanol and 10% glacial 
acetic acid) for 20 min at RT. The gel was then destained with Coomassie blue 
destaining solution (10% methanol and 10% glacial acetic acid). 
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12. Pervanadate treatment 
 
Pervanadate treatment was carried out by mixing 1 mM of Na3VO4 with 1% hydrogen 
peroxide (H2O2) and diluting two-fold with IMDM medium for 30 min at 37 ºC in a 
humidified atmosphere with 5% CO2. Due to the high intensity of the signal following 
pervanadate treatment, lysates of DMSO-treated and pervanadate-treated MEFs were 
diluted 1:500 in Laemmli sample buffer for WB analysis. 
 
13. Immunoprecipitation of Tir 
 
Cells were grown to 70-80% confluency on 150-mm plates, then washed once with D-
PBS and scraped into 700 µl modified Ripa lysis buffer [50 mM Tris-HCl (pH 7.4), 150 
mM NaCl, 15% glycerol, 2 mM EDTA, 0.1% SDS, 1% Triton X-100, 1 mM Na3VO4, 10 mM 
NaF, 1 mM PMSF, protease inhibitor cocktail (Amersham), phosphatase inhibitor 
(PhosSTOP, Roche)] and disrupted by three passages through a syringe with a 25-
gauge needle, followed by centrifugation at 12,000 x g for 15 min. 25 µl of Magnetic 
Pan mouse Dynabeads (Invitrogen) were washed and blocked with PBS containing 0.1% 
BSA for 10 min, then incubated with tumbling for 2 h with 4 µl of Tir2A5 monoclonal Ab 
per IP. After three washes with PBS-0.1% BSA, the beads were added to 300 µl of cell 
lysate and incubated with tumbling at 4 ºC for 3 h. The beads were washed three times 
with the help of a magnet (Invitrogen) and 200 µl Ripa lysis buffer diluted 1:10 in PBS. 
The beads were resuspended in 40 µl 2X Laemmli buffer and boiled for 5 min before 
SDS-PAGE. 
 
14. Immunofluorescence microscopy and quantification of pedestal 
formation 
 
For immunofluorescence studies, cells were seeded and grown overnight in 6-well-
plates with four pre-heated glass coverslips in each well. Cells were fixed with formalin 
buffered solution (containing 4% w/v formaldehyde, Sigma) for 20 min at RT and 
permeabilised with PBS containing 0.1% Triton X-100 for 5 min. After three washes for 
5 min with PBS, cells were blocked with PBS containing 2% BSA for 10 min, stained with 
the appropriate primary Ab for 1 h at RT, washed three times with PBS, and finally 
incubated for 1 h with secondary Ab. Actin cytoskeleton was visualised by staining with 
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1 µg/ml tetramethyl-rhodamine-isothiocyanate (TRITC)-phalloidin (Sigma-Aldrich) for 
15 min. After three washes with PBS, cells were stained with 4'-6-diamidino-2-
phenylindole (DAPI, 300 nM) for 5 min to visualise bacteria and nuclei. When indicated, 
bacteria were staining with 5 µg/ml of anti-LPS antibody for 1 h at RT, washed three 
times with PBS, and incubated for 1 h with Alexa Fluor 405-labeled anti-mouse. After 
three washes with PBS the coverslips were allowed to dry at RT during 20 min and 
mounted using 5 µl of mounting medium (100 mM Tris-HCl pH 8.5, 10% Mowiol 4-88 
(Calbiochem), 25% Glycerol with phenylnediamine (Sigma)). Quantification was done 
using a Nikon Eclipse TE 200-U fluorescence microscope equipped with a Hamamatsu 
camera. Images were processed with Adobe Photoshop. Confocal microscopy was 
performed at the “Parque Científico de Madrid” microscopy facility with a Leica 
Confocal SP2/DMEIR2, using Leica software (version 2.61). Quantification of pedestal 
formation was done by counting the numbers of pedestals of attached bacteria for a 
total of 100 cells in representative microscope fields. Experiments were performed at 
least three times. Statistical analyses were carried out using the two-tailed Student's t-
test (or Mann Whitney test when the data cannot be assumed to follow a Gaussian 
distribution in each group) and displayed graphically using GraphPad Prism software. 
Graphs represent mean ± SD. 
 
15. Treatment of cells with different inhibitors prior to EPEC infection 
 
Table 3. Chemical inhibitors 
 
Inhibitor and 
Usage 
Product description  
MG-132 (Calbiochem) 
50 µM 
pre-treatment for 1 h 
A potent, reversible, and cell-permeable proteasome inhibitor. 
Reduces the degradation of ubiquitin-conjugated proteins in 
mammalian cells and permeable strains of yeast by the 26S 
complex without affecting its ATPase or isopeptidase activities. 
Activates c-Jun N-terminal kinase (JNK1), which initiates apoptosis. 
Inhibits NF-κB activation (IC50 = 3 µM). Also reported to increases 
the survival rate of mesenchymal stem cells following their 
transplantation. Prevents β-secretase cleavage.  
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Protease Inhibitor 
Cocktail P8340  
(Sigma-Aldrich) 
1:1000  
pre-treatment for 4 h (or 
20 h) 
This protease inhibitor cocktail has been optimized and tested for 
mammalian cell and tissue extracts. It contains broad-specificity 
inhibitors. The specific inhibitory properties of the components 
are: 
-AEBSF – [4-(2-Aminoethyl)benzenesulfonyl fluoride 
hydrochloride] – serine proteases, e.g.., trypsin, chymotrypsin, 
plasmin, kallikrein and thrombin. 
-Aprotinin – serine proteases, e.g., trypsin, chymotrypsin, plasmin, 
and kallikrein; human leukocyte elastase, but not pancreatic 
elastase. 
-Bestatin hydrochloride– aminopeptidases, e.g., leucine 
aminopeptidase and alanyl aminopeptidase. 
-E-64 – [N-(trans-Epoxysuccinyl)-L-leucine 
4-guanidinobutylamide] – cysteine proteases, e.g.,calpain, papain, 
cathepsin B, and cathepsin L. 
-Leupeptin hemisulfate salt– both serine and cysteine proteases, 
e.g., plasmin, trypsin, papain,and cathepsin B. 
-Pepstatin A – acid proteases, e.g., pepsin, renin and cathepsin D, 
and many microbial aspartic proteases. 
Trichostatin A (TSA) 
(Sigma-Aldrich) 
5 µM 
pre-treatment for 16 h 
Trichostatin A (TSA) is a Streptomyces metabolite, which 
specifically inhibits mammalian histone deacetylase at nanomolar 
concentrations and causes accumulation of highly acetylated 
histone molecules in mammalian cells. For that reason, TSA has 
been used as a tool to study the consequences of histone 
acetylation in vivo. TSA induces cell differentiation, cell cycle arrest, 
reversal of transformed cells morphology, and apoptosis and is 
able to modulate transcription. TSA was used to establish a new 
cloning technique, which increases the success rates for mouse 
cloning (product information). 
U0186 (Calbiochem) 
2.5 µM and 5 µM 
pre-treatment for 1 h 
A potent and specific inhibitor of MEK1 and MEK2. The inhibition 
is non-competitive with respect to MEK substrate, ATP and ERK. 
U0126 also acts as an immunosuppressant by effectively blocking 
IL-2 synthesis and T cell proliferation without affecting the long-
term outcomes of either T cell activation or tolerance. 
Z-VAD-FMK (Promega) 
50 µM 
pre-treatment for 2 h 
A cell-permeable pan caspase inhibitor that irreversibly binds to 
the catalytic site of caspase proteases and can inhibit induction of 
apoptosis. For inhibition of apoptosis, Z-VAD-FMK should be 
added at the same time that apoptosis is induced. 
 
15.1. Treatment of cells with the specific proteasome inhibitor MG-132 
 
MEFs were grown in 100-mm plates to 70-80% confluency and pretreated for 1 h with 
proteasome inhibitor MG-132 (Calbiochem) at a final concentration of 50 µM 
(Ruchaud-Sparagano et al., 2007). Cells were then infected with preactivated EPEC for 3 
h in the presence of the inhibitor. After infection, cells were washed three times with 
IMDM supplemented with 10% FBS and bactericidal levels of gentamicin (100 µg/ml, 
final concentration). Cells were incubated at 37 ºC 5% CO2 with IMDM supplemented 
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with 10% FBS, gentamicin and MG-132 for various times post-infection. Then, cells were 
washed once with ice-cold D-PBS and collected at indicated times by scrapping the 
cells with 300 µl of imidazole buffer. Clarified lysates were obtained following the 
previously described protocol (see section 10; Membrane enrichment procedure). 
 
15.2. Treatment of cells with caspase and protease inhibitors 
 
The caspase inhibitor Z-VAD-FMK (Promega) was used at a final concentration of 50 
µM for 2 h prior to infections (Ching et al., 2002). The protease inhibitor cocktail P8340 
(SIGMA-ALDRICH), which contains inhibitors with a broad specificity (see Table 3), was 
used at a concentration of 1:1000 for 4 h or 20 h prior to infections. To test the effect of 
both inhibitors MEFs were grown in 6-well plates to 70-80% confluency and pretreated 
with the corresponding inhibitor for the indicated time prior to infection. Cells were 
then infected with preactivated EPEC for 3 h in the presence of the inhibitor. Then, cells 
were collected by directly adding 200 µl of 2X Laemmli sample buffer and processed as 
previously described in section 5. 
 
15.3. Treatment of cells with Trichostatin A 
 
MEFs cells were grown in 6-well-plates to 70-80% confluency and pretreated with the 
deacetylase inhibitor Trichostatin A (TSA) (from Streptomyces sp, SIGMA-ALDRICH) for 
16 h prior to infections (Zhang et al., 2007) at a final concentration of 5 µM. After 3h-
infection in the presence of the inhibitor cells were washed three times in cold D-PBS 
and lysed by adding 200 µl of 1% Triton X-100 lysis buffer, according to the protocol 
described in next section. 
 
16. Protein extraction and quantification of attached bacteria 
 
Cells were grown in 6-well-plate to 70-80% confluency and were infected with EPEC 
strains as described. The monolayers were washed three times in cold D-PBS, and the 
cells were lysed using the protocol that was kindly provided by Brendan Kenny 
(University of Newcastle. Newcastle-upon-Tyne. England) consisting of adding 200 µl of 
1% Triton X-100 lysis buffer (PBS containing 0.4 mM Na3VO4, 1 mM NaF and 0.1 mM 
PMSF). After 5 min incubation on ice, the samples were centrifuged at 21,000 x g for 5 
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min at 4 ºC (as described previously (Kenny and Finlay, 1997). Triton X-100 was used to 
solubilise the membrane proteins from the remaining insoluble fraction, which 
contained adherent bacteria, host nuclei and cytoskeleton. The soluble supernatant 
containing the cytoplasmic and membrane fractions was removed and the insoluble 
pellet was washed in 200 µl of PBS. The insoluble pellet was resuspended in 200 µl of 
1X Laemmli sample buffer by mixing with a vortex. Both fractions were boiled for 5 min 
and a volume of 30 µl of each fraction was subject to SDS-PAGE and WB as described 
above.  
Quantification of attached bacteria was done by WB analysis of the insoluble fraction 
with a monoclonal antibody against DnaK, which is an abundant bacterial heat shock 
protein. 
 
17. Inhibition of bacterial protein synthesis with chloramphenicol 
 
MEFs cells were grown in 6-well-plates to 70-80% confluency. Cells were infected 
during 15 min with 100X preactivated EPEC (at an approximate MOI of 250). After 15 
minutes of infection, chloramphenicol was added to a final concentration of 100 µg/ml 
(Rosenshine et al., 1996). As a vehicle control, a volume of 10 µl of 70% ethanol was 
added per well to the untreated cells as vehicle control. Cells were then incubated at 37 
ºC 5% CO2 for 1, 2 and 3 hours. Monolayers were then washed three times with ice-cold 
D-PBS and lysed by adding 200 µl of 1% Triton X-100 lysis buffer, according to the 
protocol previously described in section 16. 
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Part I: Role of cortactin in pedestal formation by EPEC 
1. siRNA of cortactin impairs pedestal formation by EPEC 
 
To investigate the functional role of cortactin in pedestal formation by EPEC we 
inhibited the expression of cortactin in HeLa cells (Fig. 11). For this purpose we used a 
commercially available siRNA against cortactin and a scrambled sequence nucleotide as 
negative control. As shown in Fig. 11A, 16 hours after transfection the levels of cortactin 
were reduced by 72% as quantified by western blotting. At that point the cells were 
infected with EPEC to allow the formation of pedestals. Treatment of cells with siRNA 
against cortactin results in a significantly reduced number of pedestals with respect to 
control cells. This reduction is clearly visible in images of immunofluorescence staining 
of polymerised actin using fluorescence phalloidin and bacteria using DAPI (Fig. 11B). 
Panel C of figure 11 shows that depletion of cortactin reduces the percentage of 
pedestal formation by 57% (29.0 ± 5.4 in control cells vs 12.4 ± 4.8 in cortactin siRNA 
cells). This result demonstrates that cortactin contributes to pedestal formation. 
 
2. Role of cortactin motifs in pedestal formation by EPEC 
 
Reduction of cortactin expression by siRNA (Fig. 11) or overexpression of its isolated 
SH3 domain, polyproline region or its α-helical region (Cantarelli et al., 2006) result in a 
dramatic decrease in actin-pedestal formation during infection by EPEC. We decided to 
investigate the contribution of the different motifs of cortactin to actin assembly on 
pedestals formation by EPEC. For that purpose, we performed infection experiments of 
HeLa cells transiently transfected with different constructs of cortactin fused to GFP 
(Fig. 12A). Since the constructs bear a GFP tag we were able to simultaneously assess 
the localisation of the different cortactin forms. Pedestals were visualised by 
immunofluorescence staining of actin using fluorescent phalloidin and bacteria with 
DAPI (Fig. 12B).  
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Figure 11. siRNA against cortactin blocks pedestal formation by EPEC. (A) Western-blot 
with anti-cortactin antibody showed a 72 % decrease of cortactin protein levels of cells 
treated with siRNA (average of four experiments after normalizing for actin), compared to 
control oligonucleotide treated cells (upper bands). Actin was used as a loading control 
(lower bands). (B) Immunofluorescence images of HeLa cells treated using siRNA with a 
nucleotide against cortactin compared to control treated cells were infected with 5 µl of an 
overnight EPEC culture for 3 hours. Red pictures showed actin staining. DAPI was used to 
stain EPEC microcolonies and nuclei of the cells. The merged images shown in last column 
were generated with Adobe Photoshop. Pictures are at 600X magnification. Scale bar 
represents 10 µm. (C) Quantification was done by counting the number of microcolonies of 
100 cells in representative microscope fields. Graph represents mean ± SD. Statistical analysis 
using the Student´s t-test from three independent experiments. *, p˂0.05; **, p˂0.01; ***, 
p˂0.001. The experiments in this figure were performed by Narcisa Martínez-Quiles. 
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The NTA domain of cortactin, that binds and activates the Arp2/3 complex, carries a 
20DDW22 motif which mutation to 20DDA22, hereafter referred to as W22A, abolished 
this activity (Uruno et al., 2001). We transfected HeLa cells with GFP-W22A in order to 
determine whether this motif is necessary for pedestal formation. We used wild type 
cortactin (referred to as GFP-full length, GFP-FL) and GFP alone as controls. As shown in 
figure 12, overexpression of GFP-FL cortactin allows pedestal formation to levels similar 
to those in cells expressing GFP. Figure 12C (black bars) shows normalised percentages 
and standard deviations for GFP-FL. We observed GFP-FL cortactin to localise in 70% of 
pedestals, compared to 4% for GFP-transfected cells (open bars). Importantly, the 
number of pedestals in cells expressing GFP-W22A mutant was significantly lower than 
in GFP-FL transfected cells (51% vs 83%). This result indicates that cortactin W22A 
exerts a dominant negative effect, which may mean that cortactin binding and 
activation of the Arp2/3 complex is necessary for pedestal formation. 
 
Cortactin has a C-terminal SH3 domain that binds several proteins. Mutation of a 
critical amino acid (W525K) in the SH3 domain abolishes its binding to known targets 
(Du et al., 1998) such as N-WASP (Martinez-Quiles et al., 2004). We used this mutant to 
assess the contribution of the cortactin SH3 domain to pedestal formation and found 
that its expression inhibits pedestal formation to an even greater extent than the W22A 
mutant (31% vs 51%). This indicates that cortactin W525K mutant exerts a dominant 
negative effect, corroborating previous results (Cantarelli et al., 2006). 
 
N-WASP is one of the SH3 cortactin targets, that was shown essential for pedestal 
formation, as demonstrated by the fact that N-WASP-deficient cells do not form 
pedestals (Lommel et al., 2001). In previous work, the P.I of our group described that 
the cortactin SH3 domain is able to activate N-WASP and proposed a model for the 
regulation of N-WASP activation by cortactin. According to our model cortactin is 
switched on by Erk phosphorylation at serines 405 and 418, while it is switched off by 
Src phosphorylation at tyrosines 421, 466 and 482 (Martinez-Quiles et al., 2004). Hence, 
we repeated the pedestal formation assay with cells expressing the cortactin S405,418D 
doble mutant, which mimics Erk phosphorylation and activates N-WASP in vitro, as well 
as its non-phosphorylatable counterpart (S405,418A). The S405,418D mutant allows 
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pedestal formation to a similar extent as the WT cortactin (90%) and to a greater 
extent, although not significantly, than the GFP negative control (83%). The 
phosphoserine-mimicking cortactin mutant accumulates in only 21% of pedestals and 
shows a weak, diffuse pattern of localisation in the cytoplasm and pronounced staining 
in the nucleus. In contrast, the mutant that abolishes Erk phosphorylation (S405,418A) 
impairs pedestal formation (34%) and its own translocation to them (3%). These results 
suggest that Erk phosphorylation of cortactin contributes to pedestals formation. 
 
Similarly, we wanted to address the role of Src-mediated phosphorylation of cortactin. 
We therefore used the phosphotyrosine-mimicking mutant (Y421,466,482D) and the  
phosphotyrosine deficient mutant (Y421,466,482F). In both cases, pedestal formation 
and location of these constructs on them are impaired (33%/7%; 28%/14%, Fig. 12B 
and C). These results indicate that Src-mediated phoshorylation of cortactin seems to 
inhibit pedestal formation. 
 
3. EPEC induces N-WASP-dependent tyrosine phosphorylation of 
cortactin 
 
A major regulatory mechanism of cortactin is its phosphorylation which is induced by 
different stimuli. As mentioned before, cortactin is phosphorylated on tyrosines 421, 
466 and 482 by Src family kinases (Huang et al., 1998), which decreases cortactin 
affinity for N-WASP in vitro (Martinez-Quiles et al., 2004). It has been shown that EPEC 
infection of CH7 mouse fibroblasts induces tyrosine phosphorylation of cortactin 
(Cantarelli et al., 2007). In addition, both Nck and N-WASP are indispensable for 
pedestal formation as demonstrated using mouse embryonic fibroblast (MEFs) deficient 
in these proteins (Gruenheid et al., 2001, Lommel, 2001 #41). These observations 
prompted us to examine the phosphorylation status of cortactin in two different cell 
types: N-WASP and Nck1/2-deficient MEFs.  
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Figure 12. Effect of the overexpression of WT and cortactin mutants on pedestal 
formation. (A) Schematic of cortactin domains and mutants under investigation. (B) 
Immunofluorescence images of HeLa cells transfected with WT (FL) and cortactin mutants 
and infected for 3 h with 1 µl of overnight EPEC culture per well of a 6-well-plate. Mutants 
used are: Arp2/3 activation mutant (W22A), Erk-phosphorylation-mimicking mutant 
S405,418D (SD), Erk non-phosphorylatable mutant S405,418A (2A), Src-phosphorylation-
mimicking mutant Y421,466,482D (3D), Src non-phosphorylatable mutant Y421,466,482F (3F) 
and SH3 domain mutant (W525K). GFP staining is shown in green, F-actin is in red, and 
bacteria and nuclei are in blue. The last column shows merged images of GFP and actin 
staining. Pictures are at 600× magnification. Scale bar 10 μm. (C) Quantification of pedestal 
number and cortactin localisation. Black bars represent percentages normalized to WT of 
pedestal formed after 3 hours of infection of HeLa cells expressing GFP-FL and cortactin 
mutants. White bars represent normalized percentages of localisation to pedestals. Results of 
three independent experiments were considered statistically significant (p<0.01 by Student's 
t-test).The experiments in this figure were performed by Narcisa Martínez-Quiles. 
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First, we performed Western blotting control experiments to assess the expression of 
N-WASP and Nck proteins in the different cell types. As loading control we blotted for 
cortactin and actin (Fig. 13A). Fig. 13A shows that EPEC induces phosphorylation of 
tyrosine 466 of cortactin at 3 hours of infection in WT MEFs, as detected using an 
antibody against phosphoY466-cortactin (pY466 Ab). This result was corroborated 
using a second phospho-specific antibody (pY421 Ab) (Fig. 13E). Unexpectedly, tyrosine 
phosphorylation of cortactin is not induced in N-WASP-deficient cells. This result 
suggests that tyrosine phosphorylation of cortactin during EPEC infection depends on 
the presence of N-WASP. To verify this, we infected N-WASP-deficient cells that were 
retrovirally reconstituted with N-WASP (hereafter referred to as N-WASP reconstituted 
cells, R) and examined the levels of phosphoY466-cortactin. Fig. 13A shows that N-
WASP re-expression partially restored cortactin tyrosine phosphorylation levels. In three 
independent experiments the normalised average induction was 1 ± 0.2 for WT cells, 0 
for N-WASP-deficient cells and 0.5 ± 0.1 for R cells. This supports the idea that EPEC-
induced tyrosine phosphorylation of cortactin in cultured cells requires N-WASP.  
 
On the other hand, Nck-deficient cells show a higher basal level of phosphoY466-
cortactin that is maintained or slightly reduced after EPEC infection. This higher basal 
level of cortactin phosphorylation could be explained by the higher level of cortactin 
total protein consistently found in these cells (Fig. 13A and Fig. 13C).  
 
Given the absence of induction of cortactin tyrosine phosphorylation in EPEC-infected 
N-WASP and Nck-deficient cells, we then checked Src activation, using a commercially 
available phospho-active Src antibody (pY416 Ab). Fig. 13B demonstrated that equal 
activation of Src is achieved during EPEC infection in all cell types studied, while, as 
expected, the levels of total Src remain constant during infection. This result shows that 
the lack of cortactin phosphorylation in N-WASP-deficient cells is not due to a block in 
Src activation. As a further control, we treated the cells with pervanadate and observed 
robust phosphorylation of cortactin tyrosine 466 (Fig. 13C, upper panel).  
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Then, we sought to establish the activation status of Erk in EPEC-infected cells. We used 
a phospho-specific monoclonal antibody that detects the activated form of Erk1/2 (anti 
pThr202/pTyr204). EPEC induces the activation of Erk in WT MEFs (Fig. 13D, first lane), 
in agreement with a previous report in T84 epithelial cells (Savkovic et al., 2001). 
However, infection of N-WASP-deficient cells showed reduced activation of Erk which 
Figure 13. EPEC-induced tyrosine phosphorylation of cortactin depends on N-WASP. 
WT, N-WASP-deficient cells (N-WASP-/-), N-WASP reconstituted cells (R) as well as Nck-
deficient cells (Nck1/2-/-) were infected with X preactivated EPEC for 3 h. (A) Tyrosine 
phosphorylation of cortactin occurs in WT but not in N-WASP-deficient MEFs. Cell 
lysates were subjected to SDS-PAGE and Western blotted with an antibody against phospho-
Y466 cortactin (upper panel). The same membrane was stripped and reprobed with anti-
cortactin monoclonal antibody 4F11. Anti-N-WASP and anti-Nck was performed to confirm 
the genotype of the MEFs. Actin was used as a loading control. (B) EPEC infection activates 
Src to similar extends in all cell-types studied. The activation of Src was analysed with 
anti-phospho-Y416 Src (upper panel). Medium and lower panels showed Src and actin blots, 
respectively. (C) Pervanadate treatment induces a robust phosphorylation of cortactin 
on tyrosine 466 in all cell-types studied. Lysates of vehicle DMSO-treated MEFs and 
pervanadate-treated MEFs (diluted 1/500 *) were examined by WB with antibody against 
phospho-Y466 cortactin. A second gel was loaded in parallel with the same amount of 
protein for both types of lysates and blotted for cortactin and actin for protein and loading 
controls, respectively. (D) EPEC infection induces Erk1/2 activation in WT and Nck-
deficient but not in N-WASP-deficient MEFs. Cell lysates were examined by WB using a 
MoAb specific for activated Erk phosphorylated on Thr202 and Tyr204 (upper panel). 
Medium and lower panels show Erk and actin blots for Erk protein and loading control 
respectively. Similar results were obtained in at least three independent experiments. (E) 
Tyrosine phosphorylation at Y421 cortactin occurs in WT but not in N-WASP-deficient 
MEFs. Cell lysates were examined by WB with an antibody against phospho-Y421 cortactin 
(upper panel). The same membrane was stripped and reprobed with anti-cortactin MoAb 
4F11. Actin was used as a loading control. 
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was recovered in R cells. On the contrary, Nck-deficient cells have a higher basal level 
of Erk and strong activation upon EPEC infection. These results imply that Erk is 
activated by EPEC and may phosphorylate cortactin in EPEC-infected cells. More 
importantly, N-WASP is absolutely required for the induction of Erk activation and for 
the induction of tyrosine phosphorylation of cortactin at 3 hours of infection, while Nck 
is dispensable.  
 
In collaboration with Dr. Steffen Backert (School of Biomolecular and Biomedical 
Sciences, University College Dublin, Ireland) we explored the serine phosphorylation 
status of cortactin in MEFs at 3 hours of EPEC infection by using specific antibodies 
against phosphorylated serine residues 405 and 418 (Tegtmeyer et al., 2011). A 
preliminary result corresponding to a single experiment shows that EPEC induces at 
least the phosphorylation of serine residue 405 (Fig. 14, upper panel). As it occurred 
with tyrosine phosphorylation, the phosphorylation of serine residue 405 is not induced 
in N-WASP-deficient cells. However, N-WASP re-expression does not restore serine 
phosphorylation levels of cortactin. On the other hand, Nck-deficient cells show a 
higher basal level of phosphorylation of serine residues 405 and 418 that is increased 
after EPEC infection (Fig. 14). 
 
Figure 14. EPEC induces phosphorylation of cortactin in serine residues that depends 
on N-WASP. WT, N-WASP-deficient (N-WASP KO), N-WASP reconstituted cells (R) as well as 
Nck-deficient cells (Nck1/2 KO) were infected with X preactivated EPEC for 3 h. The level of 
serine phosphorylation of cortactin was assessed by Western blotting using phospho-specific 
antibodies against S405 (upper panel) and S418 (lower panel). This preliminary result was 
performed only once and was produced by Steffen Backert (University College Dublin, 
Ireland) using our cell lysates.  
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It has been described that the Src family inhibitor PP1 has no effect on actin 
polymerisation induced by EPEC (Cantarelli et al., 2000; Swimm et al., 2004a). However, 
it was not known whether chemical inhibition of Erk would block pedestal formation. To 
that extend, we treated WT MEFs with Erk inhibitor U0126 and found that there is no 
difference in the number of pedestal formed by EPEC (Figure 15). This result has also 
been corroborated by a complementary study (Cantarelli et al., 2006) . 
 
 
4. Tir binds cortactin and induces the latter to nucleate actin in vitro 
through an Arp2/3 complex-mediated pathway 
 
The bacterial effector Tir initiates what is considered to be the principal signalling 
pathway for actin assembly in a manner dependent on phosphorylation of tyrosine 474 
(Kenny, 1999) by host cell kinases. This modification serves to recruit Nck (Gruenheid et 
al., 2001) that presumably binds N-WASP to initiate Arp2/3 complex-mediated actin 
polymerisation. We wanted to gain insights into how cortactin functions in pedestal 
signalling. Our initial hypothesis was that cortactin and Tir interact directly. Therefore 
we used the Scansite database (Yaffe et al., 2001) to search for motifs in the Tir 
sequence to which cortactin SH3 domain could bind. We found a consensus motif 
(NNSIPPAPPLPSOTD) centered on proline 20 of Tir.  
 
Figure 15. The number of pedestals is not affected by blocking Erk activation. (A) WT 
MEFs were treated with the Erk inhibitor U0126 at 2.5 µM or 5 µM for 1 hour prior to 
infection with X preactivated EPEC at indicated times. Cells were left untreated as a negative 
control. The levels of Erk activation were assessed by Western blotting with a MoAb against 
phospho-T202/T204 Erk (upper panel) and secondly with an Ab against Erk and visualised 
with the Odyssey system. (B) Quantification was done by counting the number of pedestals 
in untreated WT MEFs (white bar) and in U0126-treated WT MEFs at 2.5 µM (black bar) of 
100 cells. Non-statistical difference was found for the analysis of two independent 
experiments as shown. 
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We first performed in vitro pull-down experiments with cortactin recombinant proteins 
and with purified Tir (Fig. 16A). We produced WT GST-Tir that was purified using GSH 
beads and treated with PreScission enzyme, which excised Tir and at the same time 
removed the GST tag (Fig. 16A, Coomassie gel). Tir protein was used as the input in 
pull-down experiments with WT and mutants GST-cortactin fusion protein. The first line 
of figure 16A shows that cortactin binds Tir in vitro. 
 
To map the domains involved in the interaction, we performed pull-down experiments 
using cortactin mutants as follows: full-length W525K (mutated SH3 domain), full-
length W22A (mutated Arp2/3 binding domain), the N-terminus (NH2, residues 1-333), 
and the isolated SH3 domain (SH3, residues 458-546). GST was used as a negative 
control. In agreement with our initial hypothesis, the isolated SH3 domain of cortactin 
binds Tir. However, the N-terminal domain of cortactin also binds Tir (Fig. 16A, third 
line). This unforeseen interaction was confirmed in experiments with cortactin carrying 
the point mutations W525K and W22A (Fig. 16A). Next we tested the cortactin 
S405,418D (SD) and Y421,482,486D (3D) mutants which are similar to the WT form in 
their ability to bind Tir (Fig. 16A). These results demonstrate that cortactin and Tir 
interact directly in vitro, that this interaction involves both the N-terminal part and the 
SH3 domain, and that it appears to be independent of cortactin phosphorylation.  
 
Given the direct interaction between Tir and cortactin, we wondered whether Tir can 
activate the ability of cortactin to promote Arp2/3-mediated actin polymerisation. We 
coupled recombinant Tir protein to carboxilate beads. Next we incubated them with 
purified Arp and actin in Xb buffer containing WT and cortactin mutants. Column 2 of 
figure 16B shows that Tir activated WT cortactin as well as the SD and 3D mutants. The 
W525K mutant was also activated, although weakly. As expected, W22A cortactin was 
not activated, indicating that the effect was mediated by cortactin activation of the 
Arp2/3 complex. As a negative control we used naked beads that showed no activation 
(Fig. 16B; column 1). In addition, we also coupled recombinant Tir phospho-mimicking 
mutant TirY474D to carboxilate beads (Fig. 16B; column 3) and we obtained similar 
results. Collectively these results indicate that Tir activates the ability of cortactin to 
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Figure 16. Tir binds cortactin and promotes its activation of Arp2/3-mediated actin 
polymerisation. (A) Cortactin binds Tir through its N-terminal and SH3 domain and 
independently of cortactin phosphorylation in vitro. Recombinant Tir was incubated with 
WT cortactin (FL) and with the GST-tagged mutants: the SH3 domain mutant (W525K), the 
N-terminal (NH2) domain, the SH3 domain (SH3), Arp2/3 domain mutant (W22A), Erk-
phosphorylation-mimicking mutant (SD) and Src-phosphorylation-mimicking mutant (3D). 
GST served as a negative control. The pull-downs were subjected to SDS PAGE and blotted 
with anti-Tir MoAb. In the last line, one-fifth of the total amount of Tir that was used as input 
per pull-down sample (upper panel). Coomassie staining of proteins is also shown (lower 
panels). (B) Tir induces cortactin to nucleate actin in vitro through an Arp2/3 complex-
mediated pathway. Immunofluorescence images of Tir-coupled beads incubated with actin, 
Arp2/3 and cortactin/mutants. Uncoupled carboxilate beads (left panels) or coupled to Tir or 
TirD proteins were incubated with a solution of 500 nM WT cortactin or cortactin mutants 
proteins for 1 h. Actin and Arp were then added and incubated to allow actin polymerisation. 
After 1 h TRITC-phalloidin was added, and the samples were observed immediately on a 
fluorescence microscope. Pictures were taken at 600X magnification. Scale bar represents 40 
µm. (C) Immunofluorescence images of GSH beads coupled to GST, WT or cortactin mutants 
incubated with actin, Arp2/3 and Tir/TirD. GSH beads coupled to the proteins were incubated 
with a solution of 500 nM Tir or TirD proteins or buffer alone as a control (left panels) for 1 h. 
Then actin and Arp was added and incubated for 1 h to allow actin polymerisation. To end 
TRITC-phalloidin was added, and the samples were observed immediately on a microscope. 
Pictures were taken at 200X magnification. Scale bar represents 40 µm.  
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promote Arp2/3-mediated actin polymerisation in vitro independently of cortactin 
phosphorylation status. 
 
Conversely, experiments in which GST-cortactin and its mutants were coupled to 
Glutathione Sepharose (GSH) beads and incubated in solution with Tir or TirD were 
performed (Fig. 16C). Although WT cortactin is not activated, we obtained similar 
results with all the other mutants. 
 
5. Cortactin binding to Tir in Nck and N-WASP-deficient cells infected 
by EPEC 
 
Because cortactin binds directly Tir (Fig. 16), N-WASP (Martinez-Quiles et al., 2004) and 
Nck (Okamura and Resh, 1995), we analysed cortactin-Tir interaction in N-WASP and 
Nck-deficient cells. Keeping in mind that Nck-deficient cells allow the formation of a 
small percentage of pedestals compared to WT cells ((Campellone et al., 2004a) and 
further analysed in (Figure 28B)), while N-WASP-deficient cells are even more resistant 
to pedestal formation (Lommel et al., 2004), we wanted to analyse the possible 
complexes formed between Tir, Nck, N-WASP and cortactin in cells infected by EPEC. 
 
To address this question, we adapted a previously described fractionation protocol that 
enriches in Tir-containing membranes ((Patel et al., 2006) and Materials and Methods). 
As expected, Tir is enriched in the pellets compared to supernatants, as detected by 
western-blotting with a monoclonal antibody against Tir (Fig. 17A). We observed that a 
band with slower electrophoretic motility is the predominant form of Tir in the pellets, 
which represents fully-modified Tir (Kenny and Warawa, 2001). Unexpectedly, we found 
that the Nck-deficient cells present a drastic reduction of fully-modified Tir, while N-
WASP-deficient cells present detectable amounts of this Tir form. 
 
With the limitation that Nck-deficient cells do contain reduced levels of Tir, we 
performed pull-downs assays with cortactin construct. As full-length cortactin has a 
closed conformation (Cowieson et al., 2008; Martinez-Quiles et al., 2004), we decided to 
use N-terminal cortactin (NH2) and the isolated SH3 domain (SH3) to perform pull-
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down experiments with the membrane-enrich fraction of EPEC infected and uninfected 
WT, N-WASP-deficient and N-WASP reconstituted cells (N-WASP R), as well as Nck-
deficient cells. GST was used as a negative control. 
 
Western blotting analysis with an anti-Tir MoAb shows that NH2 binds Tir in EPEC 
infected but not uninfected cells (negative control) with no appreciable differences 
between WT, N-WASP and N-WASP reconstituted cells (Fig. 17B). No binding was 
detected using Nck-deficient cell lysates which could be attributed to the reported low 
amount of Tir protein initially present on the lysate. In contrast, neither the isolated SH3 
domain nor the GST negative control bind Tir in any of the cells type used. Similar 
results were obtained performing pull down experiments with clarified total cell lysates 
although longer exposure times where necessary to detect Tir (Fig. 17C). 
 
In view of these results, we can conclude that in cultured cells cortactin binds Tir 
primarily through its N-terminal region. It has been described that cortactin interact 
with N-WASP thought its SH3 domain (Martinez-Quiles et al., 2004). To test whether 
the SH3 domain of cortactin prefers to bind N-WASP over Tir, we performed pull-
downs experiments with clarified total lysates, and we then stripped and reprobed the 
blots with anti-N-WASP antibody. As shown in figure 17C the SH3 domain of cortactin 
is able to pull-down N-WASP in EPEC-infected WT cells but not N-WASP-deficient cells. 
However, in N-WASP reconstituted cells the SH3 domain of cortactin does not pull-
down N-WASP. On the other hand, the SH3 domain of cortactin binds N-WASP in Nck-
deficient cells. The same results were obtained in uninfected cells (Fig. 17C; -EPEC). This 
observation argues in favour of the conclusion that the N-terminal region of cortactin is 
involved in binding Tir, while the SH3 domain is involved in binding N-WASP. 
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Figure 17. Cortactin binds Tir in the absence of N-WASP and Nck1/2. (A) Tir is 
abundant in membrane-enriched fractions, except in Nck-deficient cells. WT, N-WASP-
deficient (N-WASP-/-), N-WASP reconstituted cells (R) and Nck-deficient cells (Nck-/-) were 
infected with X preactivated EPEC. Cell monolayers were lysed in imidazole buffer, 
fractionated, subjected to SDS-PAGE and blotted with anti-Tir MoAb. As previously 
described, Tir appears as a doublet whose upper band is enriched in the membrane fractions 
(pellets). Actin is shown as a loading control. (B)(C) Cortactin binds Tir in cells through its 
N terminal domain and N-WASP through its SH3 domain. The membrane fraction (B) or 
clarified total cell lysates (C) of uninfected and EPEC-infected WT, N-WASP-/-, N-WASP 
reconstituted cells (R) and Nck-/- were used for pull-down experiments with GST fusion 
proteins as follows: cortactin N-terminal truncation mutant (NH2), the isolated SH3 domain 
(SH3) and GST alone. Pull-down experiments were analysed by WB with indicated antibodies. 
In the last two lines, one-sixth of the total amount of cell lysate used for each PD assay was 
loaded (lysate from WT cells in control blots (-EPEC) and from NWASP-deficient cells in 
+EPEC blots). Coomassie staining of proteins is also shown. These experiments were 
performed at least three times.  
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Part II. Role of the adaptor Crk in pedestal formation by EPEC 
 
1. The inhibition of CrkII expression has no effect on pedestal 
formation  
 
The Crk family of adaptor proteins (CrkI, Crk II and CrkL) assembles protein complexes 
and transmits signals downstream of tyrosine kinases participating in many signalling 
pathways. Crk localises to EPEC pedestals (Goosney et al., 2001) and was shown to 
cooperate with tyrosine phosphorylated cortactin to promote actin polymerisation 
during Shigella invasion (Bougneres et al., 2004). These data prompted us to investigate 
the role of Crk isoforms in pedestal formation by EPEC. In figure 18A western blot 
analysis shows the expression of the three isoforms in HeLa cells. Endogenous levels of 
CrkII and CrkL are readily detected whereas CrkI isoform is only expressed at almost 
non-detectable levels (Fig 18A and (Dokainish et al., 2007)).  
 
First, we silenced CrkI/II expression with siRNA oligonucleotide specific for CrkI and 
CrkII. Western blot analysis indicates a 76% decrease in CrkII levels in cells after 16 
hours of transfection with siRNA, compared with control samples (average of three 
experiments after normalising for actin) (Fig. 18B). At that point we infected the cells 
with EPEC to allow the formation of pedestals. Figure 18C shows immunofluorescence 
staining of polymerised actin and bacteria. The number of pedestals does not differ 
between siRNA-treated cells and control cells in three different experiments (Fig. 18D). 
This result indicates that a reduction in the levels of expression of CrkI/II by siRNA has 
no effect in the number of pedestal formed by EPEC.  
 
2. Expression of a Crk dominant negative mutant does not affect the 
efficiency of pedestal formation 
 
To confirm the siRNA result, we used a complementary approach and performed 
transfection experiments of HeLa cells with a myc-tagged Crk dominant negative 
mutant (R38V), which is mutated in the SH2 domain (Fig. 19). The arginine residue R38 
is conserved in all SH2 domains and is essential for recognition of phosphotyrosine 
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Figure 18. Pedestal formation is not affected by siRNA depletion of CrkI and CrkII in 
HeLa cells. (A) Levels of expression of CrkI, CrkII and CrkL in HeLa cells by western blotting 
analysis with the Odyssey Scan System. (B) Western blotting analysis using 
chemiluminiscence shows the decrease of CrkII protein levels of cells treated using siRNA 
oligonucleotide against CrkI/II compared to control oligonucleotide treated cells (lower 
bands). Actin was used as a loading control (upper bands). (C) Immunofluorescence images 
of HeLa cells treated using siRNA oligonucleotide against CrkI/II compared to control 
oligonucleotide treated cells and infected with X preactivated EPEC for 2 hours. Red pictures 
show actin staining with TRITC-Phalloidin. DAPI was used to stain EPEC. The merged images 
shown in last column were generated with Adobe Photoshop. Pictures are at 600X 
magnification. Scale bar represents 20 µm. (D) Quantification was done by counting the 
number of pedestals from 100 cells in representative microscope fields. Graph represents 
mean ± SD. Non-statistical difference was found for the analysis of three independent 
experiments. 
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groups. More importantly, its mutation abolished the interaction of Crk with its binding 
partners (Kiyokawa et al., 1998) and blocked Shigella invasion (Bougneres et al., 2004). 
 
Western analysis with an anti-myc monoclonal antibody shows that the level of 
expression of wild type CrkII and R38V mutant is similar. Cells were treated with the 
transfection reagent (mock) as a negative control (Fig. 19A). Fig. 19B shows the 
immunofluorescence staining of HeLa cells transfected with WT CrkII or R38V mutant 
constructs and infected with EPEC. As shown in Fig. 19C the number of pedestal formed 
in cells transfected with the dominant negative R38V does not differ from cells 
transfected with WT CrkII or mock cells. Together our results indicate that the 
overexpression of neither the WT CrkII nor the Crk dominant negative mutant has any 
effect on pedestal formation. 
 
3. Inhibition of the three Crk isoforms is associated with enhanced 
formation of actin pedestals 
 
With the aim to test the effect of the total absence of CrkI and CrkII on the formation of 
pedestals by EPEC, we next used CrkI/II-deficient mouse embryonic fibroblasts to 
perform EPEC infection experiments. To distinguish between CrkI and CrkII 
contributions, we transfected CrkI/II-deficient cells with myc-CrkII (referred to as 
Rescued Crk, R CrkII) (Fig. 20). We quantified the number of pedestals and found no 
difference in the number of pedestals between WT, CrkI/II-deficient MEFs or CrkII 
reconstituted MEFs (Fig20C), which confirm the result obtained with HeLa cells (Fig. 18). 
 
At this point we favoured the hypothesis that CrkL could be compensating for the lack 
of CrkI/II. Therefore we inhibited the expression of CrkL in CrkI/II-deficient cells using 
siRNA and cells were then infected with EPEC. The expression levels of CrkL are reduced 
by 60% as quantified by WB analysis (Fig. 21A). Figure 21B shows immunofluorescence 
staining of polymerised actin with TRITC-phalloidin (in red). In this experiment we used 
a monoclonal antibody against E. coli LPS (in blue) to avoid the overexposure of the cell 
nuclei necessary to visualise the bacteria. The quantification of the results showed a 
significant increase in the number of pedestals in CrkI/II-deficient cells depleted for 
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CrkL with respect to WT cells (Fig. 21C). Thus, cells expressing none of the three 
isoforms formed significantly more pedestals, indicating a potential inhibitory role of 
Crk family adaptor proteins in the formation of pedestals. 
 
To further confirm this result, we expressed the R38V dominant negative Crk mutant in 
WT and CrkI/II-deficient MEFs (Fig. 22A). We observed a significant increase in the 
number of pedestals in cells transfected with the dominant negative R38V when 
compared to WT or CrkI/II-deficient cells (Fig. 22B). These results point towards a 
redundancy and a possible inhibitory role in the contribution to pedestal formation by 
Crk proteins. 
 
4. CrkL-deficient cells present no differences in the number of 
pedestals formed by EPEC 
 
To test whether CrkL could have a more relevant role than CrkII/I in pedestal formation 
we next used CrkL-deficient mouse embryonic fibroblasts to perform EPEC infection 
experiments. We quantified the number of pedestals and found no difference in the 
number of pedestals between WT, CrkL-deficient MEFs or CrkL reconstituted MEFs 
(Fig23A).  
 
Collectively these results indicate that CrkII or CrkL expression is sufficient to 
compensate for the absence of the other, confirming that Crk isoforms act redundantly 
to inhibit pedestal formation. 
 
To further corroborate the redundancy function, we followed the same approach and 
expressed the R38V dominant negative Crk mutant in WT and CrkL-deficient MEFs. 
Although the differences do not reach statistical significance with five experiments, an 
increase in the number of pedestals was observed in cells transfected with the 
dominant negative mutant (R38V) when compared to WT or CrkL-deficient cells (Fig. 
23B).  
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Figure 19. Pedestal formation is not affected in HeLa cells expressing a Crk dominant 
negative R38V mutant form. (A) The expression of transfectants was assessed by western 
blotting with anti-myc MoAb (lower bands). Actin was used as a loading control (upper 
bands). (B) Immunofluorescence images of HeLa cells transfected with WT CrkII or a 
dominant negative mutant (R38V) or treated with the vehicle (mock) and infected with X 
preactivated EPEC for 2 hours. Red pictures show actin staining; DAPI was used to stain EPEC 
(blue). The merged images shown in last column were generated with Adobe Photoshop. 
Pictures are at 600X magnification. Scale bar represents 20 µm. (C) Quantification of 
pedestals was done by counting the number of pedestals from 100 cells. Graph represents 
mean ± SD. Non-statistical difference was found for the analysis of three independent 
experiments. 
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Figure 20. Pedestal formation is not affected in CrkI/II-deficient mouse embryonic 
fibroblasts. (A) Western-blot using the Odyssey scan system with anti-CrkII antibody in 
wild type and CrkI/II-deficient MEFS to show the endogenous levels of expression and the 
reconstitution with transfected myc-CrkII (R CrkII). Actin was used as a loading control. The 
merge of both images is shown. (B) Immunofluorescence images of MEFs infected with X 
preactivated EPEC for 3 hours. Red pictures show actin staining. DAPI was used to stain 
EPEC. The merged images shown were generated using Adobe Photoshop. Transfected 
cells were stained with anti-myc MoAb followed by Alexa-488 conjugated goat anti-mouse 
secondary Ab. Pictures are at 1000X magnification. Scale bar represents 10 m. (C) 
Quantification of the number of pedestals of WT MEFs (white bar), CrkI/II-deficient MEFs 
(black bar) and Rescued CrkII cells (R CrkII, grey bar). Quantification was done by counting 
the number of pedestals from 100 cells. Graph represents mean ± SD. Non-statistical 
difference was found for the analysis of three independent experiments as shown. 
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Figure 21. Pedestal formation is enhanced in CrkI/II-deficient mouse embryonic 
fibroblasts with CrkL expression inhibited by siRNA. (A) Western-blot with anti-CrkL 
antibody in WT and CrkI/II-deficient MEFS treated using the siRNA oligonucleotide against 
CrkL compared to control oligonucleotide treated cells (lower bands). As a loading control 
the blots were probed with anti-actin antibody (upper bands). (B) Immunofluorescence 
images of WT MEFs and CrkI/II-deficient cells with CrkL expression inhibited by siRNA and 
infected with X preactivated EPEC for 3 hours. Red pictures show actin staining with TRITC-
Phalloidin. Anti-LPS MoAb followed by Alexa-405 conjugated goat anti-mouse secondary 
Ab was used to stain EPEC (in blue). The merge of both images was generated using Leica 
software. Confocal pictures are at 600X magnification. Scale bar represents 20 µm. (C) 
Quantification of pedestals of wild type (WT) and CrkI/II-deficient cells treated with a 
control oligonucleotide (white and grey bars respectively) and depleted of CrkL by siRNA 
(black and dark-grey bars respectively). Quantification was done by counting the number 
of pedestals from 100 cells. Graph represents mean ± SD. Statistical analysis was 
performed using the Student´s t-test from three independent experiments. *, p˂0.05; **, 
p˂0.01; ***, p˂0.001.  
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Figure 22. Increased pedestal formation in CrkI/II-deficient cells expressing a Crk 
dominant negative R38V mutant form. (A) The expression of transfectants was assessed 
by western blotting with anti-myc MoAb. The blot was also probed with anti-CrkII Ab to show 
the endogenous levels of expression of CrkII and the transfected Crk dominant negative 
mutant (arrows). Actin was used as a loading control. The merge of both images is shown. (B) 
Quantification of pedestals of mock treated wild type cells (white bar) and  mock treated 
CrkI/II-deficient cells (black bar) or CrkI/II-deficient cells transfected with the dominant 
negative R38V mutant (grey bar) and infected with X preactivated EPEC for 3 hours. 
Quantification was done by counting the number of pedestals from 100 cells. Graph 
represents mean ± SD. Statistical analysis were performed using the Student´s t-test from 
three independent experiments is shown. *, p˂0.05; **, p˂0.01; ***, p˂0.001. 
Figure 23. (A) Pedestal formation is not affected in CrkL-deficient mouse embryonic 
fibroblasts. Quantification of pedestals of WT MEFs (white bar), CrkL-deficient MEFs (black 
bar) and CrkL reconstituted cells (R CrkL, grey bar). Quantification was done by counting the 
number of pedestals from 100 cells. Graph represents mean ± SD. Non-statistical difference 
was found for the analysis of three independent experiments as shown. (B) Increased 
pedestal formation in CrkL-deficient cells expressing a Crk dominant negative mutant 
form. The expression of transfectants was assessed by western blotting with anti-myc MoAb. 
Actin was used as a loading control. The merge of both images is shown. Graph represents 
the quantification of number of pedestals of mock treated wild type cells (white bar) and  
mock treated CrkL-deficient cells (black bar) or CrkL-deficient cells transfected with the R38V 
dominant negative mutant (R38V, grey bar) and infected with X preactivated EPEC for 3 
hours. Quantification was done by counting pedestal number of 20 transfected cells in five 
independent experiments. Graph represents mean ± SD. The experiments in part B were 
performed by Eugenia Meiler. 
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Part III. Role of the adaptor protein Nck in pedestal formation by EPEC 
 
1. Levels of Tir are reduced in Nck-deficient MEFs infected by EPEC 
 
It is well established that in the absence of Nck in cultured mammalian cells pedestals 
are not formed by EPEC (Campellone et al., 2002; Campellone and Leong, 2005; 
Campellone et al., 2004a; Gruenheid et al., 2001). The rationale for this requirement is 
that Nck recruits and is thought to activate N-WASP promoting Arp2/3 dependent-
actin polymerisation. As shown previously in figure 17, Nck1/2-deficient MEFs 
(designated hereafter as Nck-deficient cells) present a reduced amount of Tir protein 
upon EPEC infection when compared to WT MEFs. To corroborate this initial 
observation we infected Nck-deficient cells that were retrovirally reconstituted with 
EGFP and myc-tagged Nck1 (Nck reconstituted cells, RNck). We used uninfected cells as 
a negative control.  
 
Western blot analysis from total cell lysates with a MoAb against Tir after 1, 2 and 3 
hours of EPEC infection (Fig. 24A) indicated that the levels of Tir are reduced by 88% 
(average of six experiments after normalising for actin) in Nck-deficient cells infected 
with X EPEC when compared to WT control cells. Moreover, Nck reconstituted cells 
present normal levels of Tir protein (Fig. 24A).  
 
To confirm this result we next used the fractionation protocol (Fig. 17) to enrich in Tir-
containing membranes (pellet) with respect to the cytoplasmic fraction that remains in 
the supernatant (Fig. 24B). As previously described (Fig. 17) the fully modified form is 
the predominant form of Tir in the membrane fraction. As shown in Figure 24B, WB 
analysis with anti-Tir MoAb corroborated that the membrane enriched fraction present 
a reduced amount of Tir. 
 
We next wondered whether the reduction of Tir in Nck-deficient cells would also affect 
other TTSS-secreted EPEC effectors. Therefore, we reprobed the membranes for 
detection of EspF.  In contrast to Tir levels, we found equal amounts of EspF protein in 
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all cell types analysed (Fig. 24A and B). This result demonstrated that Nck-deficient cells 
present normal levels of injected EspF effector protein. 
 
2. Depletion of Nck by siRNA in HeLa cells results in a decrease of Tir 
levels and pedestal formation 
 
To corroborate our phenotype in a different cell line we next analysed the levels of Tir 
in the absence of Nck in human epithelial HeLa cells infected by EPEC. For that purpose 
we used commercially available oligonucleotides against human Nck1 and Nck2 to 
inhibit their expression in HeLa cells and a scrambled sequence nucleotide as negative 
control (Fig. 25).  
 
Western blot analysis of the Triton X-100-soluble fraction, that contains the host 
cytoplasmic and membrane fraction (see Materials and Methods), with a MoAb against 
Nck revealed that 16 hours after transfection with the siRNAs the levels of Nck were 
reduced by 85% (average of three experiments after normalising for actin) (Fig. 25A). At 
that point the cells were infected with preactivated EPEC to allow the formation of 
pedestals. Treatment of cells with the siRNAs against Nck1/2 resulted in a statistically 
Figure 24. EPEC-infected Nck-deficient cells have lower levels of Tir, but not of EspF, 
when compared with WT cells. (A) WT, Nck-deficient cells (Nck-/-)  and Nck reconstituted 
cells (RNck) were infected with X preactivated EPEC for 1, 2 or 3 hours or left uninfected as a 
negative control. Cell monolayers from single wells of 6-well-plate was collected by directly 
adding Laemmli sample buffer and processed. Lysates were blotted with anti-Tir MoAb and 
secondly with anti-EspF. (B) WT, Nck-/- and RNck were infected with X preactivated EPEC for 
3 hours or left uninfected as a negative control. Cell monolayers were lysed in imidazole 
buffer and fractionated. The membrane fraction was resuspended in Laemmli sample buffer. 
One third of the pellet (membrane fraction) and one fiftieth of the supernatant (cytoplasmic 
fraction) were blotted with anti-Tir MoAb and anti-EspF Ab. In both (A) and (B) blots were 
visualised with the Odyssey Scan system. Actin was used as a loading control and anti-Nck 
blotting was performed to confirm the genotype of the MEFs used. 
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significant decrease of Tir levels that is more obvious in the fully-modified Tir band (Fig. 
25B). Moreover, we quantified the number of pedestals and there is a significant 
reduced number of pedestals between siRNA-treated cells and control cells (Fig. 25D). 
These results seem to indicate that a reduction of the levels of the expression of human 
Nck in HeLa cells affects the levels of Tir and the number of pedestals formed. 
  
 
3. Levels of Tir are not reduced in N-WASP-deficient MEFs infected by 
EPEC 
 
In order to analysed the levels of Tir in a cell type also resistant to EPEC pedestal 
formation we infected the previously used N-WASP-deficient MEFs (NW-/-) (see Fig. 
17). EPEC infected cells were fractionated into Triton X-100-soluble fraction, that 
contains the host cytoplasmic and membrane fraction, and therefore injected EPEC 
effectors, and Triton X-100-insoluble fraction that contains the host cytoskeleton, the 
nuclei and adherent EPEC (see Materials and Methods and (Kenny et al., 1997)). 
 
Figure 25. Tir levels are diminished in HeLa cells when the expression of Nck1/2 is 
inhibited by siRNA treatment. (A) HeLa cells were treated with siRNAs for Nck1/2 and 
infected with 5X preactivated EPEC strains for 3 hours. Monolayers were lysed in 1% Triton X-
100 lysis buffer. The soluble supernatants were analysed by WB with anti-Tir polyclonal Ab 
and visualised with the Odyssey Scan system. The levels of Nck were analysed by blotting 
with anti-Nck MoAb. Actin and tubulin were used as a loading control. (B) The quantification 
of the intensity of the three WB bands was performed with the Odyssey Scan band tool. 
Graph represents mean ± SD. Statistical analysis using the Student´s t-test from three 
independent experiments. (C) Quantification was done by counting the number of pedestals 
from 100 cells. Graph represents mean ± SD. Statistical analysis using the Student´s t-test 
from two independent experiments. *, p˂0.05; **, p˂0.01; ***, p˂0.001. 
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As noticeable in the soluble fraction of figure 26A the levels of Tir are not diminished in 
N-WASP-deficient cells when compared to WT cells. The translocated effector EspB, 
which forms the translocation pore, and EspF were analysed as controls. Actin was used 
as a loading control. Blotting with anti-N-WASP antibody was performed to confirm the 
genotype of the MEFs. This result implicates that the low levels of Tir found in Nck-
deficient cells cannot be attributed exclusively to the absent of pedestals since both cell 
types lack them. 
 
We next analysed the adhesion of EPEC to this cell line. In addition to indirect detection 
by fluorescence microscopy, another technique that has been described to 
semiquantitative attached bacteria to the cell surface is the Western blot analysis of the 
insoluble fraction with a MoAb against DnaK-an abundant bacterial heat-shock protein. 
Moreover, the levels of Tir and that of other effectors detected in the insoluble fraction 
are also an indicator of the bacterial attachment (Wolff et al., 1998). We observed 
similar levels of DnaK, Tir and EspF in N-WASP-deficient cells and N-WASP 
reconstituted cells, and these levels are even higher than in WT cells (Fig. 26B; fourth 
panel). However, contrary to the expected result EspB was not found in the insoluble 
fraction. These results seem to indicate that the bacterial attachment to N-WASP-
deficient cells is not compromised. 
 
4. Levels of Tir in Nck-deficient cells infected at higher MOIs and 
bacterial attachment to these cells 
 
As mentioned in Material and Methods, Multiplicity of infection (MOI) is the number of 
bacteria added per cell at the beginning of the infection. It has been demonstrated that 
increasing the MOI accelerates the attachment rate as well as the translocation 
efficiency of EPEC (Mills et al., 2008). Thus, we examined whether the infection at higher 
MOIs results in an increase in the levels of Tir in Nck-deficient cells. In addition, we 
wondered whether the attachment of EPEC to Nck-deficient cells is compromised and 
whether it is improved by increasing the MOI. 
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Hence, MEFs were infected at MOIs ranging from 25 (referred as 10X) to 250 (referred 
as 100X) bacteria per cell and Triton X-100-soluble fraction was subjected to WB 
analysis along with the corresponding Triton X-100-insoluble fractions. 
 
 
 
Western blot analysis of the soluble fraction with a polyclonal Ab against Tir shows that 
a remarkable increase in the number of bacteria per cell, results only in a slight increase 
in the levels of Tir in Nck-deficient cells, and the levels remain significantly lower in 
Nck-deficient cells than in WT cells in all MOIs tested (Fig. 27A; upper panel). Actin was 
used as a loading control and blotting with anti-Nck antibody was performed to 
confirm the genotype of the MEFs used.  
 
As shown in figure 27B, we found that the adhesion of EPEC to Nck-deficient cells is 
decreased with respect to WT cells or Nck reconstituted cells (see the red asterisk in 
Figure 26. EPEC-infected N-WASP-deficient cells have equal levels of Tir when 
compared to WT cells. WT, N-WASP-deficient cells (NW-/-) and N-WASP reconstituted 
cells (RNW) were infected with 10X of preactivated EPEC for 3 hours. Monolayers were lysed 
in 1% Triton X-100 lysis buffer. The soluble supernatant containing the cytoplasmic and 
membrane fractions (A) and the insoluble pellet containing the attached bacteria (B) were 
subjected to 12 % SDS-PAGE, blotted with anti-Tir, anti-EspB and anti-EspF polyclonal Abs 
and with anti-Dnak MoAb and visualised with the Odyssey Scan system. Anti-actin was used 
as a loading control and anti-N-WASP were performed to confirm the genotype of the 
MEFs. 
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figure 27). As noticeable in figure 27B, the levels of Tir and other EPEC effectors, EspB 
and EspF, in the insoluble fraction are also reduced with respect to WT cells, which 
could be the consequence of an adhesion defect to Nck-deficient cells.  
 
To determine whether the defect in EPEC adhesion to Nck-deficient cells is affecting the 
injection of EspB, we analyse in the soluble fraction by WB the levels of this effector. As 
shown in the second panel of figure 27A, the levels of EspB were not diminished in 
Nck-deficient cells, as occurred with the levels of EspF that were analysed in parallel in 
the same blot.  
 
On the other side, it can be noticed that an increase in the MOI results in a higher 
number of cell-associated bacteria, but the levels of Tir in these cells are always lower 
when compared to WT cells (Fig. 27B). In summary, we can conclude that Nck-deficient 
cells have not the same levels of Tir than WT cells or Nck1-expressing cells and that 
they have an EPEC adhesion defect. 
 
Figure 27. EPEC-infected Nck-deficient cells have slight higher levels of Tir when the 
MOI is increased. Adhesion of EPEC to these cells is affected. WT, Nck-deficient cells (Nck-
/-) and Nck reconstituted cells (R) were infected with 10X, 50X or 100X preactivated EPEC for 3 
hours. Monolayers were lysed in 1% Triton X-100 lysis buffer. The soluble supernatant 
containing the cytoplasmic and membrane fractions (A) and the insoluble pellet containing 
the attached bacteria (B) were subjected to 12 % SDS-PAGE, blotted with indicated antibodies 
and visualised with the Odyssey Scan system. Actin was used as a loading control and blotting 
with anti-Nck was performed to confirm the genotype of the MEFs used. 
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5. Immunofluorescence staining corroborates the low levels of 
pedestal formation and bacterial adhesion to Nck-deficient cells 
 
In order to confirm the bacterial adhesion defect found in Nck-deficient cells (Fig. 27B), 
semiquantitative assessment was made by counting the number of attached bacteria in 
100 cells in representative microscope fields. For that purpose, immunofluorescence 
staining of cell-associated bacteria using DAPI in WT, Nck-deficient and Nck 
reconstituted cells after EPEC infection was performed. The actin cytoskeleton was 
visualised with fluorescent phalloidin. As shown in figure 28B the number of bacteria 
attached to Nck-deficient cells is significantly lower compared to the bacteria attached 
to WT or Nck reconstituted cells (46,9% in Nck-/- vs 90,8% in RNck, considering that 
the attached bacteria to WT cells is 100%). Hence, immunofluorescence staining 
corroborates the western blot results (Fig. 27B) where we detected lower levels of 
bacterial attachment to Nck-deficient cells.  
 
In addition, quantification of pedestal formation in Nck-deficient cells was also 
assessed. It has been described that Nck-deficient cells are still capable of generating 
actin pedestals, although at fourfold less efficiency compared to Nck-expressing cells 
(Campellone et al., 2004b). Our results show a 20-fold decrease in the efficiency of 
pedestal formation in Nck-deficient cells with respect to WT cells (6% in Nck-/- vs 73% 
in RNck, considering that the pedestals formed in WT cells is 100%) (Fig. 28B; right 
graph). The disagreement cannot be attributed to differences in cell types because the 
cells used in both cases were obtained from the same Nck mutant mouse embryos 
(Bladt et al., 2003). 
 
Collectively, these results seem to indicate that the decrease in EPEC attachment to 
Nck-deficient MEFs is related to the low levels of Tir protein found in these cells. 
Collectively, these results seem to indicate that there is a decrease in EPEC attachment 
to Nck-deficient MEFs and that these cells present low levels of Tir protein and 
diminished pedestal formation. 
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Figure 28. Pedestal formation and bacterial adhesion are compromised in EPEC-
infected Nck-deficient cells. (A) Immunofluorescence images of WT, Nck-deficient cells 
and Nck reconstituted cells (RNck) infected with X preactivated EPEC for 3 hours. Red 
pictures show actin staining with TRITC-Phalloidin. DAPI was used to stain EPEC and host cell 
nuclei. The merge of both images was generated using Leica software and is shown in the 
last column. Pictures were taken in a confocal microscope at 600X magnification. Scale bar 
represents 20 µm. (B) The number of attached bacteria and pedestals of a total of 100 cells 
was quantified from immunofluorescence images. Graph represents mean ± SD. Statistical 
analysis were performed using the Student´s t-test from at least three independent 
experiments is shown. *, p˂0.05; **, p˂0.01; ***, p˂0.001.  
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6. EPEC adhesion to murine cells has a higher dependence on intimin-
Tir interaction than in the case of HeLa cells. 
 
As mentioned in the introduction, the final step of EPEC adhesion to cells involves an 
intimate adherence that is mediated by the interaction between intimin and the 
translocated effector Tir (Kenny et al., 1997).  
 
With the aim to study the role of the interaction between intimin and Tir in EPEC 
adhesion to mouse embryonic fibroblast (MEFs), we performed infection experiments 
of MEFs with an EPEC strain lacking intimin (Δeae mutant) and with a strain lacking Tir 
(Δtir mutant). As a control we used the strain lacking Tir complemented with Tir 
expressed on a low-copy-number plasmid (Δtir+ptir). In order to compare EPEC 
adhesion to murine cells with the adhesion to human cells we also infected HeLa cells 
in parallel. We analysed by WB the Triton X-100-soluble supernatant containing the 
cytoplasmic and membrane fractions along with the Triton X-100-insoluble pellet 
containing the host cell nuclear and cytoskeletal proteins and adherent EPEC.  
 
Western blot analysis of the soluble fraction (Fig. 29A) of Δeae mutant-infected cells 
shows that the levels of Tir in murine cells are really low with respect to human cells 
(Fig. 29A, upper panel), in contrast to the levels of EspB and EspF effectors that were 
clearly comparable. In the upper panel of figure 29A, although the intensity of the 
bands is low, it is also noticeable that the levels of Tir in Nck-deficient cells infected 
with Δeae mutant are lower than the levels of Tir in WT MEFs. Actin was used as a 
loading control and blotting with anti-Nck antibody was performed to confirm the 
genotype of the MEFs used.  
 
To examine the amount of attached bacteria to MEFs with respect to HeLa cells we 
analysed by WB the Triton X-100-insoluble fraction with Dnak MoAb. As shown in 
figure 29B, we found that the adhesion of Δeae mutant to murine fibroblasts (MEFs) is 
clearly reduced with respect to Hela cells. As detectable in figure 29B, the levels of the 
effectors Tir, EspB and EspF also indicate the lower adhesion of Δeae mutant to MEFs 
with respect to HeLa cells. We then infected MEFs and HeLa cells with a strain lacking 
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Tir (Δtir mutant) and obtained similar results. Western blot analysis with the antibody 
against Tir corroborated the absence of Tir in this strain (Fig. 29A and B).  
 
When Δtir mutant was complemented with ptir, the levels of Tir in murine WT and Nck 
reconstituted cells are almost restored at the level observed in HeLa cells (Fig. 29A). It is 
very remarkable that the level of Tir in Nck-deficient cells is higher than previously 
detected in these cells. 
 
Moreover, the adhesion of Δtir+ptir strain to MEFs is increased with respect to Δeae or 
Δtir mutants, as shown by western blot analysis of the insoluble fraction when probed 
with Dnak MoAb (Fig. 29B). As occurred with WT EPEC strain (Fig. 29), the adhesion of 
Δtir+ptir strain to Nck-deficient cells is lower when compared to WT MEFs or Nck 
reconstituted cells (see the red asterisk, Fig. 29B).  
 
Collectively, these results show that the adhesion of EPEC to murine cells in the absence 
of intimin or Tir is clearly diminished with respect to HeLa cells. Hence, the adhesion of 
EPEC to murine cells has a higher dependence on intimin-Tir interaction than in the 
case of HeLa cells.  
 
7. The small fraction of Tir protein present in Nck-deficient MEFs is 
tyrosine-phosphorylated and stable up to 6 hours postinfection 
 
Next we wanted to analyse certain characteristics of the small but detectable fraction of 
Tir present in Nck-deficient cells. Clustering of Tir apparently unleash signal 
transduction events including its phosphorylation at tyrosine residue 474 (Y474) within 
the C-terminal cytoplasmic domain (Kenny, 1999) by several mammalian tyrosine 
kinases including c-Fyn, a Src family kinase (Phillips et al., 2004), Abl, Arg and Etk 
(Bommarius et al., 2007; Swimm et al., 2004a). This phosphotyrosine is the binding site 
for Nck (Gruenheid et al., 2001).  
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In order to examine the phosphorylation status of injected Tir in Nck-deficient cells, we 
performed immunoprecipitation experiments using an anti-Tir MoAb, followed by WB 
with a generic phospho-tyrosine MoAb. As shown in figure 30A, the small fraction of Tir 
present in Nck-deficient cells is tyrosine phosphorylated as visualised in the merge of 
both images.  
 
Subsequently, we examined the stability of Tir present in MEFs treating the cells with 
bactericidal levels of gentamicin, which is a broad spectrum antibiotic that inhibits 
bacterial protein synthesis by binding to the 30S subunit of the ribosome. It is 
established that gentamicin stops the infection process and the injection of effectors by 
EPEC by killing extra-cellular bacteria (Ruchaud-Sparagano et al., 2007). After three 
hours of infection we treated the cells with gentamicin and incubated the cells during 
six hours post-infection. We detected the fully-modified Tir band (Kenny and Warawa, 
2001) even six hours after infection in WT and Nck-deficient cells (Fig. 30B). It is also 
noticeable in figure 30B that the band with faster electrophoretic motility, that 
represents the partially modified Tir form (Kenny and Warawa, 2001), seem to be 
converted to the fully modified form over time. As it has been mentioned in the 
Figure 29. Higher dependence on intimin-Tir interaction of EPEC to adhere to mouse 
embryonic fibroblasts (MEFs). WT, Nck-deficient cells (Nck-/-) and Nck reconstituted cells 
(R) were infected with 20X preactivated EPEC strains for 3 hours. EPEC strains used were Δeae 
mutant (strain lacking intimin), Δtir mutant (strain lacking Tir) and Δtir+ptir (Δtir mutant 
complemented with Tir). Cell monolayers were lysed in 1% Triton X-100 lysis buffer. The 
soluble supernatant containing the cytoplasmic and membrane fractions (A) and the 
insoluble pellet containing the attached bacteria (B) were subjected to 12 % SDS-PAGE, 
blotted with indicated antibodies and visualised with the Odyssey Scan system. Actin was 
used as a loading control and blotting with anti-NWASP was performed to confirm the 
genotype of the MEFs. 
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introduction, the increase in apparent molecular mass of Tir molecule observed in cells 
is not due to tyrosine phosphorylation (Kenny, 1999). Although Tir levels in Nck-
deficient cells are decreased with respect to WT cells in all conditions, we could 
conclude that the fraction of Tir is stable and inserted into the membrane even six 
hours after infection in both cell types (Fig. 30B).  
 
 
8. Levels of Tir are also diminished in Nck-deficient cells infected with 
Tir phosphorylation-deficient mutants of EPEC 
 
Phosphorylation of Tir in tyrosine residue 474 (Y474) generates a docking site for the 
host cell adaptor protein Nck. However, Tir also nucleates actin inefficiently through a 
second phosphorylated-tyrosine (Y454). In addition, it has been identified two serine 
residues in Tir (S434 and S463) that are phosphorylated by PKA. Serine phosphorylation 
Figure 30. Phosphorylation and stability of the small fraction of Tir protein present in 
Nck-deficient MEFs. (A) Tir is tyrosine phosphorylated in Nck-deficient cells. WT, Nck-
deficient cells (Nck-/-) and Nck reconstituted cells (RNck) were infected with 10X 
preactivated EPEC for 3 hours. Cell monolayers were lysed in Ripa buffer and the lysates were 
used to perform IPs using a Tir MoAb that were examined by WB first with a generic 
phospho-tyrosine MoAb (in red) and second with Tir Ab (in green) and visualised with the 
Odyssey system. The merge of both images is shown. The isotype control IP (IgG) and the 
cell lysates loaded in the same gel are shown. (B) Fully modified Tir is stable even 6 hours 
after infection in Nck-deficient cells. WT and Nck-/- cells were infected with 5X 
preactivated EPEC for 3 hours or left uninfected as a negative control. After 3 hours of 
infection, the cells were treated with gentamicin (100 µg/ml) and incubated for 6 hours post-
infection. Cell monolayers from a single well of a 6-well-plate were collected at indicated 
times by directly adding Laemmli sample buffer. Lysates were blotted with anti-Tir MoAb and 
visualised with the Odyssey system.  Actin was used as a loading control. 
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has been shown to be responsible for Tir molecular mass shift and it has been 
proposed that these modifications may induce changes in the three-dimensional 
structure of Tir that may promote its insertion into the host plasma membrane (Kenny, 
1999) (Warawa and Kenny, 2001). Taking into consideration the former data, we wanted 
to analyse the levels of Tir protein in Nck-deficient cells infected by Tir 
phosphorylation-deficient mutants of EPEC.  
 
For that purpose we infected MEFs with strains lacking tir and complemented with a 
low-copy number plasmid expressing non-phosphorylatable forms of Tir. The strain 
referred as dY (Δtir+ptirY474F/Y454F) expresses Tir with substitutions in tyrosine 
phosphorylation sites 474 and 454, the strain referred as dS (Δtir+ ptirS434/463A) 
expresses Tir with substitutions in serine phosphorylation sites 434 and 463, and the 
strain referred as quad (Δtir+ptirY474F/Y454F S434/463A) expresses Tir with 
substitutions in the two tyrosine and the two serine sites. Infection with Δtir+ptir strain 
(Δtir mutant complemented with a low-copy number plasmid expressing Tir) was used 
as a control.  
 
Western blot analysis of the Triton X-100-soluble fraction revealed lower levels of Tir in 
Nck-deficient cells infected with all EPEC strains used with respect to WT cells (Fig. 31A). 
The analysis of DnaK protein in the Triton X-100-insoluble fraction also indicates that 
the adhesion of the different strains to Nck-deficient cells is diminished when 
compared to WT cells (Fig. 31B).  
 
These results show that Nck-deficient cells infected with Tir phosphorylation-deficient 
mutants also have low levels of Tir and that the adhesion of these mutants to Nck-
deficient cells is also diminished, as occurred in infection experiments using WT EPEC. 
Thus, the mutation in the tyrosine and serine relevant residues of the Tir molecule does 
not impact on the low levels of Tir in Nck-deficient cells. 
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9. Tir does not undergo full modification in Nck-deficient MEFs when 
bacterial protein synthesis is inhibited  
 
It has been described that the induction of pedestal formation and tyrosine 
phosphorylation of Tir by preactivated EPEC is dependent on de novo bacterial protein 
synthesis during the few first minutes of the encounter between the bacteria and the 
host cell (Rosenshine, 1996). Accordingly, 15 to 20 minutes of infection at a high MOI is 
sufficient for EPEC to trigger the process of pedestal formation and tyrosine 
phosphorylation of injected Tir which continued during the treatment with an antibiotic 
that inhibits protein synthesis, chloramphenicol.  
 
The phosphorylation of Tir on non-tyrosine residues is linked to shifts in apparent 
molecular mass converting the unmodified Tir population to the modified Tir form. 
Moreover, this modified form undergoes modifications leading to the fully-modified 
form, detected as the band that has the slowest electrophoretic motility (represented 
with the upper arrow in figure 37) (Kenny and Warawa, 2001). These shifts in Tir are 
Figure 31. Nck-deficient cells infected with Tir phosphorylation-deficient mutants also 
have lower levels of Tir when compared with WT cells . WT, Nck-deficient cells (Nck-/-) 
and Nck reconstituted cells (R) were infected with 20X preactivated EPEC strains for 3 hours. 
EPEC strains used were Δtir+ptirY474F/Y454F strain (referred as dY), Δtir+ptirS434/463A 
strain (referred as dS) and Δtir+ptirY474F/Y454F S434/463A strain (referred as quad). 
Infection with Δtir mutant complemented with Tir was used as a control. Monolayers were 
lysed in 1% Triton X-100 lysis buffer. The soluble supernatant containing the cytoplasmic and 
membrane fractions (A) and the insoluble pellet containing the attached bacteria (B) were 
subjected to 12 % SDS-PAGE, blotted with indicated antibodies and visualised with the 
Odyssey Scan system. Actin was used as a loading control. 
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thought to reflect phosphorylation-induced conformational changes facilitating the 
insertion into the plasma membrane (Kenny, 1999).  
 
Taken the previous findings into account, we ought to analyse the distinct forms of Tir 
at early time points following infection at a high MOI and after inhibiting protein 
synthesis. For that purpose, WT and Nck-deficient cells were infected for 15 minutes at 
a MOI of 250 with preactivated EPEC and bacterial protein synthesis was then inhibited 
by adding chloramphenicol. The cells were incubated for 1, 2 and 3 hours, and then 
proteins were extracted in 1% Triton X-100-lysis buffer and used for WB with a 
polyclonal antibody against Tir. WB analysis of the Triton X-100-soluble fraction with 
anti-Tir Ab after 3 hours in the presence of chloramphenicol, revealed the shift from the 
band which represent the partially modified Tir form to the slower electrophoretic 
motility band of Tir, which represents fully-modified Tir form in WT cells (Fig. 32, left 
panel).  
 
 
On the contrary, we could not detect the fully-modified Tir form in Nck-deficient cells 
at any time (Fig. 32, right panel). Moreover, after 180 minutes of treatment with 
chloramphenicol we were not able to detect the band of partially modified Tir form in 
Nck-deficient cells. In summary, these results suggest that de novo protein synthesis in 
Figure 32. The inhibiton of bacterial protein synthesis results only in partial 
modification of Tir protein in MEFs lacking Nck. WT and Nck-deficient cells were infected 
with 100X (equivalent to a MOI of 250) of preactivated EPEC for 15 minutes. Cells were then 
treated with chloramphenicol (+Cmp, 100 µg/ml) or vehicle-treated as a control (-Cmp) and 
incubated for 1, 2 and 3 h. Monolayers were lysed in 1% Triton X-100 lysis buffer. The soluble 
supernatant containing the cytoplasmic and membrane fractions were used for WB with anti-
Tir Ab and anti-EspF and visualised with the Odyssey Scan system. Actin was used as a 
loading control.  The image of Tir Ab in the part of the gel that corresponds to the untreated 
infected-cells was adjusted at lower intensity for better visualisation of the different bands of 
Tir. Arrows indicate the partially modified and the fully-modified Tir forms. 
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EPEC is necessary for the conversion of the partially modified to fully modified Tir form 
in the absence of Nck. In addition, the results seemed to indicate that the non fully-
modified Tir can be degraded in the absence of Nck. 
 
10. Map, another CesT-dependent EPEC effector, is also diminished in 
infected-Nck-deficient cells 
 
The efficiency of bacterial attachment to the host cell and the interaction of the 
effectors with chaperones are important parameters that regulate translocation 
efficiencies (Mills et al., 2008). Because of the tight regulation of the process of 
secretion and translocation, some proteins are stored in the bacterial cytoplasm before 
they are secreted. In some cases, these proteins require the presence of a dedicated 
family of TTS chaperones. Certain TTS chaperones are thought to bind a single effector 
(class IA), whereas others have been demonstrated to bind more than one effector 
(class IB) (Parsot et al., 2003). The class IB chaperone CesT binds and enhances the 
translocation of Tir and Map (Creasey et al., 2003), and probably also influences the 
translocation of EspH, EspZ, and some non-LEE efectors (Thomas et al., 2005). With the 
aim of analysing the levels of other CesT-dependent effector, we infected Nck-deficient 
cells with a modified EPEC strain that expresses a haemagglutinin (HA)-tagged Map 
effector.  
 
Western blot analysis of Triton X-100-soluble fraction with a monoclonal antibody 
against HA shows a reduction in the levels of Map in Nck-deficient cells when 
compared with WT cells (Fig. 33). This result indicates that in addition to Tir, another 
EPEC effector is diminished in Nck-deficient cells. A possible interpretation considering 
this result is an Nck-dependent translocation defect of CesT-dependent effectors, such 
as Tir and Map, or alternatively, a specific degradation process dependent on the CesT 
chaperone. In any case these defects do not impact on EspF or EspB (Fig. 33), which use 
a different chaperone for their delivery process. 
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11. Analysis of the possible degradation of bacterial Tir 
11.1. Ectopic expression of Tir is not reduced in Nck-deficient MEFs 
 
A possible explanation for the reduction of Tir levels in Nck-deficient cells could be that 
the rate of Tir degradation is increased during infection in the host cell. Hence, to 
determine whether the expression of ectopically expressed EPEC Tir was compromised, 
we transfected Nck-deficient cells with a mammalian expression plasmid encoding His-
tagged full length Tir. We found that transfected Tir is not reduced in Nck-deficient 
cells when compared to WT cells (Fig. 34A). Parallel transfections of GFP-tagged 
cortactin served as a control for the transfection efficiency (Fig. 34A). This result seems 
to indicate that transfected Tir is not being degraded within Nck-deficient cells.  
 
However, the EPEC-infection of transfected WT MEFs showed that both bands of 
transfected Tir display smaller apparent molecular masses than the EPEC-delivered Tir 
(Fig. 34B). This result demonstrates that ectopically expressed Tir only undergoes partial 
modification within host cell as it has been published (Kenny and Warawa, 2001). 
Moreover, the studies of Kenny and Warawa indicate that transfected Tir does not get 
inserted into the membrane for intimin interaction and predict that EPEC encodes 
additional factors that have to be coexpressed or codelivered with Tir to enable its full 
Figure 33. The levels of Map effector protein in infected-Nck-deficient cells are lower 
than in WT cells. WT, Nck-deficient cells and Nck reconstituted MEFs (R) were infected with 
20X of preactivated WT EPEC or EPEC strain that expresses tagged-Map (T7MapHA) for 3 
hours. Monolayers were lysed in 1% Triton X-100 lysis buffer. The soluble supernatant 
containing the cytoplasmic and membrane fractions were analyse for WB with anti-Tir Ab, 
anti-HA and with anti-EspF and visualised with the Odyssey Scan system. Actin was used as a 
loading control.  
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modification (Kenny and Warawa, 2001). The former data represent a limitation for the 
use of the ectopic expression of Tir in our study. 
 
 
 
11.2. Proteasome inhibitor and two distinct protease inhibitors failed to 
recover the levels of Tir in Nck-deficient cells 
 
Ubiquitination followed by proteasomal degradation (Kubori and Galan, 2003) or 
degradation by cytoplasmic proteases (Thomas et al., 2005) are two mechanisms by 
which bacterial pathogens control the intracellular effector protein activity in the host 
cell. Hence, we tested the effect of chemical inhibitors in order to block a possible 
degradation of Tir.  
 
To this end we treated the cells prior to infection with a specific proteasome inhibitor, 
MG-132, at a concentration of 50 µM for 1 hour known to prevent EPEC-induced 
protein degradation in infected cells (Ruchaud-Sparagano et al., 2007; Savkovic et al., 
2001). Untreated cells were used as a control. EPEC infections were stopped by 
Figure 34. The levels of ectopically expressed Tir are neither reduced nor modified in 
Nck-deficient cells. (A) WT, Nck-deficient cells (Nck-/-) and Nck reconstituted cells (R) were 
transfected with pcDNA3.1HisB-Tir or pC2-EGFP-cortactin. Cell monolayers from a single well 
of 6-well-plates were collected after 20 h of transfection by directly adding Laemmli sample 
buffer. Lysates were blotted with anti-Tir MoAb and anti-cortactin MoAb and visualised with 
the Odyssey Scan system. Tubulin was used as a loading control. (B) WT MEFs were 
transfected with pcDNA3.1HisB-Tir and infected with X preactivated EPEC for 3 hours. Cell 
monolayers from a single well of 6-well-plates were collected by directly adding Laemmli 
sample buffer. Lysates were blotted with anti-Tir MoAb and visualised with the Odyssey Scan 
system. Actin was used as a loading control. 
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gentamicin treatment and cellular extracts were collected at indicated times after 
infection. As shown in figure 35A western blot analysis of the cellular extracts with a 
monoclonal antibody against Tir revealed that the levels of Tir do not differ between 
treated or untreated Nck-deficient cells.  
 
On the other hand, it has been proposed that caspase-1, which belongs to a family of 
cysteine proteases implicated in apoptosis and inflammation, might be subverted by 
several enteropathogenic bacteria. The activation of RhoGTPases might represent a 
novel type of signalling input that can activate caspase-1 signalling (Muller et al., 2010). 
Hence, caspases could be activated in EPEC infection and implicated in degradation of 
EPEC effectors. We treated WT and Nck-deficient MEFs with a general cell-permeable 
caspase inhibitor (Z-VAD-FMK) for 2 hours prior infection or cells were left untreated as 
a control. As shown in Figure 35B (left panel) the treatment with Z-VAD-FMK does not 
increase the levels of Tir in WT cells or in Nck-deficient cells.  
 
Finally, considering the possible role of host proteases in degradation of bacterial 
effectors we analysed the levels of Tir after inhibiting a broad spectrum of cellular 
proteases. For that purpose, we treated WT and Nck-deficient cells with protease 
inhibitor cocktail P8340 for 4 hours prior infection or cells were left untreated as a 
control. As shown in Figure 35B (right panel) the treatment does not increase the levels 
of Tir in any of the cell types studied. We also treated the cells with P8340 for 20 hours 
pre-infection with similar results (data not shown). Collectively, these results seem to 
indicate that Tir is not being degraded by proteasome, caspases or proteases in EPEC-
infected Nck-deficient cells. 
 
11.3. The lack of calpain 1 and calpain 2 does not increase the levels of 
Tir in Nck-deficient cells 
 
The calpains are a family of cysteine proteases that are found in many tissue types and 
cleave a large number of host proteins. Calpain 4 is a small regulatory subunit required 
for expression and activity of the ubiquitously expressed calpains 1 and 2. Moreover, 
EPEC infection leads to the activation of host calpains (Dean et al., 2010).  
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In order to test the effect of the absence of calpains in the levels of Tir we infected WT 
and calpain 4-deficient MEFs with EPEC. As a control we infected MEFs that were 
retrovirally reconstituted with calpain 4. As shown in figure 35C we did not detect any 
variation in the levels of Tir in cells that lack calpain 1 and calpain 2. This result seems 
to indicate that calpains are not involved in Tir degradation.  
 
 
 
 
 
Figure 35. Tir levels are not recovered in Nck-deficient cells after the treatment with 
different inhibitors. The absence of calpain1 and calpain2 does not promote an 
increase in Tir levels. (A) Treatment with proteasome inhibitor failed to recover Tir 
protein levels. WT and Nck-deficient cells were treated with the proteasome inhibitor 
MG132 (50 µM) for 1 h prior to 3h-infection with 5X preactivated EPEC. Cells were left 
untreated as a control. After infection, cells were treated with gentamicin (100 µg/ml) and 
incubated for 1.5 h post-infection. Monolayers were collected at indicated times and lysed in 
imidazole buffer. Clarified lysates were obtained by centrifugation, were analysed by WB with 
anti-Tir MoAb. The numbers to the left of the blots indicate the molecular mass in KDa. (B) 
Treatment with caspase inhibitor and general protease inhibitor failed to recover Tir 
protein levels. WT and Nck-/- cells were treated with caspase inhibitor Z-VAD-FMK (50 µM) 
for 2 h prior to infection or with protease inhibitor cocktail P8340 (1:1000) for 4 h prior to 3h-
infection with 5X preactivated EPEC. (C) In the absence of calpain 1/2 the levels of Tir do 
not increase. WT, calpain-deficient cells and calpain reconstituted cells (Rcalpain) were 
infected with X preactivated EPEC for 1, 2 and 3 hours. In both (B) and (C) cell monolayers 
from a single well of 6-well-plates were collected by directly adding Laemmli sample buffer 
and analysed by WB with anti-Tir MoAb. The blots were visualised with the Odyssey Scan 
system. Actin was used as a loading control. 
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11.4. The treatment with Trichostatin A increases the levels of Tir and 
improves EPEC attachment 
 
Trichostatin A (TSA) was isolated from the metabolites of strains of Streptomyces 
hygroscopicus and originally characterised as an anti-fungal antibiotic (Tsuji et al., 1976) 
and later identified as specific histone deacetylase inhibitor (HDACi). TSA specifically 
inhibits class I and II histone deacetylases (Matsuyama et al., 2002), such as HDAC6 
which acts as a tubulin and cortactin deacetylase. HDACis have shown promise in 
inhibiting tumorigenesis and metastasis due to their potent anti-proliferative and 
apoptotic effects in malignant cells (reviewed in (Barneda-Zahonero and Parra, 2012)). 
HDAC inhibitors have been shown to exhibit anti-inflammatory activity. Thus, recently it 
has been demonstrated that TSA directly inhibits nuclear factor kB (NF-kB) induced 
transcription and the induction of inflammatory genes by tumour necrosis factor-α 
(TNF- α) (Furumai et al., 2011). Interestingly, it has been also reported that HDAC6 
controls autophagosome maturation essential for the autophagy independent of 
nutrient status named quality-control autophagy (Lee et al., 2010). Hence, the 
prototypical HDAC inhibitor TSA could suppress autophagy, as has been recently 
described in pathological cardiac remodelling (Cao et al., 2011). 
 
In order to test the effect of the treatment with TSA in the levels of Tir we treated Nck-
deficient cells and their WT counterparts for 16 h prior to infection, or left them 
untreated as a control. Nck reconstituted cells were used as a control. Western blotting 
analysis of the Triton X-100-soluble fraction with a polyclonal antibody against Tir 
revealed that the levels of Tir are increased in TSA-treated Nck-deficient cells with 
respect to untreated Nck-deficient cells. Moreover, the treatment with TSA also 
increases Tir levels in WT and Nck reconstituted cells (Fig. 36A, upper panel). It is 
noticeable that the levels of EspB and EspF are also increased with TSA treatment (Fig. 
36A). These results seem to indicate that the treatment with TSA has a general effect on 
TTSS-dependent effectors. 
 
To determine whether TSA treatment affects the attachment of EPEC to MEFs we 
analyse by WB the levels of DnaK in the Triton X-100-insoluble fraction. As shown in 
figure 36B, we found a general increment in the levels of EPEC adhesion after TSA 
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treatment. Thus, we can conclude that TSA treatment increases the levels of Tir and the 
adhesion of EPEC to mouse embryonic fibroblast.  
 
 
 
11.5. The treatment with Trichostatin A increases the efficiency of 
pedestal formation 
 
In order to study if the increased levels of Tir after TSA treatments correlate with an 
increment in the number of pedestal formed in Nck-deficient cells we quantified the 
number of pedestals formed in TSA treated and untreated cells. The 
immunofluorescence staining for actin in figure 37A shows that the treatment with TSA 
increases significantly the efficiency of pedestal formation with respect to untreated 
MEFs.  
 
Figure 36. TSA treatments increase the levels of Tir in EPEC-infected MEFs and also 
increase bacterial attachment. WT, Nck-deficient cells (Nck-/-) and Nck reconstituted cells 
(RNck) were treated with the Trichostatin A (TSA, 5 µM) for 16 hours prior to 3h-infection 
with 5X preactivated EPEC. Cell monolayers were lysed in 1% Triton X-100 lysis buffer. The 
soluble supernatant containing the cytoplasmic and membrane fractions (A) and the 
insoluble pellet containing the attached bacteria (B) were subjected to 12 % SDS-PAGE, 
blotted with indicated antibodies and visualised with the Odyssey Scan system. Actin was 
used as a loading control and blotting with anti-Nck was performed to confirm the genotype 
of the MEFs. 
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As shown in the graph, the number of pedestals formed in TSA-treated-Nck-deficient 
cells increases four fold with respect to untreated Nck-deficient cells (Fig. 37B). This 
result implicates that a recovery in Tir levels induced by TSA corresponds with higher 
pedestal formation efficiency. In addition, it can be noticed that TSA treatments also 
result in an increase in EPEC attachment to cells (Fig 37B, bottom graph). 
 
The levels of Tir were further supported by immunofluorescence staining using a 
monoclonal antibody against Tir in TSA-treated or untreated MEFs. As shown in figure 
38 the staining of Tir in Nck-deficient cells is remarkably fainter than in WT cells. This 
observation corroborates previous results obtained by WB analysis of Tir levels in Nck-
deficient MEFs (Fig. 24). Importantly, TSA-treated Nck-deficient cells exhibited higher 
staining levels of Tir. In summary, the results obtained with WB and 
immunofluorescence assays demonstrate that treatments with Trichostatin A increase 
the levels of Tir, the number of pedestals and the adhesion of EPEC to mouse 
embryonic fibroblasts. 
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Figure 37. TSA treatments increase the formation of pedestals and the bacterial 
attachment to MEFs. (A) WT, Nck-deficient cells (Nck-/-) and Nck reconstituted cells (RNck) 
were treated with Trichostatin A for 16 h and infected with X preactivated EPEC for 3 hours. 
Red pictures show actin staining with TRITC-Phalloidin. DAPI was used to stain EPEC. The 
merge of both images was generated with Leica software and is shown in the last column. 
Pictures were taken in a confocal microscope at 600X magnification. Scale bar represents 20 
µm. (B) The number of attached bacteria and pedestals of a total of 100 cells were quantified 
from immunofluorescence images. Graph represents mean ± SD. Statistical analysis using 
Mann Whitney test from two independent experiments for the number of bacteria or four 
independent experiments for the number of pedestals is shown. *, p˂0.05; **, p˂0.01 
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Figure 38. Tir staining by immunofluorescence in MEFs treated with TSA. 
Immunofluorescence images of WT, Nck-deficient cells (Nck-/-) and Nck reconstituted cells 
(RNck) treated with Trichostatin A for 16 h (or left untreated as a control) and infected with X 
preactivated EPEC for 3 hours. Immunofluorescence staining was done using Tir 2A5 MoAb 
(in green) and DAPI was used to stain EPEC (in blue). The merge of both images was 
generated with Leica software and is shown in the last column. Pictures were taken in a 
confocal microscope at 600X magnification. Scale bar represents 20 µm. 
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DISCUSSION 
 
Numerous pathogens have evolved mechanisms to subvert for their own benefit the 
cellular regulatory complexes that control actin polymerisation. Enteropathogenic 
Escherichia coli (EPEC) manipulates the host actin cytoskeleton from an extracellular 
position providing a potent model system to study eukaryotic signalling events in 
response to external stimuli (Hayward et al., 2006). 
 
Diverse host cell proteins implicated in cytoskeletal remodelling, and normally localised 
as part of focal adhesions, are recruited to the site of EPEC attachment including α-
actinin, talin, vinculin (Goosney et al., 2001) as well as actin regulatory proteins such as 
cortactin (Cantarelli et al., 2000), linking the extracellular bacterium to the host cell 
cytoskeleton. Besides those proteins, several adaptor proteins are also recruited to the 
pedestal such as p130Cas, Grb2 and Crk (Goosney et al., 2001). Although over 10 years 
have passed since this study, the precise role of most of these proteins in pedestal 
formation remains to be elucidated.  
 
EPEC initiates localised actin assembly to generate pedestals by injecting its 
translocated intimin receptor (Tir) into the host cell. Once Tir is inserted into the host 
plasma membrane, its extracellular domain is available to bind the bacterial adhesin 
intimin. The clustering of Tir in the host cell membrane upon intimin binding appears to 
trigger downstream signalling cascade leading to the formation of actin pedestals 
(Kenny et al., 1997). The formation of pedestals is dependent on phosphorylation of Tir 
in tyrosine residue 474 which is a docking site for the host adaptor protein Nck 
(Gruenheid et al., 2001). Nck recruits and activate N-WASP, leading to Arp2/3 complex 
activation promoting actin polymerisation. Cortactin, which is required for pedestal 
formation ((Cantarelli et al., 2002) and this study), is an additional activator of N-WASP 
protein. In addition to binding and activating N-WASP (Martinez-Quiles et al., 2004), 
cortactin can promote actin nucleation by activating the Arp2/3 complex (Uruno et al., 
2001). Furthermore, cortactin can bind Nck (Okamura and Resh, 1995) and WIP (Kinley 
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et al., 2003), which makes cortactin a potential candidate protein for participating in the 
complex scenario of Tir-mediated signalling to actin polymerisation. 
In the present study we tried to gain further insight into the contribution of cortactin 
and the adapter Crk to pedestal formation. Moreover, we investigated the reduced 
amount of Tir protein we found in mouse embryonic fibroblast lacking Nck. This issue 
might have important consequences on the current model for pedestal formation since 
the Tir:Nck:N-WASP signalling pathway has been the principal one considered both 
necessary and sufficient for actin polymerisation. Tir is the first effector injected into the 
cell and has the highest steady-state levels (Mills et al., 2008). Indeed, Tir is a major 
translocated effector shown to be essential for disease development (Deng et al., 2003; 
Marches et al., 2000). Moreover, in vitro cultured cells appear to be a selective pressure 
for the preservation of the Tir Y474 or Y454 signalling pathways responsible for actin 
polymerisation leading pedestal formation. Collectively, the former data highlight the 
importance of studying a possible regulation of Tir in the absence of Nck. 
Cortactin contributes to Tir:Nck:N-WASP signalling pathway 
 
Although it was described that cortactin localises to EPEC pedestals (Cantarelli et al., 
2000) and its NTA domain truncated form exerts a dominant negative effect (Cantarelli 
et al., 2002), its role in pedestal formation was uncertain. The inhibition of the 
expression of cortactin with specific siRNA oligonucleotides resulted in a drastic 
reduction in the number of pedestals formed by EPEC. This result has been 
corroborated by a complementary study (Cantarelli et al., 2006) and it further supports 
an essential role for cortactin in actin assembly induced by EPEC.  
 
Overexpression of wild type cortactin in HeLa cells has no effect on pedestal formation 
when compared with mock cells. However, overexpression of W22A cortactin mutant, 
that fails to bind the Arp2/3 complex, and that of the W525K, that abrogates the 
binding to SH3-binding targets, inhibit pedestal formation (Fig. 12). These results 
indicate that both constructs exerts a dominant negative effect, which may mean that 
cortactin binding and activation of the Arp2/3 complex through the NTA domain, and 
N-WASP or any other SH3-binding partner, is necessary for pedestal formation. 
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Collectively, these results demonstrate that cortactin indeed contributes to efficient 
actin polymerisation. In addition, the study of Cantarelli and colleagues corroborated 
our results regarding WT cortactin and the W525K mutant, although the W22A mutant 
was not studied in their work (Cantarelli et al., 2006).  
 
With the aim to address the role of Erk and Src phosphorylation of cortactin, we next 
used both phosphorylation-mimicking and non-phosphorylatable mutants. The mutant 
that mimics phosphorylation by Erk has a 'neutral' effect on pedestal formation, while 
the Erk non-phosphorylatable form blocked pedestal formation (Fig. 12). These results 
prompted us to conclude that phosphorylation of cortactin by Erk may positively 
regulate pedestal formation. The presence of endogenous cortactin could explain 
why the phosphoserine-mimicking mutant did not lead to significantly more pedestals 
than WT cortactin, although an increase was detectable. Otherwise, this mutant 
accumulates in only one-fourth of pedestals and shows weak diffuse staining in the 
cytoplasm and a strong nuclear staining. The role of this distribution needs further 
investigation. In contrast, Cantarelli and colleagues did not use the phosphoserine-
mimicking mutant concluding that this phosphorylation is not necessary for pedestal 
formation (Cantarelli et al., 2006).  
 
To continue, we overexpressed the mutant that mimics phosphorylation by Src and the 
corresponding non-phosphorylatable mutant. In both cases pedestal formation is 
impaired, as well as the accumulation of the mutant proteins to the EPEC-induced 
pedestals (Fig. 12). These results seem to indicate that tyrosine phosphorylation of 
cortactin inhibits pedestal formation. The same conclusion was reached using the 
double Y421,466D mutant which partially mimics Src phosphorylation (Cantarelli et al., 
2006). However, the fact that both Src mimicking and non-phosphorylatable cortactin 
forms inhibited the formation of pedestals might indicate that a dynamic tyrosine 
phosphorylation play a role in the formation of pedestals.  
 
We next analysed the phosphorylation status of cortactin following EPEC infection 
concluding that the presence of N-WASP is required for EPEC-induced tyrosine 
phosphorylation of cortactin in mouse embryonic fibroblast (MEFs) (Fig. 13). Moreover, 
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we showed that EPEC induces at least the phosphorylation of cortactin at serine residue 
405 which, as occurred with tyrosine-phosphorylation, is not up-regulated in EPEC 
infected N-WASP-deficient cells (Fig. 14). On the other hand, MEFs depleted for Nck 
show higher basal levels of phosphotyrosine cortactin that were maintained or slightly 
reduced after EPEC infection (Fig. 13). These cells also show a higher basal level of 
phosphorylation at S405 and S418 that was increased after EPEC infection (Fig. 14). The 
higher levels of total cortactin protein consistently found on Nck-deficient MEFs could 
explain the higher basal levels of cortactin phosphorylation. Together these findings 
suggest that tyrosine/serine phosphorylation of cortactin induced by EPEC infection 
could require the presence of N-WASP, while Nck is not required at least for the serine 
phosphorylation of cortactin. 
 
We reported a robust phosphorylation of Y466 of cortactin after pervanadate 
treatment, thus the signalling cascade leading to cortactin phosphorylation was not 
impaired in any of the cell types used (Fig. 13). Importantly, we also concluded that 
EPEC-induced Src activation is not affected by the absence of N-WASP, whereas Erk 
activation is seriously compromised. Hence, the lack of cortactin tyrosine 
phosphorylation found in N-WASP-deficient cells is not due to a defect on Src 
activation, whereas the lack of serine phosphorylation could be due to a defect on Erk 
activation (Figs. 13 and 14). The former result implicates that Erk could potentially 
phosphorylate cortactin during the process of pedestal formation by EPEC, while other 
tyrosine kinase distinct of Src could phosphorylate cortactin.  
 
It was shown that EPEC is still capable of forming pedestals on cells lacking Abl-1 and 
Abl-2 or those lacking Src, Yes and Fyn (SYF cells) and that the Src family inhibitor PP1 
has no effect on actin polymerisation induced by EPEC (Cantarelli et al., 2000; Swimm et 
al., 2004a). Likewise, we observed that treatments with the Erk inhibitor U0126 do not 
affect the number of pedestals formed by EPEC (Fig. 15). Knowing that EPEC uses any of 
several functionally redundant tyrosine kinases to ensure Tir phosphorylation (Swimm 
et al., 2004a), it might be possible that in the presence of inhibitors other redundant 
kinases would lead to pedestal formation.  
  
153 
 
DISCUSSION 
Collectively, the results obtained with the overexpression of the cortactin mutants seem 
to indicate that serine phosphorylation of cortactin contributes to pedestal formation, 
whereas tyrosine phosphorylation inhibits it. On the other hand, we reported that the 
infection with EPEC induces the N-WASP-dependent phosphorylation of cortactin in 
tyrosine and serine residues. These findings strongly suggest a coordinated action of 
cortactin and N-WASP during pedestal formation, consistent with the on/off switching 
mechanism by which cortactin activates N-WASP in vitro (Martinez-Quiles et al., 2004). 
In like manner, the serine phosphorylation of cortactin would positively regulate 
pedestal formation by allowing the interaction of cortactin with N-WASP.  
 
Recently it has been shown in a commentary that cortactin can be simultaneously 
phosphorylated in serine and tyrosine residues as evidence opposing the ‘S-Y Switch’ 
model (Kelley et al., 2011). However, the ‘S-Y Switch’ model only proposes that the 
tyrosine phosphorylation of cortactin abrogates the effect of the serine 
phosphorylation with respect to the activation of N-WASP, and it does not assume that 
cortactin cannot be phosphorylated in serine and tyrosine residues simultaneously. A 
remaining question is whether cortactin is phosphorylated sequentially, e.g. serine 
followed by tyrosine phosphorylation. Future studies will clarify the still controversial 
regulation of this protein. 
 
A crucial finding of this study is that cortactin and Tir bind each other directly in vitro, 
as demonstrated using purified recombinant proteins (Fig. 16A). Since Tir possesses a 
consensus motif for binding to cortactin, centered on proline residue P20, our initial 
hypothesis was that they would interact directly through the SH3 domain of cortactin. 
Indeed, the SH3 domain of cortactin is able to bind Tir, but unexpectedly, the NH2 
domain is also found to bind Tir. In addition, we did not detect differences in the 
affinity binding of cortactin mutants that mimic phosphorylation by Erk and Src (Fig. 
16A). These results contrast the previous binding studies of Martinez-Quiles and 
colleagues in which a mutant that mimics phosphorylation by Erk was found to bind 
preferentially to N-WASP (Martinez-Quiles et al., 2004). In summary, cortactin binds Tir 
through both its N-terminal region and the SH3 domain, and this interaction seems to 
occur independently of cortactin phosphorylation.  
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In agreement with this conclusion, experiments using a two-hybrid system show that 
both the N-terminal region and the SH3 domain of cortactin bind Tir of the related 
pathogen EHEC (Cantarelli et al., 2007). Moreover, Cantarelli and colleagues also 
corroborate the induction of cortactin tyrosine phosphorylation after EPEC infection 
(Cantarelli et al., 2007). Contrary to these findings, the authors show that EHEC induces 
dephosphorylation of cortactin that occurs concomitantly with a transient interaction 
between the N-terminal part of TirEHEC and the N-terminal domain of cortactin. These 
results highlight the fine-tuned nature of cortactin regulation during EPEC and EHEC 
infections. 
 
Cortactin can directly binds to and activate the Arp2/3 complex through its NTA 
domain (Uruno et al., 2001). We report here that Tir-coated beads activate cortactin in 
vitro leading to Arp2/3 complex-dependent actin polymerisation. Furthermore, the 
activation of cortactin by Tir is not affected by the phosphorylation status of cortactin, 
as occurred for the binding (Fig. 16B). These results further support the idea that Tir 
binds and activates cortactin independently of the latter's phosphorylation status in 
EPEC signalling. The fact that the phosphorylation mimicking Tir mutant (Y474D) did 
not show significant differences from WT Tir in both binding and activation 
experiments may means: (I) the mutant does not behave like the phosphorylated form 
or (II) the binding and activation of cortactin is independent of Tir phosphorylation on 
residue 474. Further experiments are needed to address this question. 
 
Considering all the data we hypothesised that the relevant contribution underlying 
cortactin-Tir binding occurs through the N-terminal moiety of cortactin, since our 
previous studies indicated that phosphorylation of cortactin affects mainly its 
interaction with partners through the SH3 domain.  
 
To test this hypothesis, we used lysates from cultured MEFs that represent a more 
restrictive scenario. Consistent with our reasoning, cortactin binds Tir primarily through 
its N-terminal region, while the contribution of the SH3 domain seems to be irrelevant. 
Furthermore, this interaction does not require N-WASP (Fig. 17). Alternatively, the SH3 
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domain of cortactin may be occupied by other SH3 domain-containing proteins such as 
tyrosine kinases (Swimm et al., 2004a) or may have a preference for binding N-WASP. 
We were not able to detect the binding of cortactin to Tir in Nck-deficient cells. 
Notably, the dramatic reduction of Tir found in those cells infected by EPEC could 
explain why we failed to detect such interaction. Alternatively, it is possible that the 
interaction between Tir and cortactin requires Nck. Further experiments will be required 
to determine if cortactin and Tir interact in the absence of Nck in MEFs.   
 
Finally, in an attempt to understand what kind of complexes could be formed in vivo, 
we considered all available in vitro data concerning the interaction of Tir, Nck, N-WASP 
and cortactin. Thus, Nck binds cortactin only when phosphorylated by Src (Tehrani et 
al., 2007). Therefore since Tir and Nck interact through the single SH2 domain of Nck, 
formation of a Tir-Nck-cortactin complex appears to be impossible. Cortactin 
phosphorylated by Src is not able to interact with N-WASP, as shown with recombinant 
proteins (Martinez-Quiles et al., 2004) and further corroborated in the yeast two-hybrid 
assay (Cantarelli et al., 2007). That adds to the evidence against the possibility that 
cortactin bridges both proteins, i.e. Nck-cortactin-N-WASP.  
 
The previous data leave three possible types of complexes: (I) Tir-Nck-N-WASP-
cortactin, (II) Tir-cortactin-N-WASP and (III) Tir-cortactin. Given the fact that cortactin 
depletion by siRNA inhibits pedestal formation ((Cantarelli et al., 2006) and this study), 
that EPEC infection induces cortactin phosphorylation in an N-WASP-dependent 
fashion (Fig. 13), and that Tir binds and activates cortactin (Fig. 16) we hypothesise that 
cortactin contributes to the Tir:Nck:N-WASP pathway, possibly by regulating N-WASP 
activity. The fact that the SH3 domain of cortactin pulls down N-WASP ((Martinez-
Quiles et al., 2004) and Fig. 17) supports the hypothesis that cortactin binds Tir through 
the N terminus and N-WASP through the SH3 domain. In other words, cortactin and N-
WASP would act in a complex in this scenario.  
 
If we envision pedestals as a dynamic actin structure, and in fact pedestal motility has 
been shown (Sanger et al., 1996), then it is reasonable to think that proteins promoting 
actin polymerisation would act in a cyclic manner. We speculate that cortactin is a 
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cycling switch for N-WASP in pedestals. In this case, phosphorylation switch should 
affect only the binding of cortactin to N-WASP, hence, cortactin phosphorylated on 
serine would bind both Tir and N-WASP whereas cortactin phosphorylated on tyrosine 
would bind only Tir (Model). 
 
Notably, it has been shown that in the case of EHEC infection, cortactin is recruited by 
different mechanisms in cultured cells than in human in vitro organ cultures (IVOC). 
Thus, the recruitment of cortactin via an EspFu- and N-WASP-independent pathway in 
IVOC contrasts with the EspFu dependent recruitment of cortactin in cells (Mousnier et 
al., 2008). Therefore, cortactin seems to have a more influential role during EHEC 
infection of mucosal surfaces than of cultured cells in vitro.  
 
Crepin and colleagues have recently shown that Tir:Nck signalling pathway is not 
necessary for A/E lesion formation or N-WASP recruitment during Citrobacter 
rodentium infection of mice (Crepin et al., 2010) or EPEC infection of human intestinal 
IVOC (Crepin et al., 2010; Schuller et al., 2007). These studies prove that the A/E lesions 
induced in vivo and ex vivo are not strictly comparable to studies in cultured cells in 
vitro. Finally we speculate that cortactin could have an important role in mediating A/E 
lesion formation in vivo although this assumption needs further investigation.  
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Crk negatively regulates actin polymerisation in EPEC pedestals 
 
Crk proteins are a ubiquitously expressed family of adaptors that assembles protein 
complexes playing an important role in intracellular signal transduction integrating 
signals from a wide variety of sources, including bacterial pathogens. The observation 
by Goosney et al. that Crk adaptors, named in general Crk by the authors, localise to 
pedestals formed by EPEC (Goosney et al., 2001) raises the possibility that Tir signalling 
may involve these host adaptors. Hence, we investigated the role of CrkI, CrkII, and the 
paralog Crk-like (CrkL) in EPEC pedestal formation.  
 
We observed that the inhibition of the expression of CrkI/II by siRNA or the 
overexpression of the dominant negative mutant of Crk (R38V) in HeLa cells has no 
effect on EPEC-induced pedestal formation (Figs. 18 and 19). Moreover, EPEC infection 
of MEFs lacking both CrkI and CrkII allowed us to corroborate the previous results, 
since pedestal formation is not affected in this cell line (Fig. 20). Considering that CrkI 
isoform is only expressed at almost non-detectable levels in HeLa cells (Fig. 18A), and 
Model of coordinated action by cortactin and N-WASP on EPEC pedestals. In theory, 
cortactin may bind Tir and N-WASP simultaneously, via its N-terminal and SH3 domain 
interaction respectively. EPEC-induced tyrosine phosphorylation of cortactin would terminate 
cortactin interaction with N-WASP but not with Tir. This could constitute a cyclical regulatory 
mechanism of actin polymerisation on EPEC pedestals. Phosphotyrosine-cortactin might as 
well compete for the SH2 domain of Nck, thus uncoupling Tir from the Nck/N-WASP 
complex. 
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that CrkL shares high sequence identity with CrkII and have overlapping functions in 
certain cases, our results might indicate that Crk adaptors could be compensating for 
each other in pedestal formation.  
 
Interestingly, depletion of CrkL by siRNA in MEFs cells that lack both CrkI and CrkII 
allowed us to determine that the absence of all major isoforms of Crk adaptors 
significant increases the number of pedestals formed by EPEC (Fig. 21). We 
corroborated this unexpected result overexpressing the dominant negative mutant of 
Crk in this cell line (Fig. 22).  
 
The redundant function of the proteins was further confirmed with CrkL-deficient MEFs. 
As occurred with CrkI/II, the absence of CrkL does not affect the formation of pedestals 
induced by EPEC, indicating that CrkII and CrkL adaptors could be compensating for 
each other. In addition, the expression of a dominant negative mutant of Crk in CrkL-
deficient cells elicits an increase in the number of pedestals formed (Fig. 23). It seems 
that the effect of the dominant negative mutant is obvious only when the expression of 
at least one isoform (CrkI/II or alternatively CrkL) is previously knock-down.  
 
Finally, we inhibited the expression of CrkL by siRNA in HeLa cells and observed that 
the number of pedestals remains unchanged (data not shown) pointing again to a 
functional redundancy of Crk family proteins.  Although the study of knock-out mice of 
CrkI/II and CrkL and other observations show independent roles for these proteins, a 
number of recent studies suggest that CrkI/II and CrkL can compensate to each other in 
different signalling pathways. Thus, Crk adaptors show overlapping functions in 
promoting cell migration stimulated by PDGF and in the formation of focal adhesions 
(Antoku and Mayer, 2009).  
 
Collectively, the results seem to indicate a redundant inhibitory role of Crk family 
adaptors during actin polymerisation in pedestals formed by EPEC, although the 
mechanism requires further investigations.  
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The fact that tyrosine phosphorylated cortactin cooperates with Crk to trigger actin 
polymerisation during Shigella invasion of epithelial cells (Bougneres et al., 2004) 
prompted us to investigate a possible interaction between cortactin and Crk after EPEC 
infection. Moreover, the uptake of Yersinia involves the tyrosine phosphorylation of 
p130Cas and the subsequent formation of p130Cas-Crk complexes (Weidow et al., 
2000). Hence, we also analysed the interaction of Crk with other partners, such as 
p130Cas. Based on immunoprecipitation assays, we could not detect an interaction 
between Crk and cortactin in uninfected or EPEC-infected HeLa cells (data not shown). 
Likewise, we could not detect an interaction between Crk and p130Cas (data not 
shown). Although further experiments, such as in vitro pull down assays, will be 
required to discard a possible interaction of these proteins following EPEC infection, 
presumably cortactin and p130Cas are not interacting with Crk in the process of 
pedestal formation. 
 
As mentioned, Crk family adaptors are required for the remodelling of actin 
cytoskeleton and for the formation and turnover of focal adhesions (Antoku and Mayer, 
2009). Crk has also been implicated in the regulation of migration, proliferation and 
cellular adhesion (Feller, 2001). Therefore, we could contemplate that the inhibition of 
Crk expression affects cytoskeleton-related proteins that could favour the formation of 
pedestals. The implication of Crk family adaptor in regulating the formation of finger-
like protrusive structures that contain actin bundles called filopodia (Antoku et al., 
2008), could be also be related to the formation of pedestals. The effector Map induces 
the formation of transient filopodia at the bacterial attachment sites (Kenny et al., 2002; 
Kenny and Jepson, 2000). The retraction that occurs at early times post-infection is 
dependent on Tir (Kenny et al., 2002). The model proposed by Berger and colleagues 
suggests that the rapid withdraw of Map-induced filopodia leads to widespread 
pedestals. The authors also showed that eliminating Nck blocked pedestal formation 
and promoted a long-term presence of filopodia (Berger et al., 2009). In like manner, 
depletion of Crk could interfere in the formation of filopodia leading to increased 
number of pedestals. However, the fact that the cells with knockdown of Crk family 
proteins increased filopodium formation (Antoku et al., 2008) does not point in favour 
of this hypothesis. 
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In addition, CrkII and CrkL are phosphorylated by Abl, and in fact the Abl-family kinases 
Abl and Arg have also been shown to phosphorylate Tir and associate with an N-
terminal proline-rich peptide of Tir using their SH3 domain (Bommarius, Maxwell et al. 
2007). One possible hypothesis is that the binding of Crk proteins to Abl could compete 
for the binding to Tir. Thus, depletion of Crk proteins would liberate Abl resulting in the 
enhancement of pedestal formation. 
 
Another possibility could be that Crk participates in the Tir:Nck:N-WASP signalling 
pathway for pedestal formation. It will be very interesting to determine if Crk interacts 
with bacterial Tir through its SH2 domain and moreover if this interaction is directly or 
mediated by others proteins, such as N-WASP. The phosphorylation of Tir in tyrosine 
residue 474 generates the binding site for the SH2 domain of Nck. In addition, the 
second tyrosine residue phosphorylated (Y454) is responsible for the low actin 
polymerisation that occurs independently of Nck (Campellone and Leong, 2005). 
Likewise, it is possible that Y454 recruits other phosphotyrosine-binding molecule that 
can promote actin assembly. It has been described that the adaptor Grb2, although 
localised to pedestals formed by EPEC (Goosney et al., 2001), does not interact with any 
of two tyrosine residues.  It is tempting to speculate that Crk adaptor proteins could 
bind to tyrosine residue Y474 or Y454 playing an inhibitory role in EPEC signalling.  
 
These and others intriguing hypotheses are currently under investigation by our group. 
In summary, the major finding of this part of the study is the inhibitory role of Crk 
family adaptors during actin polymerisation in pedestals. Future experimentation will 
clarified the underlying mechanism of the role of Crk family proteins.  
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Depletion of Nck affects the levels of bacterial protein Tir  
 
Mouse embryonic fibroblast lacking Nck produced by the group of Dr. Tony Pawson 
(Bladt et al., 2003) are routinely used to study EPEC-induced pedestal formation. Our 
experimental results based on this cell line demonstrated an unforeseen reduced 
amount of the bacterial effector Tir. The reduction observed in both total cell lysates 
and Tir-enriched cell fractions of EPEC-infected Nck-deficient cells is recovered when 
Nck1 expression was restored (Fig. 24). 
 
In order to corroborate that the observed phenotype was not linked to the cell line 
used, Nck1/2 expression was inhibited in human epithelial Hela cells. Similarly, our 
results demonstrated that the depletion of Nck1/2 by siRNA in HeLa results in a 
decrease of Tir levels (Fig. 25). This reduction is not as high as the one observed in 
infected Nck-deficient cells. This difference could be explained because the inhibition of 
the expression of Nck by siRNA is only partial and not complete as in Nck-deficient 
cells. Furthermore, Nck-depleted Hela cells present a reduction in the number of 
pedestals formed by EPEC, although not as drastic as in Nck deficient cells. In view of 
these results we decided that the initial observation deserved further investigations. 
 
We report here a 20-fold reduction in the efficiency of pedestal formation by EPEC. 
Furthermore, we describe an 88% of decrease in Tir levels in Nck-deficient MEFs with 
respect to WT MEFs by WB analysis (Figs. 24 and 28). This dramatic decrease in Tir 
levels was also corroborated by immunofluorescence with a monoclonal antibody 
against Tir (Fig. 38). These results contrast with the 4-fold decrease in the efficiency of 
pedestal formation (Campellone et al., 2004b), and with the 25% decrease of Tir 
translocated into Nck-deficient cells with respect to Nck1 reconstituted cells as 
measured by HA staining by Campellone´s group (Campellone and Leong, 2005). 
Campellone and colleagues used in their experiments an EPEC strain that lacks a 
chromosomal copy of tir and that is complemented with a plasmid expressing HA-
tagged Tir (pHA-tir). However, in our opinion the usage of this strain does not justify 
the reported differences since it regained the ability to cause A/E lesions in IVOC 
(Schuller et al., 2007). We speculate that the authors would have found more 
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pronounced differences if they had compared cells lacking Nck isoforms with cells 
expressing both Nck1 and Nck2 isoforms like in our study.  
 
Moreover, another major conclusion of our study is that Nck might be required for 
efficient intimin-Tir mediated bacterial attachment to murine cells (Fig. 28). To our 
knowledge, this is the first reported decrease in bacterial attachment to MEFs lacking 
Nck. As mentioned, the intimate adherence of EPEC to HeLa cells requires the 
interaction between intimin and Tir (Kenny et al., 1997). We concluded that there exist a 
higher dependence of the presence of intimin and Tir for EPEC binding to MEFs than in 
the case of EPEC binding to human HeLa cells (Fig. 29), which could have implications 
for the use of these cells as a model system.  
 
In this line of reasoning, the diminished adhesion of EPEC to Nck-deficient cells might 
be a consequence of the low levels of Tir found in these cells, which is supported by the 
fact that tir-intimin interaction is needed for the adhesion of EPEC to murine cells. 
 
Interestingly, in N-WASP-deficient cells, which are also resistant to EPEC pedestal 
formation, Tir and bacterial attachment levels are equal to the ones observed in WT 
cells (Fig. 26). Accordingly, it has been shown that EPEC translocates Tir into N-WASP 
deficient cells at wild type levels (Vingadassalom et al., 2010). These results prompted 
us to conclude that the low levels of Tir and bacterial attachment found in Nck-
deficient cells cannot be due exclusively to the absence of pedestals.  
 
Two hypotheses to explain the reduced Tir levels found in MEFs lacking Nck were 
formulated:  
(I) A defect in the delivery of Tir effector into the host cells 
(II) An increased rate of degradation of Tir in the host cells 
 
In an attempt to test the hypothesis of a defective delivery process, we examined by 
western blotting the protein levels of another two TTSS-secreted EPEC effectors, EspF 
and EspB. EspB is especially interesting as it is inserted into the host membrane forming 
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the translocation pore (Wolff et al., 1998). We observed normal levels of EspF and EspB 
in Nck-deficient cells concluding that the reduction of Tir is not affecting the delivery 
process or the degradation of these effectors. We next tried to improve EPEC 
translocation efficiency by increasing the MOI (Mills et al., 2008), however higher 
number of bacteria per cell does not result in increased levels of Tir in Nck-deficient 
cells (Fig. 27).  
 
Our results contrast with the current injection model that proposes that Tir is one of the 
EPEC effectors that has high translocation efficiency (Mills et al., 2008). Furthermore, it 
was proposed that the injection of EPEC effectors follows a hierarchical order and that 
Tir is required for the efficient injection of other effectors, including EspF (Thomas et al., 
2007). However, this idea is questioned by others studies where tir deficient strains 
have EPEC capacities to induce effector-driven cellular alterations in macrophages, 
HeLa cells and polarised epithelial models (Dean et al., 2006). In addition, our findings do 
not indicate a requirement of Tir for the efficient delivery of other effectors, such as 
EspB or EspF. 
 
Interestingly, Vingadassalom and colleagues have recently described the requirement 
of N-WASP and actin assembly for the translocation of TirEHEC and EspFu into 
mammalian cells by EHEC. They also reported that N-WASP is required for efficient 
EHEC attachment to the cell surface. An interesting approach used in this study is the 
induction of the formation of pedestals in N-WASP-deficient cells, which normally do 
not form them, using an EPEC-derived strain to enhance the translocation of TirEHEC and 
EspFu. They hypothesised that EspFu can signal to the Arp2/3 complex by recruiting an 
alternative host factor. However, the authors use the same bacterial strain in a different 
N-WASP-deficient cell line (Lommel et al., 2001) and pedestals were not formed. The 
authors tried to reconcile these different results assuming that Lommel´s cells may lack 
the alternative actin promoting factor (Vingadassalom et al., 2010). Considering these 
results with the related pathogen EHEC, we could point in favour of the hypothesis that 
Nck is required for the translocation of Tir by EPEC.  
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Trying to gain some insight on the degradation hypothesis we analysed the tyrosine-
phosphorylation status of the low but detectable fraction of Tir in Nck-deficient cells. 
We concluded that the underlying process is not dependent on the lack of Tir 
phosphorylation, since Tir is tyrosine phosphorylated and stably inserted into the 
membrane even six hours after EPEC infection (Fig. 30). The stability of Tir in HeLa cells 
90 minutes after infection was already known (Mills et al., 2008). 
 
We also analysed the levels of non-phosphorylatable Tir mutants in Nck-deficient cells 
using EPEC strains lacking tir that are complemented with a plasmid expressing Tir. We 
use the WT form of Tir and Tir with point mutations in the relevant residues sites 
susceptible for tyrosine and serine phosphorylation. The results seem to indicate that 
the levels of Tir are not affected by a different conformation of the protein due to 
mutations in serine residues, since low levels of Tir in Nck-deficient cells were also 
observed with serine/tyrosine mutated Tir (Fig. 31).  
 
Once the process of pedestal formation is triggered in infected HeLa cells, de novo 
bacterial protein synthesis is not needed for the tyrosine phosphorylation of Tir 
(Rosenshine et al., 1996). Chloramphenicol is an antibiotic long known to inhibit 
bacterial protein synthesis (Rendi and Ochoa, 1962). Accordingly, a period of 15 
minutes of infection with preactivated EPEC prior to chloramphenicol treatment is 
sufficient to detect the “upper” band of Tir that represents fully-modified Tir (Fig. 32, 
WT cells treated with chloramphenicol). This result indicates that once Tir is inserted in 
the plasma membrane, it is stable for at least 20 hours (data not shown). Interestingly, 
although the fully-modified Tir form was detected in WT cells treated for 180 minutes 
with chloramphenicol, we could not detect fully-modified Tir in chloramphenicol-
treated Nck-deficient cells at any time.  
 
Moreover, after 180 minutes of chloramphenicol treatment the band of partially 
modified Tir observed after 1 hour of treatment in Nck-deficient cells was not detected 
by WB. These results seem to indicate that, in the absence of Nck, de novo bacterial 
protein synthesis is required to maintain steady-state levels of the fully modified Tir 
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form. Notably, the form of Tir that is not fully modified seems to be degraded in Nck-
deficient cells. Considering that the shifts in Tir are thought to reflect phosphorylation-
induced conformational changes facilitating the insertion into the plasma membrane 
(Kenny, 1999), it is tempting to speculate that the non-fully modified Tir could be more 
susceptible for degradation.  
 
We next tested the infection with a modified EPEC strain that expresses HA-tagged 
Map and determined that the levels of Map in Nck-deficient cells are also reduced 
when compared to WT cells (Fig. 33). Unfortunately, we could not corroborate this 
result infecting with WT EPEC due to the lack of a specific antibody to detect Map. In 
view of this result we could consider that the reduction in Tir and Map levels relates to 
an Nck-dependent translocation defect of CesT-dependent effectors, or alternatively, to 
a specific degradation process of these effectors. Then, it would be wise to analyse the 
levels of other CesT-dependent effectors such as NleA, NleF, NleH1 and NleH2 (Creasey 
et al., 2003; Thomas et al., 2007). 
 
In order to test the hypothesis of a possible degradation of Tir, we thought of using 
ectopically expressed Tir as a model system to determine the effect of various chemical 
inhibitors. Therefore we determined Tir expression by transfecting the cells with a 
mammalian expression plasmid encoding Tir. The transfections of Nck-deficient cells 
allowed us to conclude that ectopically expressed Tir is not reduced in these cells with 
respect to WT cells (Fig. 34), consequently we discarded this line of study.  
 
For the purpose of blocking a possible degradation of Tir in Nck-deficient cells we 
tested the effect of several protease inhibitors. Treatments of 1 hour prior to EPEC 
infection with proteasome inhibitor (MG-132) failed to recover the levels of Tir in Nck-
deficient cells. In agreement with this result it has been described in an elegant study 
that the translocation rate of the six EPEC effectors EspF, EspG, EspH, EspZ, Map and Tir 
in HeLa cells is not affected by proteasome inhibition (Mills et al., 2008). In this line, 
neither a general caspase inhibitor (Z-VAD-FMK) nor a broad spectrum protease 
inhibitor cocktail (P8340) recovered the levels of Tir in Nck-deficient cells. Moreover, we 
observed that the lack of calpains in MEFs does not affect the levels of Tir. Collectively, 
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these results indicate that Tir is not being degraded by proteasome, caspases or 
proteases. 
 
Finally, treatments with Trichostatin A (TSA), a known deacetylase and autophagy 
inhibitor (Lee et al., 2010; Matsuyama et al., 2002), resulted in a significant increment of 
the levels of Tir in Nck-deficient cells. Moreover, TSA treatments significantly increased 
the bacterial attachment and the number of pedestals formed in these cells, as 
visualised by immunofluorescence staining. We might think that the increase in the 
efficiency of pedestal formation is a consequence of the higher levels of Tir after TSA 
treatment. This unforeseen result indicates that the absence of pedestals found in these 
cells could be due to the dramatic decrease of Tir levels, and not merely due to a lack 
of N-WASP activation as a result of the absence of Nck, as it is currently assumed. Thus, 
when the levels of Tir are restored the number of pedestals increases concomitantly. 
Consequently, in TSA-treated Nck-deficient cells another host adaptor could recruit N-
WASP to promote pedestal formation. This assumption allows us to speculate that 
cortactin could bridge Tir and N-WASP promoting actin polimerisation that leads to 
pedestal formation in the absence of Nck.  
 
It is difficult to comprehend the mechanism by which TSA increases the levels of Tir 
protein in MEFs lacking Nck, because this inhibitor can affect many cellular processes. It 
is thought that TSA specifically inhibits class I and II histone deacetylases such as 
HDAC6 (known as class II), which acts as a tubulin and cortactin deacetylase. Indeed, 
HDAC6 and cortactin are implicated in quality-control autophagy, which is independent 
of nutrient status. HDAC6 is recruited to ubiquitinated substrates where it stimulates 
the fusion of the autophagosome with the lysosome by promoting F-actin remodeling 
in a cortactin-dependent manner (Lee et al., 2010). Autophagy is an ubiquitous 
degradation pathway recently reported to play an important role in host defense 
against Citrobacter rodentium infection in intestinal epithelial cells (Inoue et al., 2012). 
However, the sole inhibition of the expression of HDAC6 by siRNA treatment does not 
increase the levels of Tir in Nck-deficient cells (data not shown) which could indicate 
that another TSA sensitive deacetylase it is responsible for the phenotype. 
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On the other hand, we have to consider that the drug is having a general effect on cell 
cytoskeleton, since the general morphology of cells dramatically changes during 
treatments with TSA ((Hoshikawa et al., 1994) and our observation). It has been 
described that the effect of TSA is related to histone deacetylase inhibition activity and 
to the enhancement of expression of an actin-regulatory protein, gelsolin (Hoshikawa 
et al., 1994). It is tempting to speculate that the TSA-induced rearrangement of the 
cytoskeleton could favor the translocation of EPEC effectors. Likewise, there are 
evidences indicating that F-actin assembly promotes type III translocation of effectors 
by others pathogens such as Yersinia and Shigella (Mejia et al., 2008; Mounier et al., 
2009) and the related EHEC (Vingadassalom et al., 2010).  
 
It has to be noticed that we found variability in TSA treatments and the increase in the 
levels of Tir following TSA treatment was not observed by WB analysis in all the 
experiments performed. Interestingly, the number of pedestals does not increase in 
TSA-treated Nck-deficient cells when the levels of Tir are not restored (data not shown). 
This result discards the possibility that the effect of the treatment on the cells could be 
influencing on pedestal formation and seems to indicate that the increment in pedestal 
formation is due to an increase in the levels of Tir.  
 
Finally, considering that the lysosome is a common intracellular destination for 
endocytic, autophagic, and secretory molecules targeted for degradation (Knecht et al., 
2009), it will be worthy to test lysosomal degradation inhibitors.  
 
To summarise, our results partially point to a defective delivery of Tir, however we 
cannot discard the initial alternative hypotheses of a possible degradation of Tir protein 
inside the host cell. It is tempting to speculate that both processes could be occurring 
simultaneously. In any case, it seems that the process affects CesT-dependent effectors 
since levels of both Tir and Map are reduced in Nck-deficient cells, while levels of EspF 
and EspB, which use different chaperones for their delivery process, are not affected.  
 
The experiments to definitively discern whether the drastic reduction of Tir levels in the 
absence of Nck is due to degradation, to a defective delivery process or even to both 
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simultaneously, is the real-time measurement of the translocation kinetics of EPEC 
effectors in Nck-deficient cells. The failure to obtain funding to perform the 
experiments using “the real-time, high-throughput translocation assay” in the 
laboratory of Dr. Rosenshine in Israel (Mills et al., 2008) did not allow us to obtain the 
quantitative data required to determine the underlying mechanism.  
 
The importance of the results obtained in this study is highlighted by the fact that the 
mouse embryonic fibroblast lacking Nck has been widely used since Gruenheid et al.  
described the binding of Nck to Tir leading pedestal formation (Gruenheid et al., 2001). 
The finding that infected Nck-deficient cells have reduced amount of Tir levels and 
reduced bacterial attachment could have consequences in the results obtained and in 
future experiments that will be performed with these cells.  
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Part I 
 
1. Cortactin is necessary for pedestal formation by enteropathogenic Escherichia coli 
(EPEC). Moreover, the integrity of the Arp2/3 complex binding domain and the SH3 
domain of cortactin is required for pedestal formation by EPEC. 
2. Serine phosphorylation of cortactin, probably by the kinase Erk positively regulates 
EPEC pedestal formation while dynamic cycles of tyrosine phosphorylation and 
dephosphorylation of cortactin are required for the process. 
3. N-WASP is required for EPEC-induction of serine and tyrosine phosphorylation of 
cortactin. Moreover, Src activation following EPEC infection is independent of N-
WASP presence, whereas the activation of Erk is N-WASP dependent.  
4. Serine phosphorylation of cortactin is independent of Nck presence and both Src 
and Erk kinases are induced by EPEC infection in mouse embryonic fibroblast that 
lack Nck.  
5. Cortactin and Tir protein bind each other directly in vitro. This interaction promotes 
Arp2/3 complex-mediated actin polymerisation in vitro independently of the 
phosphorylation status of cortactin. 
6. Cortactin binds Tir in EPEC-infected cells in the absence of N-WASP. 
 
Part II 
 
1. Crk family adaptor proteins have a redundant inhibitory role in regulating actin 
polymerisation in pedestals formed by EPEC. 
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Part III 
 
1. The absence of Nck in EPEC-infected mouse embryonic fibroblasts results in a 
reduction of bacterial Tir levels, in contrast ectopically expressed Tir is not reduced. 
The levels of EspF or EspB effectors are not altered in Nck-deficient cell, whereas 
the levels of Map effector are also reduced in these cells. 
2. Nck depletion in the human cell line HeLa results in the reduction of Tir levels, 
although less remarkable than in mouse embryonic fibroblasts. 
3. The levels of Tir are not reduced in N-WASP-deficient cells infected by EPEC. 
4. The number of bacteria per cell is not the limiting factor for the reduced levels of Tir 
in cells that lack Nck. 
5. The adhesion of EPEC to murine cells is affected by the absence of Nck and is more 
dependent on Tir-intimin interaction than that of HeLa cells. 
6. The tyrosine phosphorylation of the small fraction of Tir found in Nck-deficient cells 
is not impaired and Tir is stably inserted in the membrane up to six hours.  
7. The reduction in the levels of Tir in Nck-deficient cells is not dependent of the 
phosphorylation status of Tir.  
8. De novo protein synthesis in EPEC is necessary for the conversion of the modified to 
fully modified form of Tir in Nck-deficient cells. 
9. Neither the inhibition of proteasome, nor of caspases or proteases was 
accompanied by an increase in the levels of Tir in Nck-deficient cells. The absence 
of calpain1/2 does not promote an increase in the levels of Tir. 
10. The treatment of Nck-deficient cells with Trichostatin A increases the levels of Tir, 
EspF and EspB, the efficiency of pedestal formation and the adhesion of EPEC to 
these cells. 
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(Resumen en Español) 
 
Escherichia coli enteropatógena (EPEC) es un patógeno entérico que causa inflamación 
intestinal y diarrea aguda, constituyendo una de las principales causas de mortalidad 
infantil en los países en vías de desarrollo. EPEC es capaz de adherirse a las células del 
epitelio intestinal formando una lesión histopatológica conocida como de adherencia y 
destrucción (A/E) (del inglés attaching and effacing) caracterizada por la destrucción 
local de las microvellosidades, la adherencia íntima de la bacteria a la membrana 
plasmática de la célula hospedadora y la formación de una estructura rica en filamentos 
de actina denominada pedestal. De esta forma la bacteria induce la reorganización del 
citoesqueleto de actina permaneciendo en la superficie extracelular y constituye un 
modelo útil para el estudio de las rutas de señalización celular en respuesta a estímulos 
externos. 
 
Una de las proteínas bacterianas esenciales para la formación del pedestal es Tir (del 
inglés translocated intimin receptor) que es translocada por la bacteria a través de la 
membrana plasmática gracias a un sistema de secreción tipo III. Una vez en el interior 
de la célula, Tir se inserta en la membrana plasmática siendo susceptible de 
fosforilación por proteínas quinasas celulares. Numerosas proteínas celulares, incluidas 
N-WASP, cortactina y el complejo Arp2/3, son atraídas a los sitios de adhesión de la 
bacteria para estimular la polimerización de actina dando lugar a la formación del 
pedestal. El reclutamiento de N-WASP es inducido principalmente por la interacción de 
la proteína adaptadora Nck con la proteína Tir fosforilada en el residuo de tirosina 
Y474. Hasta el momento la ruta de señalización Tir:Nck:N-WASP es considerada la vía 
principal para la polimerización de actina en los pedestales formados por la bacteria. 
Sin embargo, también se produce la polimerización de actina inducida por Tir de 
manera independiente de la proteína Nck en menor grado. 
 
Cortactina es una proteína de unión a filamentos de actina que fue inicialmente 
identificada como un sustrato de la tirosina quinasa v-Src. Hoy en día se sabe que 
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cortactina es una oncoproteína implicada en migración, invasión y metástasis tumoral. 
Esta proteína está involucrada además en muchos otros procesos relacionados con la 
dinámica de membrana y la reorganización del citoesqueleto, incluyendo fenómenos 
de motilidad celular, endocitosis, formación de uniones intracelulares e invasión 
bacteriana.  
 
Existen numerosos patógenos bacterianos como EPEC, Shigella y Helicobacter pylory, 
capaces de manipular en su propio beneficio el citoesqueleto de actina de las células 
eucariotas. Muchos de estos patógenos tienen como diana la oncoproteína cortactina. 
El primer objetivo de la tesis doctoral ha sido el estudio de la contribución de la 
proteína cortactina en el proceso de polimerización de actina durante la formación del 
pedestal por EPEC. Este objetivo se enmarca dentro del modelo propuesto de 
regulación de la interacción de cortactina y N-WASP denominado “interruptor de 
encendido-apagado” (del inglés S-Y switch model), según el cual la activación de N-
WASP por cortactina es promovida por la fosforilación por la serina treonina quinasa 
Erk e inhibida por la fosforilación por la tirosina quinasa Src (Martinez-Quiles et al., 
2004). 
 
En el momento de inicio de este trabajo existían dos publicaciones del mismo grupo 
acerca de la contribución de cortactina en la formación del pedestal. En primer lugar el 
grupo de Cantarelli demostró mediante técnicas de  microscopia confocal que 
cortactina se acumula en los sitios de adhesión de EPEC en células HeLa (Cantarelli et 
al., 2000). En el año 2002 el mismo grupo describió que la sobreexpresión de formas 
truncadas de la proteína que carecen del extremo amino terminal inhibe la formación 
de pedestales en células HeLa infectadas por EPEC. Estos datos sugerían un papel 
esencial de cortactina en la formación del pedestal por EPEC. Además, en este trabajo 
observaron mediante técnicas de inmunoprecipitación que los complejos de Tir 
contienen cortactina (Cantarelli et al., 2002). Basándose en los datos expuestos, la 
hipótesis inicial era la participación de cortactina en la ruta principal de señalización 
Tir:Nck:N-WASP para la polimerización de actina en la formación de pedestales por 
EPEC.  
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La infección por EPEC provoca el reclutamiento de otras muchas proteínas de la célula 
eucariota, algunas de ellas implicadas en la regulación de adhesiones focales, como 
talina y vinculina, y también diversas proteínas adaptadoras como p130Cas y Crk. La 
función de muchas de estas proteínas es desconocida, tal es el caso de la proteína 
adaptadora Crk cuya localización en los pedestales formados por EPEC en células HeLa 
se describió en el año 2001 (Goosney et al., 2001). Además la proteína Crk había sido 
implicada en la internalización de Shigella en células epiteliales mediante la interacción 
con cortactina fosforilada en residuos de tirosina. La interacción entre Crk y cortactina 
se describió como necesaria para la polimerización de actina requerida para la entrada 
de la bacteria en la célula hospedadora. Teniendo en cuenta estos datos, en la segunda 
parte de la tesis nos propusimos investigar el papel de Crk durante la formación de los 
pedestales por EPEC. 
 
Durante la consecución del primero de los objetivos se realizaron experimentos usando 
como herramienta la línea celular de fibroblastos embrionarios de ratón que carecen de 
la proteína Nck. Los resultados obtenidos demostraron que las células deficientes en 
Nck infectadas por EPEC presentaban una drástica reducción de los niveles de la 
proteína bacteriana Tir. Debido a la importancia de esta proteína en el proceso de 
formación de pedestales por EPEC, contribuyendo a la ruta de señalización principal, 
decidimos estudiar este fenómeno en profundidad.   
 
Así mismo los objetivos de esta tesis se han dividido en tres partes: 
 
Parte I 
1. Estudio del papel de cortactina en la formación del pedestal por Escherichia coli 
enteropatógena (EPEC) y de la implicación del modelo “interruptor de encendido- 
apagado” propuesto para la regulación de cortactina por fosforilación por las 
quinasas Erk y Src. 
2. Estudio de contribución de cortactina a la activación de la polimerización de actina 
mediada por complejo Arp2/3 en los pedestales formados por EPEC. 
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Parte II 
1. Estudio del papel de la proteína adaptadora Crk en la formación del pedestal por 
EPEC. 
 
Parte III 
1. Papel de la proteína adaptadora Nck en la regulación de la translocación y/o 
degradación de la proteína bacteriana Tir. 
 
Las principales conclusiones obtenidas del trabajo son: 
 
Parte I 
1. La proteína cortactina es necesaria para la formación del pedestal por EPEC. 
Asimismo, tanto el dominio NTA de cortactina, mediante el cual se une al complejo 
Arp2/3, como el dominio SH3 tienen un papel importante en la formación del 
pedestal.  
2. La fosforilación en serinas de cortactina, presumiblemente por la serina treonina 
quinasa Erk, regula positivamente la formación del pedestal. Por otro lado, es 
necesaria la existencia de fosforilación en tirosinas de manera cíclica para la 
formación del pedestal por EPEC. 
3. EPEC induce la fosforilación de cortactina tanto en residuos de tirosina como en 
residuos de serina. Además, esta fosforilación es dependiente de la proteína N-
WASP. Así mismo se demuestra que la activación de la tirosina quinasa Src es 
independiente de la ausencia de la proteína N-WASP, mientras que la activación de 
Erk si depende de N-WASP. 
4. La fosforilación en serinas de cortactina es independiente de la presencia de Nck. 
Además, tanto Src como Erk se activan en las células murinas embrionarias que 
carecen de Nck tras la infección con EPEC. 
5. La interacción directa entre cortactina y la proteína bacteriana Tir in vitro promueve 
la polimerización de actina mediada por el complejo Arp2/3, de manera además 
independiente del estado de fosforilación de cortactina. 
6. La interacción entre cortactina y Tir ocurre en ausencia de la proteína N-WASP. 
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Parte II 
1. Las proteínas adaptadoras de la familia Crk tienen un papel redundante e 
inhibitorio en la formación del pedestal por EPEC. 
 
Parte III 
1. Las células murinas embrionarias que carecen de Nck infectadas por EPEC 
presentan una notable reducción de los niveles de la proteína bacteriana Tir. Por el 
contrario, los niveles de expresión de Tir transfectado en estas células no se ven 
disminuidos. Los niveles de otros dos efectores de EPEC, EspF y EspB no se han 
visto alterados en ausencia de Nck, sin embargo los niveles del efector Map 
también aparecen reducidos en las células murinas deficientes en Nck. 
2. La inhibición de la expresión de Nck mediante ARN de interferencia en la línea de 
células humana HeLa también conlleva una reducción en los niveles de Tir en 
células infectadas con EPEC, sin embargo esta reducción no es tan drástica como se 
observa en la línea celular carente de Nck. 
3. Los niveles de Tir detectados en las células deficientes en N-WASP infectadas por 
EPEC no se han visto alterados. 
4. El número de bacterias por célula (multiplicidad de infección o MOI) no es el factor 
limitante en la reducción de los niveles de Tir en las células deficientes en Nck. 
5. La adhesión de EPEC a las células murinas deficientes en Nck requiere la presencia 
de Nck y tiene mayor grado de dependencia de la presencia de intimina y Tir que a 
las células humanas HeLa. 
6. La fracción de Tir detectable en las células murinas deficientes en Nck está 
fosforilada en tirosinas y establemente insertada en la membrana de la célula 
hospedadora después de seis horas de infección por EPEC.  
7. La reducción de Tir observada en las células murinas deficientes en Nck no es 
dependiente del estado de fosforilación de Tir. 
8. La síntesis proteica bacteriana de novo es necesaria para la correcta conversión de 
la forma parcialmente modificada de Tir a la forma completamente modificada de 
Tir en las células murinas deficientes en Nck. 
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9. La inhibición del proteasoma, de proteínas caspasas, proteasas o la ausencia de las 
calpainas1/2 no afecta a los niveles de Tir en las células murinas deficientes en Nck. 
10. El tratamiento con el inhibidor Trichostatin A (TSA) en células murinas deficientes 
en Nck conlleva un aumento en los niveles de Tir, de EspF y de EspB. Asimismo 
dicho tratamiento aumenta tanto la eficiencia de formación de pedestales como la 
adhesión de EPEC a dichas células.  
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Abstract
Background: Cortactin activates the actin-related 2/3 (Arp2/3) complex promoting actin
polymerization to remodel cell architecture in multiple processes (e.g. cell migration, membrane
trafficking, invadopodia formation etc.). Moreover, it was called the Achilles' heel of the actin
cytoskeleton because many pathogens hijack signals that converge on this oncogenic scaffolding
protein. Cortactin is able to modulate N-WASP activation in vitro in a phosphorylation-dependent
fashion. Thus Erk-phosphorylated cortactin is efficient in activating N-WASP through its SH3
domain, while Src-phosphorylated cortactin is not. This could represent a switch on/off mechanism
controlling the coordinated action of both nucleator promoting factors (NPFs). Pedestal formation
by enteropathogenic Escherichia coli (EPEC) requires N-WASP activation. N-WASP is recruited by
the cell adapter Nck which binds a major tyrosine-phosphorylated site of a bacterial injected
effector, Tir (translocated intimin receptor). Tir-Nck-N-WASP axis defines the current major
pathway to actin polymerization on pedestals. In addition, it was recently reported that EPEC
induces tyrosine phosphorylation of cortactin.
Results: Here we demonstrate that cortactin phosphorylation is absent on N-WASP deficient
cells, but is recovered by re-expression of N-WASP. We used purified recombinant cortactin and
Tir proteins to demonstrate a direct interaction of both that promoted Arp2/3 complex-mediated
actin polymerization in vitro, independently of cortactin phosphorylation.
Conclusion: We propose that cortactin binds Tir through its N-terminal part in a tyrosine and
serine phosphorylation independent manner while SH3 domain binding and activation of N-WASP
is regulated by tyrosine and serine mediated phosphorylation of cortactin. Therefore cortactin
could act on Tir-Nck-N-WASP pathway and control a possible cycling activity of N-WASP
underlying pedestal formation.
Background
Enteropathogenic Escherichia coli (EPEC) are an important
cause of infantile diarrhea, especially in developing coun-
tries. EPEC adhere, and cause the local effacement of the
microvilli of intestinal epithelial cells, giving raise to so-
called attaching and effacing (A/E) lesions. In vitro, EPEC
attach to infected cells by forming pedestal-like structures
enriched in polymerized actin and other host cell proteins
[1]. The type III secretion system delivers into host cells
the translocated intimin receptor (Tir), which is inserted
into the cell plasma membrane such that a loop is
exposed on the cell surface that binds to another bacterial
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Cell Communication and Signaling 2009, 7:11 http://www.biosignaling.com/content/7/1/11protein, the adhesin intimin [2]. This binding induces the
clustering of Tir, followed by its phosphorylation on tyro-
sine residue 474 in the cytoplasmic C-terminal domain.
The phosphotyrosine moiety recruits the host cell adaptor
protein Nck [3], which binds and presumably activates N-
WASP, leading to actin polymerization mediated by the
Arp2/3 complex [4]. Although this pathway is recognized
as the principal one operating in EPEC, another Nck-inde-
pendent pathway has also been described in these bacteria
[5]. Furthermore, the complexity of EPEC signal transduc-
tion is not fully understood [6].
Tir is inserted in the cell membrane, where it adopts a
hairpin-loop structure, with both N and C termini project-
ing into the host cytoplasm [2]. Pedestals are dynamic
structures that undergo constant remodeling by cycles of
actin polymerization/depolymerization [7]. It is impor-
tant to understand the contribution of other signals to
pedestal formation, not only for EPEC but also for other
actin-based processes. For instance, it has been postulated
that Tir-Nck signaling mimics the nephrin-Nck-actin
pathway [8].
Cortactin is a key regulator of the actin cytoskeleton which
plays a crucial role in cell invasion [9] and actin-based
motility during the infection of many microbial patho-
gens [10]. Cortactin possesses an N-terminal acidic
domain (NTA) which harbors a DDW motif that activates,
albeit weakly, the Arp2/3 complex at branching points
[11,12]. The NTA domain is followed by a series of repeat
domains that bind filamentous actin (F-actin). The C-ter-
minal SH3 domain of cortactin [13] binds various pro-
teins, such as N-WASP [14], which is a ubiquitously
expressed member of the WASP (Wiskott-Aldrich Syn-
drome) family of proteins. Cortactin can be phosphor-
ylated by tyrosine kinases (Src, Fer, Syk and Abl) and
serine/threonine kinases (Erk and Pak) [15]. Src kinase
targets tyrosine residues 421, 466 and 482 while Erk phos-
phorylates serines 405 and 418 [16] which lie in a proline-
rich area. Interestingly, a Src family member (Fyn) [17]
and Abl kinases phosphorylate Tir [18].
The Arp2/3 complex can be independently activated to
initiate actin polymerization by the VCA (Verprolin Cofi-
lin Acidic) domain of WASP members and by both the
NTA and F-actin-binding repeats of cortactin. Theoreti-
cally N-WASP, cortactin and the Arp2/3 complex can form
ternary complexes [19]. Cortactin has been shown in vitro
to bind and activate N-WASP via an SH3 proline-rich
domain interaction [14]. This activation is regulated pos-
itively and negatively when cortactin is phosphorylated by
Erk and Src respectively. Erk phosphorylation of cortactin
or the double mutation S405,418D in cortactin that mim-
ics this phosphorylation enhance the protein's binding to
and activation of N-WASP. Conversely, Src phosphoryla-
tion inhibits the ability of both Erk-phosphorylated cort-
actin, and that doubly mutated S405,418D cortactin, to
activate N-WASP. Furthermore, phospho-mimetic muta-
tion of the three tyrosine residues targeted by Src (Y421,
Y466, and Y482) inhibited the ability of S405,418D cort-
actin to activate N-WASP. These results led us to hypothe-
size that Erk phosphorylation liberates the SH3 domain of
cortactin from intramolecular interactions, allowing it to
synergize with N-WASP in activating the Arp2/3 complex,
and that Src phosphorylation terminates cortactin activa-
tion of N-WASP. This proposed on/off switching mecha-
nism suggests that phosphorylation of cortactin regulates
the accessibility and/or affinity of its SH3 domain towards
its targets. 'S/Y model' may be relevant for actin dynamics
in multiple cell processes [15] and it may partially explain
the coordinated action of cortactin and N-WASP proteins,
therefore connecting the two major families of Arp2/3
complex activators. Consistent with this model, recent
structural data showed that cortactin adopts a 'closed'
globular conformation in which its SH3 domain interacts
with the actin-binding repeats [20].
This model has opened up new directions for studies in
many cell systems. For example, serine phosphorylation
of cortactin has been proposed to be relevant for actin
polymerization, while tyrosine phosphorylation have
been shown to selectively control adhesion turnover [21].
This suggests that different phosphocortactin forms par-
ticipate in distinct signaling pathways.
Although it is clear that cortactin participates in pedestal
actin dynamics, the underlying mechanism is not well
understood. Previous studies have shown that cortactin
translocates to EPEC pedestals. Over-expression of trun-
cated forms of cortactin blocks pedestal formation [22]. A
follow-up study to this work focused on the role of cortac-
tin domains and Erk/Src phosphorylation, and it con-
firmed that truncated forms of cortactin exert a dominant
negative effect in pedestal formation by EPEC and EHEC
(Enterohemorrhagic Escherichia coli). This study suggests
that cortactin is recruited through its α-helical region, and
the authors conclude that tyrosine phosphorylation is rel-
evant to pedestal formation, whereas serine phosphoryla-
tion seems to have no effect on actin assembly underneath
the bacteria [23]. However, this conclusion is based exclu-
sively on experiments with phosphorylation-mimicking
mutants, without any comparison with the corresponding
non-phosphorylatable counterparts.
Nck is not involved in N-WASP recruitment by EHEC.
Instead, the EspFu/Tccp effector activates N-WASP,
thereby mimicking Cdc42 signaling [24,25]. Cantarelli et
al. have proposed cortactin as the 'missing link' connect-
ing TirEHEC and EspFu/Tccp [26]. They showed that EHEC
initially induces tyrosine phosphorylation of cortactinPage 2 of 14
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transient cortactin phosphorylation during Helicobacter
pylori infection [27]. However, using the two-hybrid sys-
tem, they reported that tyrosine-phosphorylated cortactin
binds both TirEHEC and EspFu/Tccp, and consistent with
previously described binding assays using recombinant
purified proteins [14], only Erk-phosphorylated cortactin
binds N-WASP. Recent in vitro studies using cells deficient
in N-WASP suggest that cortactin recruitment to EHEC
pedestals occurs downstream of EspFu/Tccp and N-WASP
[28]. It is therefore necessary to gain further insights into
cortactin function in both systems. Major unresolved
questions include whether cortactin and TirEPEC interact
directly, whether cortactin participates in the Tir-Nck-N-
WASP pathway, and how cortactin binding partners mod-
ulate its nucleating activity on pedestals. Thus, deepening
our understanding of the involvement of cortactin on
pedestals dynamics is relevant for many reasons.
Results
Role of cortactin motifs in pedestal formation
Reduction of cortactin expression by siRNA or over-
expression of its isolated SH3 domain, polyproline region
or its α-helical region resulted in a drastic decrease in
actin-pedestal formation during infection with EPEC [23].
However the role of cortactin's Arp2/3 binding and acti-
vating region has not been addressed [23]. Therefore, we
investigated its contribution to actin assembly on pedes-
tals using EPEC to infect HeLa cells transiently transfected
with GFP-cortactin. Pedestals were visualized by immun-
ofluorescent staining of actin using fluorescent phalloidin
and bacteria with DAPI. As previously reported [23], no
differences on the number of attached bacteria were
observed for the transfectants used (data not shown).
The cortactin NTA domain carries a 20DDW22 motif that
binds and activates the Arp2/3 complex. Mutation of this
motif to 20DDA22, hereafter referred to as W22A, abol-
ished this activity [11]. To determine whether this motif is
necessary for pedestal formation we transfected HeLa cells
with GFP-W22A. We used wild-type (WT) cortactin (GFP-
FL) and GFP alone as controls. As shown in Fig. 1, over-
expression of GFP-FL cortactin allowed pedestal forma-
tion to levels similar to those in cells expressing GFP. Fig.
1C (black bars) shows normalized percentages and stand-
ard deviations for GFP-FL. Results of three independent
experiments were considered statistically significant (p <
0.01 by Student's t-test). Since the constructs bear a GFP-
tag we were able to simultaneously assess the localization
of different cortactin forms (Fig. 1A, B and 1C). We
observed GFP-FL cortactin to localize in 70% of pedestals,
compared to 4% for GFP-transfected cells (open bars).
Importantly, the number of pedestals in cells expressing
GFP-W22A mutant was significantly lower than in GFP-FL
transfected cells (51% vs 83%). This result indicates that
cortactin W22A exerts a dominant negative effect, which
may mean that cortactin binding and activation of the
Arp2/3 complex is necessary for pedestal formation.
Cortactin has a C-terminal SH3 domain that binds several
proteins. Mutation of a critical amino acid (W525K) abol-
ishes its binding to known targets [29] such as N-WASP
[14]. We used this mutant to assess the contribution of the
cortactin SH3 domain to pedestal formation; we found
that its expression inhibits pedestal formation to an even
greater extent than the W22A mutant (31% vs 51%). This
indicates that cortactin W525K mutant exerts a dominant-
negative effect, corroborating previous results [23]. In pre-
vious work, we described that the cortactin SH3 domain is
able to activate N-WASP and we proposed a model for the
regulation of N-WASP activation by cortactin, in which
cortactin is switched on by Erk phosphorylation of serines
405 and 418, while it is switched off by Src phosphoryla-
tion of tyrosines 421, 466 and 482 [14]. Next we repeated
the pedestal formation assay with cells expressing the cort-
actin S405,418D double mutant, which mimics Erk phos-
phorylation and activates N-WASP in vitro, as well as its
non-phosphorylatable counterpart (S405,418A). The
S405,418D mutant allowed pedestal formation to a simi-
lar extent as the WT cortactin (90%) and to a greater
extent, although not significantly greater, than the GFP
negative control (83%). The phosphoserine-mimicking
cortactin mutant accumulated in only 21% of pedestals
and showed a weak, diffuse pattern of localization in the
cytoplasm and pronounced staining in the nucleus. In
contrast, the mutant that abolished Erk phosphorylation
(S405,418A) impaired pedestal formation (34%) and its
own translocation to them (3%). These results suggest
that Erk phosphorylation of cortactin contributes to ped-
estals formation.
Similarly, we wanted to address the role of Src-mediated
phosphorylation of cortactin. We therefore used the phos-
photyrosine-mimicking mutant (Y421,466,482D) and
the phosphotyrosine deficient mutant (Y421,466,482F).
In both cases pedestal formation and location of these
constructs on them were impaired (33%/7%; 28%/14%,
Fig. 1B and 1C). These results indicate that Src-mediated
phoshorylation of cortactin seems to inhibit pedestal for-
mation and that a dynamic phosphorylation of these tyro-
sine residues play a role in the formation of pedestals.
Total F-actin content of cells transfected with different 
cortactin mutants
Although no appreciable changes in the cellular architec-
ture were observed, we wanted to exclude the possibility
that over-expression of cortactin mutants induces a gen-
eral alteration of the actin cytoskeleton. We therefore used
flow cytometry to assess the total basal F-actin content of
the different transfectants. Fig. 1C (grey bars) and 1DPage 3 of 14
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Effect of the overexpression of WT and cortactin mutants on pedestal formation and total actin content. (A) 
Schematic of cortactin domains and mutants under investigation. (B) Cortactin mutants block pedestal formation. Immunofluo-
rescence images of HeLa cells transfected with WT (FL) and cortactin mutants and infected with EPEC for three hours. 
Mutants used are: Arp2/3 activation mutant (W22A), Erk-phosphorylation-mimicking mutant S405,418D (SD), Erk non-phos-
phorylatable mutant S405,418A (2A), Src-phosphorylation-mimicking mutant Y421,466,482D (3D), Src non-phosphorylatable 
mutant Y421,466,482F (3F) and SH3 domain mutant (W525K). GFP staining is shown in green, F-actin is in red, and bacteria 
and nuclei are in blue. The last column shows merged images of GFP and actin staining. Pictures are at 600× magnification. 
Scale bar 10 μm. (C) Quantification of pedestal number, cortactin localization and total F-actin content of transfectants. Black 
bars represent percentages normalized to WT of pedestal formed after 3 hours of infection of HeLa cells expressing GFP-FL 
and cortactin mutants. White bars represent normalized percentages of localization to pedestals. Grey bars represent the 
mean fluorescence of total actin content determined by flow cytometry. Experiments were performed at least three times with 
similar results. (D) Total actin content of HeLa cells transfected with WT and cortactin mutants. Histogram charts of HeLa 
cells expressing WT and cortactin mutants. Cells were permeabilized and stained with TRITC-phalloidin and total F-actin con-
tent was analyzed by flow cytometry. Overlaid histograms show the actin content of cortactin/mutants with respect to GFP 
transfected control cells (green curve). Pretreatment with cytochalasin D (blue curve) of cells expressing WT cortactin is 
shown as a control.Page 5 of 14
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EPEC-induced tyrosine phosphorylation of cortactin depends on N-WASP. (A) Tyrosine phosphorylation of cortac-
tin occurs in WT but not in N-WASP-deficient MEFs. WT, N-WASP-deficient and N-WASP reconstituted cells were infected 
with EPEC for three hours. The level of tyrosine phosphorylation of cortactin was assessed by Western blotting using an anti-
body against phospho-Y466 cortactin (upper panel). The same membrane was stripped and reprobed with anti-cortactin mon-
oclonal antibody 4F11. N-WASP Western blotting was also performed to confirm the genotype of the MEFs. Actin was used as 
a loading control. Similar results were obtained in at least three independent experiments. (B) EPEC infection activates Src to 
similar extends in WT, N-WASP-deficient and R cells. WT, N-WASP-deficient and N-WASP reconstituted cells were infected 
with EPEC for three hours and analyzed for Src activation (phospho-Y416 Src) (upper panel). Medium and lower panels 
showed Src and actin blots, respectively. (C) Pervanadate treatment induces a robust phosphorylation of cortactin on tyrosine 
466 in WT, N-WASP-deficient and R cells. Lysates of vehicle (DMSO)-treated MEFs and lysates of pervanadate-treated MEFs 
(diluted 1/500 *) were subjected to SDS-PAGE and Western blotted with antibody against phospho-Y466 cortactin. A second 
gel was loaded in parallel with the same amount of protein for both types of lysates and blotted for cortactin and actin for pro-
tein and loading controls, respectively (medium and lower panels). (D) EPEC infection induces Erk1/2 activation in WT but not 
N-WASP-deficient MEFs. WT, N-WASP-deficient and R cells were infected with EPEC for three hours. The level of Erk activa-
tion was assessed by Western blotting using a mAb specific for activated Erk phosphorylated on Thr202 and Tyr204 (upper 
panel). Medium and lower panels show Erk and actin blots for Erk protein and loading control respectively. Experiments were 
performed at least three times.
Cell Communication and Signaling 2009, 7:11 http://www.biosignaling.com/content/7/1/11show the mean fluorescence of GFP transfectants, which
did not significantly differ based on Student's t-test. As a
control, transfected cell were pretreated with Cytochalasin
D, a drug known to inhibit actin polymerization (Fig. 1D,
bottom right panel). In addition, this experiment allowed
us to calculate the transfection efficiency, which was esti-
mated as 60–70%, based on the analysis of the expression
of GFP constructs (data not shown).
EPEC induces N-WASP-dependent tyrosine 
phosphorylation of cortactin
Contrary to the transient phosphorylation induced by
EHEC, EPEC infection of CH7 mouse fibroblasts induces
tyrosine phosphorylation of cortactin [26]. Src has been
shown to phosphorylate cortactin on tyrosines Y421, 466
and 482 [30], which decreases cortactin affinity for N-
WASP in vitro [14]. In addition, N-WASP-deficient cells do
not form pedestals [31]. These observations prompted us
to examine the phosphorylation status of cortactin in WT
mouse embryonic fibroblasts (MEFs), MEFs deficient in
N-WASP and MEFs deficient in N-WASP in which the pro-
tein was later restored through retroviral transduction
(rescued, R). First, we performed Western blotting control
experiments to assess the expression of N-WASP, cortactin
and actin (Fig. 2A).
Fig. 2A shows that EPEC induces phosphorylation of tyro-
sine 466 at 3 hours of infection in WT MEFs, as detected
using an antibody against phospho-Y466-cortactin. This
result was corroborated using a second phospho-specific
antibody (pY421, data not shown). Unexpectedly, phos-
phorylation of tyrosine residue 466 was not induced in N-
WASP-deficient cells. This result suggests that tyrosine
phosphorylation of cortactin during EPEC infection
depends on the presence of N-WASP. To verify this, we
infected R cells with EPEC and examined levels of
phosphoY466-cortactin. Fig. 2A shows that N-WASP re-
expression partially restored cortactin tyrosine phosphor-
ylation levels. In three independent experiments the nor-
malized average induction was 1 ± 0.2 for WT cells, 0 for
N-WASP-deficient cells and 0.5 ± 0.1 for R cells. This sup-
ports the idea that EPEC-induced tyrosine phosphoryla-
tion of cortactin in cells requires N-WASP.
Given the absence of cortactin tyrosine phosphorylation
in EPEC-infected N-WASP-deficient cells, we then checked
Src activation, using a commercially available phospho-
active Src antibody (pY416). Fig. 2B demonstrated that
equal activation of Src was achieved during EPEC infec-
tion in all cell types studied, while, as expected, the levels
of total Src remained constant during infection. This result
showed that the lack of cortactin phosphorylation in N-
WASP-deficient cells was not due to a block in Src activa-
tion. As a further control, we treated the cells with per-
vanadate and observed robust phosphorylation of
cortactin tyrosine 466 (Fig. 2C, upper panel).
Similarly we sought to establish the activation status of
Erk in EPEC-infected cells. We used a phospho-specific
monoclonal antibody that detects the activated form of
Erk1/2 (anti pThr202-pTyr204). EPEC induced the activa-
tion of Erk on WT MEFs (Fig. 2D first lane), in agreement
with a previous report on T84 epithelial cells [32]. How-
ever, infection of N-WASP-deficient cells showed reduced
activation of Erk which was recovered in R cells. This
result implies that Erk is activated by EPEC and may phos-
phorylate cortactin in vivo. More importantly, N-WASP is
absolutely required for the induction of Erk activation at
3 hours of infection. However, WT MEFs treated with ERK
inhibitors PD98056 or U0126 showed no difference in
the number of pedestals formed ([23] and data not
shown).
Tir binds cortactin and induces the latter to nucleate actin 
in vitro through an Arp2/3 complex-mediated pathway
The bacterial protein called Tir initiates what is considered
to be the principal signaling cascade, which consists of Tir
clustering and concomitant phosphorylation on its tyro-
sine 474, which then recruits Nck. The latter presumably
binds N-WASP to initiate Arp2/3 complex-mediated actin
polymerization [1]. We wanted to gain insights into how
cortactin functions in pedestal signaling. Our initial
hypothesis was that cortactin and Tir interact directly.
Therefore we used the Scansite database [33] to search for
motifs in the Tir sequence to which cortactin SH3 domain
could bind. We found a consensus motif (NNSIPPAPPLP-
SOTD) centered on proline 20 of Tir.
We first performed pull-down experiments with purified
recombinant Tir [34] and cortactin proteins (Fig. 3). We
produced WT GST-Tir that was purified using GSH beads
and treated with PreScission enzyme, which excised Tir
and at the same time removed the GST tag (Fig. 3,
Coomassie gel). This Tir protein was used as the input in
pull-down experiments with GST-cortactin. The first line
of Fig. 3A shows that cortactin binds Tir in vitro.
To map the domains involved in the interaction, we per-
formed pull-down experiments using cortactin mutants as
follows: full-length W525K (mutated SH3 domain), the
N-terminus (NH2, residues 1–333), and the isolated SH3
domain (SH3, residues 458–546). GST was used as a neg-
ative control. In agreement with our initial hypothesis, the
isolated SH3 domain of cortactin bound Tir. However, the
N-terminal domain of cortactin also bound Tir (Fig. 3A,
third line). This unforeseen interaction was confirmed in
experiments with cortactin carrying the point mutation,
W525K in the SH3 domain (Fig. 3A). We obtained similar
results using as input the Tir phospho-mimicking mutantPage 6 of 14
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actin S405,418D (SD) and Y421,466,482D (3D) mutants
which were similar to the WT form in their ability to bind
both Tir (Fig. 3B) and TirD (data not shown). These
results demonstrate that cortactin and Tir interact directly
in vitro, that this interaction involves both the N-terminal
part and the SH3 domain, and that it appears to be inde-
pendent of cortactin phosphorylation.
Given the direct interaction between Tir and cortactin, we
wondered whether Tir can activate the ability of cortactin
to promote Arp2/3-mediated actin polymerization. We
coupled recombinant Tir protein (or TirD, data not
shown) to 1 μm beads, and then we washed the beads
with Xb buffer and blocked them in Xb buffer containing
1% BSA. Next we incubated them with purified Arp and
actin in Xb buffer containing WT and cortactin mutants.
Fig. 3C shows that Tir activated WT cortactin and both SD
and 3D mutants. Similar results were obtained for TirD
(data not shown). The W525K mutant was also activated,
although weakly. As expected, W22A cortactin was not
activated, indicating that the effect was mediated by cort-
actin activation of the Arp2/3 complex. As a negative con-
trol we used naked beads that showed no activation.
Conversely, experiments in which cortactin and its
mutants were coupled to GSH beads showed similar
results (data not shown). These results indicate that Tir
activates the ability of cortactin to promote Arp2/3-medi-
ated actin polymerization in vitro.
Tir binds cortactin and promotes its activation of Arp2/3-mediated actin polymerizationF gure 3
Tir binds cortactin and promotes its activation of Arp2/3-mediated actin polymerization. (A) Cortactin binds Tir 
through the N-terminal and the SH3 domains in vitro. Recombinant Tir was incubated with WT cortactin (FL) and with the 
three mutants expressed as GST fusion proteins: the SH3 domain mutant (W525K), the N-terminal (NH2) domain and the 
SH3 domain (SH3). GST alone served as a negative control. The pull-downs were subjected to SDS-PAGE and blotted with 
anti-Tir monoclonal antibody. In the last line, one-fifth of the total amount of Tir that was used as input per pull-down sample 
(upper left panel). Coomassie staining of proteins is also shown (lower panels). Half of the GST-proteins and on-fifth of Tir that 
was used in the pull-downs was stained with Coomassie blue. (B) Cortactin binds Tir independently of phosphorylation in vitro. 
Recombinant Tir was incubated with WT cortactin (FL) and with the three mutants expressed as GST fusion proteins: Arp2/3 
domain mutant (W22A), Erk-phosphorylation-mimicking mutant (SD) and Src-phosphorylation- mimicking mutant (3D). GST 
alone served as a negative control (right upper panel). Coomassie staining of proteins is also shown (lower panels). Half of the 
GST-proteins and one-fifth of Tir that were used in the pull-downs were stained with Coomassie blue (shown in A). (C) 
Immunofluorescence images of Tir-coupled beads incubated with actin, Arp2/3 and cortactin/mutants. Carboxilate beads 
(diameter 1 μm) uncoupled (left panels) or coupled to Tir protein (right panels) were incubated with a solution of 500 nM WT 
cortactin or cortactin mutants proteins for 1 hour. Then, actin and Arp were added and incubated at RT to allow actin polym-
erization. After 1 hour TRITC-phalloidin was added, and the samples were observed immediately on a microscope. Pictures 
were taken at 600× magnification. Scale bar 40 μm.Page 7 of 14
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by EPEC
Because cortactin binds directly both Tir (Fig. 3) and N-
WASP [14], we analyze cortactin-Tir interaction in N-
WASP-deficient cells. Since those cells do not form pedes-
tals [35], we wondered if Tir would be present at similar
levels to WT cells. To address this question, we used a pre-
viously described fractionation protocol that enriches in
Tir-containing membranes ([36] and Materials and Meth-
ods). As shown in Fig. 4A, as expected Tir was enriched in
the pellets compared to supernatants, as detected by west-
ern-blotting with anti-Tir mAb. We observed that a band
with slower electrophoretic motility was the predominant
form of Tir in the pellets, which represents fully-modified
Tir [37]. WT and N-WASP-deficient cells presented detect-
able amounts of mature Tir that was slightly reduced on R
cells.
FL cortactin has a closed conformation [14,20]. Therefore,
we decided to use N-terminal cortactin (NH2), the SH3
domain (SH3) and GST as a negative control to perform
pull-down experiments with lysates of EPEC infected and
uninfected WT, N-WASP-deficient and R cells. Western
blotting in Fig. 4B shows that NH2 bound Tir in EPEC
infected but not uninfected cells, with no appreciable dif-
ferences between WT, N-WASP and R cells. Similar results
were obtained with total cell lysates although longer expo-
sure times where necessary to detect Tir (data not shown).
In contrast, neither the isolated SH3 domain nor the GST
negative control bound Tir in any of the cells types used.
In view of these results, we can conclude that in cells, cort-
actin binds Tir primarily through its N-terminal region. To
test whether the SH3 domain of cortactin prefers to bind
N-WASP over Tir, we performed pull-downs with clarified
total lysates, and we then stripped and reprobed the blots
with anti-N-WASP antibody. This approach was necessary
because the pellets did not contain easily detectable levels
of N-WASP (data not shown). As previously described
[14], the SH3 domain of cortactin was able to pull-down
N-WASP in WT cells but not N-WASP-deficient cells (data
not shown). This argues in favor of the conclusion that the
N-terminal region of cortactin is involved in binding Tir,
while the SH3 domain is involved in binding N-WASP.
Cortactin binding to Tir in N-WASP-deficient cells infected by EPECFigure 4
Cortactin binding to Tir in N-WASP-deficient cells infected by EPEC. (A) Tir is abundant in membrane-enriched 
fractions. EPEC-infected and uninfected P100 monolayers of WT, N-WASP-deficient, and R MEFs were lysed in imidazole 
buffer, fractionated, subjected to SDS-PAGE and blotted with anti-Tir mAb. As previously described, Tir appears as a doublet 
whose upper band is enriched in the membrane fractions (pellets). The signal from the anti-actin antibody is shown as a loading 
control. (B) Cortactin binds Tir in cells through its N-terminal domain. Cell lysates of uninfected and EPEC- infected WT, N-
WASP-deficient, and R (R) MEFs were analyzed in pull-down experiments using GST fusion proteins as follows: cortactin N-
terminal truncation mutant (NH2), the isolated SH3 domain (SH3), and GST alone. Western blotting with anti-Tir monoclonal 
antibody revealed a unique band corresponding to the slower-moving band. This band was present only in the NH2 pull-down 
conducted on all three types of lysates. These experiments were performed at least three times.Page 8 of 14
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Cortactin is a scaffold protein implicated in many cellular
processes since it directly contributes to cytoskeleton
remodeling. Cortactin also has oncogenic properties due
to its role in controlling invadopodia formation and cell
migration. Moreover, cortactin has emerged as an impor-
tant target of numerous pathogens, including enteropath-
ogenic E. coli that manipulate the actin cytoskeleton in
order to invade the host and propagate there [10]. EPEC
cause severe diarrheal disease in humans by colonizing
the gut mucosa and producing A/E lesions. EPEC attach to
mammalian intestinal cells and induce reorganization of
the actin cytoskeleton into 'pedestal-like' structures under-
neath the bacteria. A crucial event for pedestal formation
is the insertion into the host-cell membranes of the EPEC
effector Tir, which is initially injected into the cell by a
type III secretion system. Tir mimics signaling pathways of
the infected cell. Thus it can serve as a powerful model sys-
tem to study eukaryotic transmembrane signaling [38]. In
fact, the Tir-Nck-N-WASP pathway is the principal one
through which actin polymerizes in EPEC pedestals.
Those reasons prompted us to study cortactin signaling
during EPEC infection using N-WASP-deficient cells.
Although cortactin localizes to pedestals and its truncated
forms exert a dominant negative effect, its function is not
clear. For example, does cortactin on its own contribute to
actin polymerization in pedestals? Our transfection exper-
iments with the GFP-W22A cortactin point mutant dem-
onstrate that cortactin binding and activation of the Arp2/
3 complex is necessary for pedestal formation, which sug-
gests that cortactin indeed contributes to efficient actin
polymerization. A complementary study used a similar
approach to examine the role of cortactin domains on
pedestal formation [23]. It reported identical results to
ours regarding WT cortactin and the mutant W525K.
However, the W22A mutant was not studied in that work.
To address the role of Erk and Src phosphorylation of cort-
actin, we used both phosphorylation-mimicking and
non-phosphorylatable mutants; previous studies have
used only the former [23]. Therefore, we were able to
detect a 'neutral' effect on pedestal formation of mutant
that mimics phosphorylation by Erk, while the Erk non-
phosphorylatable form blocked pedestal formation. Thus,
we conclude that phosphorylation of cortactin by Erk may
positively regulate pedestal formation. Our conclusion is
also supported by other studies: over-expression of a
mutant of cortactin mimicking phosphorylation on serine
enhanced invadopodia formation in cells in which endog-
enous cortactin expression had previously been reduced
by siRNA [39]. We could not use a similar approach in the
present study because the cells detached and died upon
EPEC infection (data not shown). The presence of endog-
enous cortactin may explain why the SD mutant did not
lead to significantly more pedestals than WT, although an
increase was detectable. Experiments with cortactin-defi-
cient cells may provide the definitive answer to this ques-
tion. In contrast, phosphoserine-mimicking cortactin
accumulated in only one-fourth of pedestals and showed
weak diffuse staining in the cytoplasm and a strong
nuclear staining. We do not understand this distribution,
and we are currently investigating it.
Src phosphorylates cortactin on positions Y421, 466, and
482 [30]. Therefore we used phosphorylation-mimicking
and non-phosphorylatable triple mutants. In both cases
pedestal formation was impaired, as well as the accumu-
lation of the mutant proteins to the pedestals that did
form. These results indicate that phoshorylation of cortac-
tin by Src inhibits pedestal formation. The same conclu-
sion was reached using the double Y421,466D mutant
which partially mimics Src phosphorylation [23], which
further supports the idea that cortactin phosphorylated on
tyrosine inhibits pedestal formation. The fact that both Src
mimicking and non-phosphorylatable cortactin forms
inhibited the formation of pedestals might indicate that a
dynamic phosphorylation of these tyrosine residues play
a role in the formation of pedestals (Fig. 5). Finally, we
can exclude that the effects on pedestals were due to
changes in the total actin content of the transfectants,
because the content was similar for all transfectants exam-
ined (Fig. 1). This argues that our results on pedestal for-
mation reflect the specific effects of phosphorylation or
lack of phosphorylation.
A crucial finding of this study is that tyrosine phosphor-
ylation of cortactin is abrogated in N-WASP-deficient cells
but recovered by N-WASP re-expression (Fig. 2). In agree-
ment with these results, preliminary data using an anti-
body against cortactin phosphorylated on serine 405
show that EPEC induces serine phosphorylation of cortac-
tin, which is not up-regulated in EPEC infected N-WASP-
deficient cells (Narcisa Martínez-Quiles and Steffen Back-
ert, unpublished results). Importantly, the lack of cortac-
tin tyrosine phosphorylation was not due to a defect on
Src activation. We think that only the fraction of cortactin
that has translocated to the pedestals is available for serine
and tyrosine phosphorylation. These findings strongly
suggest a coordinated action of cortactin and N-WASP
during pedestal formation, consistent with the on/off
switching mechanism by which cortactin activates N-
WASP in vitro [14]. A remaining question is whether cort-
actin is phosphorylated sequentially, e.g. serine followed
by tyrosine phosphorylation. The lack of induction of
cortactin phosphorylation in N-WASP-deficient cells
should prove to be examined in many signaling transduc-
tion studies.
On the other hand, most studies have used inhibitors to
establish the role of kinases on pedestal signaling andPage 9 of 14
(page number not for citation purposes)
Cell Communication and Signaling 2009, 7:11 http://www.biosignaling.com/content/7/1/11have mainly focused on Tir phosphorylation [25]. To our
knowledge this is the first report that establishes the status
of Src activity during pedestal formation on N-WASP-defi-
cient cells. Another conclusion that can be drawn is that
Erk and Src kinases become activated in response to differ-
ent signals. Thus Src is not affected by ablation of N-WASP
whereas Erk activity is seriously compromised (Fig. 2). Erk
activation is shut off sooner in N-WASP-deficient cells
than in WT cells as seen in timing experiments. In con-
trast, the basal level of cortactin phosphorylated on serine
was higher in Nck-deficient cells than in WT cells, and it
was increased upon EPEC infection (data not shown).
Thus we can be confident that the lack of cortactin phos-
phorylation is not merely due to the lack of pedestals,
since cells deficient in either N-WASP or Nck do not form
pedestals [3,31].
We report here that cortactin and Tir bind each other
directly in vitro (Fig. 3A). Our initial hypothesis was that
they would interact directly through the SH3 domain cort-
actin, because Tir possess a consensus motif centered on
proline P20. Indeed, the SH3 domain was able to bind Tir,
but unexpectedly, the NH2 domain was also found to
bind Tir (Fig. 3). In addition, we did not detect differences
in the affinity binding of mutants that mimic phosphor-
ylation by Erk and Src, which contrast our previous bind-
ing studies in which a mutant that mimics
phosphorylation by Erk was found to bind preferentially
Model of cortactin action on EPEC pedestalsFigure 5
Model of cortactin action on EPEC pedestals. (A) Model of coordinated action by cortactin and N-WASP on EPEC ped-
estals. In theory, cortactin may bind Tir and N-WASP simultaneously, via its N-terminal and SH3 domain interaction respec-
tively. EPEC-induced tyrosine phosphorylation of cortactin would terminate cortactin interaction with N-WASP but not with 
Tir. This could constitute a cyclical regulatory mechanism of actin polymerization on EPEC pedestals. Phosphotyrosine-cortac-
tin might as well compete for the SH2 domain of Nck, thus uncoupling Tir from the Nck/N-WASP complex. (B) In the absence 
of N-WASP protein, cortactin would only interact with Tir, which would not be sufficient for pedestal formation.Page 10 of 14
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and Tir interact directly in vitro, through both the N-termi-
nal region and the SH3 domain of cortactin, and this
interaction seems to occur independently of cortactin
phosphorylation. In agreement with this conclusion,
experiments using a two-hybrid system show that both
the N-terminal region and the SH3 domain of cortactin
bind TirEHEC. However, a major difference with our results
is that only tyrosine-phosphorylated cortactin bind TirE-
HEC, which contrasts with the transient phosphorylation
of cortactin induced by EHEC. Both findings were recon-
ciled by suggesting cortactin and Tir initially bind tran-
siently coincident with the tyrosine phosphorylation of
cortactin [26]. In our system, EPEC-infected cells still
showed high levels of N-WASP-dependent cortactin phos-
phorylation three hours after infection. These results high-
light the fine-tuned nature of cortactin regulation during
EPEC and EHEC infections.
Cortactin can activate the Arp2/3 complex directly
through its NTA domain [11,12], and indirectly by using
its SH3 domain to activate N-WASP [14]. We wondered
whether the binding of Tir to cortactin would activate the
latter and promote Arp2/3 complex-dependent actin
polymerization. As shown in Fig. 3B, Tir-coated beads
activated cortactin. Furthermore, as for the binding, the
activation of cortactin by Tir was not affected by the phos-
phorylation status of cortactin, which further supports the
idea that in EPEC signaling, Tir binds and activates cortac-
tin independently of the latter's phosphorylation status.
At this point, we favored the conclusion that the relevant
contribution underlying cortactin-Tir binding occurs
through the N-terminal moiety of cortactin, since our pre-
vious studies indicated that phosphorylation of cortactin
affects mainly its interaction with partners through the
SH3 domain [14]. To test this hypothesis, we used cell
lysates that represent a more restrictive scenario with
greater similarity to binding conditions in vivo. Consistent
with our reasoning, the N-terminal region of cortactin
bound Tir, whereas the isolated SH3 domain did not in
any of the cells type tested. In view of these results, we can
conclude that in cells cortactin binds Tir primarily
through its N-terminal region, while the contribution of
the SH3 domain seems to be irrelevant. Furthermore, the
interaction between Tir and cortactin is independent of
phosphorylation and does not require N-WASP, since we
detected similar levels of interaction in WT, N-WASP-defi-
cient and R cells.
Alternatively, the cortactin SH3 consensus site on Tir may
be occupied by other SH3 domains such as tyrosine
kinases [40] or the cortactin SH3-domain may have a pref-
erence for binding N-WASP. As previously described [14],
the SH3 domain of cortactin pulls down N-WASP. This
supports the idea that cortactin binds Tir through the N-
terminus and N-WASP through the SH3 domain. In this
case, phosphorylation should affect only the binding of
cortactin to N-WASP; in other words, cortactin phosphor-
ylated on serine would bind both Tir and N-WASP
whereas cortactin phosphorylated on tyrosine would bind
only Tir.
Both binding and activation experiments were also per-
formed with the Tir phosphorylation mimicking Y474D
mutant of Tir (data not shown). The fact that we did not
observe significant differences from WT Tir may means:
(i) the mutant does not behave like the phosphorylated
form or (ii) the binding and activation of cortactin is inde-
pendent of Tir phosphorylation on residue 474. Further
experiments are needed to address this question.
Finally, in our effort to understand what kind of com-
plexes form in vivo, we considered all available in vitro data
concerning the interaction of Tir, Nck, N-WASP and cort-
actin. Thus Nck binds cortactin only when phosphor-
ylated by Src [41], through an interaction between the
phosphotyrosine and the SH2 domain [42]. Therefore
since Tir and Nck interact through the single SH2 domain
of Nck, formation of a Tir-Nck-cortactin complex appears
to be impossible. Cortactin phosphorylated by Src is not
able to interact with N-WASP, as shown with recombinant
proteins [14] and further corroborated in the two-hybrid
assay [26]. That adds to the evidence against the possibil-
ity that cortactin bridges both proteins, i.e. Nck-cortactin-
N-WASP. This leaves three possible types of complexes: (i)
Tir-Nck-N-WASP-cortactin, (ii) Tir-cortactin-N-WASP and
(iii) Tir-cortactin. Given the fact that reducing of cortactin
expression with siRNA inhibits pedestal formation ([23]
and our unpublished results), that EPEC infection induces
cortactin phosphorylation in an N-WASP-dependent fash-
ion (Fig. 2), and that Tir binds and activates cortactin (Fig.
3) we conclude that cortactin contributes to the Tir-Nck-
N-WASP pathway, possibly by regulating N-WASP activ-
ity. In other words, cortactin and N-WASP would act in a
complex in this scenario. If we envision pedestals as a
dynamic actin structure, and in fact pedestal motility has
been shown [7], then it is reasonable to think that pro-
teins promoting actin polymerization would act in a cyclic
manner. We speculate that cortactin is a cycling switch for
N-WASP in pedestals (Model in Fig. 5).
Deletion of Tir abrogates pedestal formation by EPEC [24]
implying that Tir mediates the major but not only path-
way for actin assembly in pedestals. Indeed, elegant work
has shown that the EPEC effector protein EspF directly
activates N-WASP [43]. We can not exclude that cortactin
participates in this pathway.Page 11 of 14
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The function of cortactin in pedestals, and how its func-
tion is regulated, seems to differ between EPEC and EHEC.
EHEC induces tyrosine dephosphorylation of cortactin
[26] whereas EPEC induces its tyrosine phophorylation
([26] and this study). During EHEC infection, the Tir-cort-
actin interaction was mapped to the N-terminal region of
both molecules, but only cortactin phosphorylated by Src
bound to TirEHEC.
In our study, cortactin bound directly to TirEPEC independ-
ently of phosphorylation since cortactin mutants mimick-
ing phosphorylation by Erk and Src interacted with Tir,
and were activated to a similar extent in vitro. This finding
further supports our results using EPEC-infected cells that
show that the interaction between Tir and cortactin is
mediated through the N-terminal part of the cortactin
molecule. Our results are compatible with the formation
of complexes in which cortactin may interact with Tir via
its N-terminal domain and with N-WASP via its SH3
domain. The later interaction would be terminated upon
tyrosine phosphorylation of cortactin (Model in Fig. 5).
Methods
Cells, bacteria, reagents and antibodies
HeLa human epithelial cells were obtained from ATCC
and grown in Iscove's Modified Dulbecco's Media
(IMDM) supplemented with 10% FBS (fetal bovine
serum). N-WASP-deficient and R mouse embryonic
fibroblasts (MEFs) were obtained from Dr. Scott Snapper
(Massachusetts General Hospital, Boston, USA) and
Nck1/2-deficient MEFs from Dr. Tony Pawson (Samuel
Lunenfeld Research Institute, Mount Sinai Hospital,
Toronto, Canada). Enteropathogenic Escherichia coli
(EPEC) E2348/69, as well as monoclonal antibodies
against the N- and C-termini Tir (2A5 and 2C3, respec-
tively) were provided by Dr. Brett B. Finlay (University of
British Columbia, Vancouver, Canada). Anti-N-WASP
antibody was previously described [44]. Commercial anti-
bodies used were: anti-cortactin 4F11 monoclonal anti-
body, anti-Src GD11 monoclonal and polyclonal anti-
phosphoY416 (activated Src) antibodies (Millipore), and
anti-actin C4 monoclonal antibody (MP Biomedical).
Anti-phospho-cortactin Y466 polyclonal antibody was
from Abcam (Cambridge, UK). Polyclonal anti-Erk1/2
(p44/42) and monoclonal anti-phospho-Erk (Thr202/
Tyr204, clone E10) antibodies were from Cell Signaling.
Anti-rabbit and anti-mouse horseradish peroxidase (HRP)
antibodies were from Amersham Pharmacia Biotech.
Cortactin and Tir constructs
Wild-type cortactin and selected mutants [14] were sub-
cloned in frame with GFP at the N-terminus in the plas-
mid pC2-EGFP (Invitrogen) and verified by sequencing.
The constructs used were full-length wild-type cortactin
(FL), and the following derivatives: the single point
mutants W22A and W525K; the double mutant
S405,418D; the triple mutant Y421,466,482D; an N-ter-
minal fragment of cortactin (NH2) containing residues 1–
333, and a cortactin fragment (residues 458–546) con-
taining the SH3 domain (SH3) aas. Two new mutants:
S405,418A and Y421,466,482F, were generated using
PCR and GST-FL as the template with the QuikChange
site-directed mutagenesis kit (Stratagene). The Tir Y474D
mutant was produced using the QuikChange kit.
Cell transfection, Western blotting and pedestal formation 
by EPEC
Cell transfection was carried out using Lipofectamine
2000 (Invitrogen). Briefly, HeLa cells were grown to 60–
70% confluence in 6-well plates. Transfections were incu-
bated for 16 hours in medium containing 10% FBS but no
antibiotics. Western blotting was done on cells from a sin-
gle well by directly adding 300 μl of 2× Laemmli buffer
and scraping the cells. Samples were homogenized by six
passages through a syringe with a 25-gauge needle, fol-
lowed by centrifugation at 21,000 g for 15 min at 4°C.
Samples were resolved by 10% SDS-PAGE and analyzed
by Western blotting and developed with ECL (Amer-
sham). Band densitometry was carried out using NIH
ImageJ software. Normalization for each experiment was
done by first, normalizing actin and next, the protein. The
average difference was calculated from three independent
experiments and reported as ± standard deviations.
EPEC infections were carried out as follows. Overnight
bacterial culture were grown at 37°C with shaking at 200
r.p.m., and 1 μl of culture was added per well of a 6-well-
plate. Pedestals were allowed to form for 3 hours in
medium containing 10% FBS and no antibiotics at 37°C
and 5% CO2. When indicated, EPEC was preactivated by
incubating a 1/100 dilution of the O/N culture for 2 hours
in medium containing 10% FBS and no antibiotics at
37°C and 5% CO2; the amount of bacteria from this pre-
activated culture that was added to wells was 1/8 that of
non-preactivated bacteria. Quantification was done by
counting the numbers of pedestals of attached bacteria for
a total of 100 cells. Experiments were performed at least
three times. Statistical analysis was carried out using Stu-
dent's t-test in Microsoft Excel.
Immunofluorescence microscopy and determination of 
total content of F-actin
Cells were fixed with 4% formalin solution (Sigma) at
room temperature and permeabilized with 0.1% Triton X-
100 for 5 min. After two washes with PBS, cells were
blocked with 2% BSA in PBS for 10 min and then sequen-
tially stained with 1 μg/ml tetramethyl rhodamine isotio-
cianate (TRITC)-phalloidin (Sigma) and DAPI (300 nM).
Photographs were taken using a Nikon Eclipse TE 200-UPage 12 of 14
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camera. Images were processed with Adobe Phothoshop.
For determination of total content of F-actin, TRITC-phal-
loidin was used at 5 μg/ml. As a control, cells were pre-
treated 15 min with cytochalasin D at 2 μg/ml. Samples
were sorted by fluorescence using a FACS Scalibur station.
Experiments were performed at least three times. Statisti-
cal analysis was carried out using Student's t-test in Micro-
soft Excel.
Actin polymerization assays
GST recombinant proteins were produced, purified and,
when necessary, treated with PreScission protease accord-
ing to the manufacturer's recommendations (GE Health-
care) to remove GST. Carboxilate microspheres (1 μm;
Polysciences Inc.) were coupled to Tir/TirD in solution
(500 nM) and washed once with Xb buffer (10 mM
HEPES pH 7.8, 100 mM KCl, 0.1 mM CaCl2, 1 mM MgCl2,
1 mM ATP) and twice with Xb buffer-1% BSA to block
nonspecific interactions. Purified actin (2.5 μM) and Arp
(300 nM) were used. Cortactin and its mutants (500 nM)
were added to a final volume of 25 μl of Xb buffer. After 1
hour TRITC-phalloidin was added to a final concentration
of 3.3 μM. The solution containing the beads was placed
on a slide and sealed with paraffin. Pictures were acquired
while keeping all relevant parameters fixed (gain, expo-
sure time) to allow for fluorescence intensity comparison.
Experiments were performed at least three times.
Membrane enrichment procedure, pull-down experiments, 
and pervanadate treatment
After EPEC infection, MEFs were fractionated as described
[36] with some modifications. Briefly, MEFs were grown
to 70–80% confluence in 150-mm plates and infected
with preactivated EPEC. After 3 hours of infection, cells
were washed once with ice-cold PBS and rapidly lysed at
4°C by overlaying the cell monolayer for 10 min with 1
ml of buffer containing imidazole (pH 7.4), 250 mM
sucrose, protease-phosphatase inhibitor cocktail (Com-
plete™) and phosphatase inhibitor (PhosStop, Amer-
sham). Then the cells were collected using a cell scraper
(Sarstedt) and disrupted by six passages through a syringe
with a 25-gauge needle, followed by 15 min centrifuga-
tion at 3,000 g to remove cellular debris, bacteria and
nuclei. Clarified lysates were centrifuged again for 1 hour
at 21,000 g to separate the membrane (pellet) from the
cytoplasmic fraction (supernatant). Both of these final
fractions were stored at -70°C until further use.
For pull-down experiments pellets were resuspended in
400 μl of lysis buffer containing 0.1% Triton-X100, and a
fourth was used for each pull-down. GST, the GST-N ter-
minal (NH2) cortactin fragment and the GST-SH3 cortac-
tin domain were produced in BL21 E. coli, purified and
coupled to GSH-beads. Pull-downs were washed three
times with 100 μl of lysis buffer diluted 1:10 in PBS con-
taining 0.05% Tween 20.
Pull-down experiments with recombinant proteins were
performed as previously described [14]. When necessary
the GST was removed by Precission enzyme treatment
(Amersham).
Pervanadate treatment was carried out by mixing 1 mM of
NaVO4 with 1% H2O2 and diluting two-fold with IMDM
medium for 30 min at 37°C and 5% CO2.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
ENP and NMQ performed and designed the experiments.
NMQ, the Senior/corresponding author, supervise the
experiments and prepare the manuscript with the help of
ENP.
Acknowledgements
We are very grateful to Marie-France Carlier for providing support, to 
members of her laboratory Dominique Didry and Diep Lê for Arp2/3 and 
actin purification and to Christophe Le Clainche for support and helpful dis-
cussions. We are very grateful to Dr. Finlay (University of British Columbia, 
Vancouver, Canada) for E2348/69 EPEC strain and anti-Tir moAbs, to Dr. 
Scott Snapper (Massachusetts General Hospital, Boston, USA) for N-
WASP K.O. and Rescued cells, and to Dr. Phillip Hardwidge (University of 
Kansas Medical Center) for reading the manuscript. We express our appre-
ciation to Dr. César Nombela, Dr. María Molina and Dr. Rafael Rotger for 
support and laboratory space, Dr Isabel Rodriguez-Escudero and Dr. Victor 
Cid for Tir DNA, and María Moreno Coca for help with experiments in Fig-
ure 2.
This work was funded by a Marie Curie International Reintegration grant 
(IRG 028995-cortactinNMQ) and a FIS grant (PI 060004) to NMQ. ENP 
was supported by the IRG grant. NMQ is a 'Ramón y Cajal' MEC-UCM 
researcher, partially funded by the European Social Fund (ESF).
References
1. Caron E, Crepin VF, Simpson N, Knutton S, Garmendia J, Frankel G:
Subversion of actin dynamics by EPEC and EHEC.  Current
opinion in microbiology 2006, 9(1):40-45.
2. Kenny B, DeVinney R, Stein M, Reinscheid DJ, Frey EA, Finlay BB:
Enteropathogenic E. coli (EPEC) transfers its receptor for
intimate adherence into mammalian cells.  Cell 1997,
91(4):511-520.
3. Gruenheid S, DeVinney R, Bladt F, Goosney D, Gelkop S, Gish GD,
Pawson T, Finlay BB: Enteropathogenic E. coli Tir binds Nck to
initiate actin pedestal formation in host cells.  Nature cell biology
2001, 3(9):856-859.
4. Kalman D, Weiner OD, Goosney DL, Sedat JW, Finlay BB, Abo A,
Bishop JM: Enteropathogenic E. coli acts through WASP and
Arp2/3 complex to form actin pedestals.  Nature cell biology
1999, 1(6):389-391.
5. Campellone KG, Leong JM: Nck-independent actin assembly is
mediated by two phosphorylated tyrosines within enter-
opathogenic Escherichia coli Tir.  Molecular microbiology 2005,
56(2):416-432.
6. Hardwidge PR, Rodriguez-Escudero I, Goode D, Donohoe S, Eng J,
Goodlett DR, Aebersold R, Finlay BB: Proteomic analysis of the
intestinal epithelial cell response to enteropathogenicPage 13 of 14
(page number not for citation purposes)
Cell Communication and Signaling 2009, 7:11 http://www.biosignaling.com/content/7/1/11Escherichia coli.  The Journal of biological chemistry 2004,
279(19):20127-20136.
7. Sanger JM, Chang R, Ashton F, Kaper JB, Sanger JW: Novel form of
actin-based motility transports bacteria on the surfaces of
infected cells.  Cell Motil Cytoskeleton 1996, 34(4):279-287.
8. Blasutig IM, New LA, Thanabalasuriar A, Dayarathna TK, Goudreault
M, Quaggin SE, Li SS, Gruenheid S, Jones N, Pawson T: Phosphor-
ylated YDXV motifs and Nck SH2/SH3 adaptors act cooper-
atively to induce actin reorganization.  Mol Cell Biol 2008,
28(6):2035-2046.
9. Weaver AM: Cortactin in tumor invasiveness.  Cancer letters
2008, 265(2):157-166.
10. Selbach M, Backert S: Cortactin: an Achilles' heel of the actin
cytoskeleton targeted by pathogens.  Trends in microbiology 2005,
13(4):181-189.
11. Uruno T, Liu J, Zhang P, Fan Y, Egile C, Li R, Mueller SC, Zhan X:
Activation of Arp2/3 complex-mediated actin polymeriza-
tion by cortactin.  Nature cell biology 2001, 3(3):259-266.
12. Weaver AM, Karginov AV, Kinley AW, Weed SA, Li Y, Parsons JT,
Cooper JA: Cortactin promotes and stabilizes Arp2/3-induced
actin filament network formation.  Curr Biol 2001,
11(5):370-374.
13. Wu H, Parsons JT: Cortactin, an 80/85-kilodalton pp60src sub-
strate, is a filamentous actin-binding protein enriched in the
cell cortex.  The Journal of cell biology 1993, 120(6):1417-1426.
14. Martinez-Quiles N, Ho HY, Kirschner MW, Ramesh N, Geha RS:
Erk/Src phosphorylation of cortactin acts as a switch on-
switch off mechanism that controls its ability to activate N-
WASP.  Nat Cell Biol 2001, 3(5):484-491.
15. Lua BL, Low BC: Cortactin phosphorylation as a switch for
actin cytoskeletal network and cell dynamics control.  FEBS
letters 2005, 579(3):577-585.
16. Cosen-Binker LI, Kapus A: Cortactin: the gray eminence of the
cytoskeleton.  Physiology (Bethesda, Md) 2006, 21:352-361.
17. Phillips N, Hayward RD, Koronakis V: Phosphorylation of the
enteropathogenic E. coli receptor by the Src-family kinase c-
Fyn triggers actin pedestal formation.  Nature cell biology 2004,
6(7):618-625.
18. Swimm A, Bommarius B, Li Y, Cheng D, Reeves P, Sherman M, Veach
D, Bornmann W, Kalman D: Enteropathogenic Escherichia coli
use redundant tyrosine kinases to form actin pedestals.
Molecular biology of the cell 2004, 15(8):3520-3529.
19. Weaver AM, Heuser JE, Karginov AV, Lee WL, Parsons JT, Cooper
JA: Interaction of cortactin and N-WASp with Arp2/3 com-
plex.  Curr Biol 2002, 12(15):1270-1278.
20. Cowieson NP, King G, Cookson D, Ross I, Huber T, Hume DA, Kobe
B, Martin JL: Cortactin adopts a globular conformation and
bundles actin into sheets.  The Journal of biological chemistry 2008,
283(23):16187-16193.
21. Kruchten AE, Krueger EW, Wang Y, McNiven MA: Distinct phos-
pho-forms of cortactin differentially regulate actin polymer-
ization and focal adhesions.  Am J Physiol Cell Physiol 2008.
22. Cantarelli VV, Takahashi A, Yanagihara I, Akeda Y, Imura K, Kodama
T, Kono G, Sato Y, Iida T, Honda T: Cortactin is necessary for F-
actin accumulation in pedestal structures induced by enter-
opathogenic Escherichia coli infection.  Infect Immun 2002,
70(4):2206-2209.
23. Cantarelli VV, Kodama T, Nijstad N, Abolghait SK, Iida T, Honda T:
Cortactin is essential for F-actin assembly in enteropatho-
genic Escherichia coli (EPEC)- and enterohaemorrhagic E.
coli (EHEC)-induced pedestals and the alpha-helical region is
involved in the localization of cortactin to bacterial attach-
ment sites.  Cellular microbiology 2006, 8(5):769-780.
24. Campellone KG, Rankin S, Pawson T, Kirschner MW, Tipper DJ,
Leong JM: Clustering of Nck by a 12-residue Tir phosphopep-
tide is sufficient to trigger localized actin assembly.  The Jour-
nal of cell biology 2004, 164(3):407-416.
25. Garmendia J, Phillips AD, Carlier MF, Chong Y, Schuller S, Marches
O, Dahan S, Oswald E, Shaw RK, Knutton S, et al.: TccP is an enter-
ohaemorrhagic Escherichia coli O157:H7 type III effector
protein that couples Tir to the actin-cytoskeleton.  Cellular
microbiology 2004, 6(12):1167-1183.
26. Cantarelli VV, Kodama T, Nijstad N, Abolghait SK, Nada S, Okada M,
Iida T, Honda T: Tyrosine phosphorylation controls cortactin
binding to two enterohaemorrhagic Escherichia coli effec-
tors: Tir and EspFu/TccP.  Cellular microbiology 2007,
9(7):1782-1795.
27. Selbach M, Moese S, Hurwitz R, Hauck CR, Meyer TF, Backert S: The
Helicobacter pylori CagA protein induces cortactin dephos-
phorylation and actin rearrangement by c-Src inactivation.
The EMBO journal 2003, 22(3):515-528.
28. Mousnier A, Whale AD, Schuller S, Leong JM, Phillips AD, Frankel G:
Cortactin recruitment by enterohemorrhagic Escherichia
coli O157:H7 during infection in vitro and ex vivo.  Mol Cell Biol
1998, 18(10):5838-5851.
29. Du Y, Weed SA, Xiong WC, Marshall TD, Parsons JT: Identification
of a novel cortactin SH3 domain-binding protein and its
localization to growth cones of cultured neurons.  Mol Cell Biol.
1998, 18(10):5838-5851.
30. Huang C, Liu J, Haudenschild CC, Zhan X: The role of tyrosine
phosphorylation of cortactin in the locomotion of endothe-
lial cells.  The Journal of biological chemistry 1998,
273(40):25770-25776.
31. Lommel S, Benesch S, Rottner K, Franz T, Wehland J, Kuhn R: Actin
pedestal formation by enteropathogenic Escherichia coli and
intracellular motility of Shigella flexneri are abolished in N-
WASP-defective cells.  EMBO reports 2001, 2(9):850-857.
32. Savkovic SD, Ramaswamy A, Koutsouris A, Hecht G: EPEC-acti-
vated ERK1/2 participate in inflammatory response but not
tight junction barrier disruption.  American journal of physiology
2001, 281(4):G890-898.
33. Yaffe MB, Leparc GG, Lai J, Obata T, Volinia S, Cantley LC: A motif-
based profile scanning approach for genome-wide prediction
of signaling pathways.  Nature biotechnology 2001, 19(4):348-353.
34. Race PR, Solovyova AS, Banfield MJ: Conformation of the EPEC
Tir protein in solution: investigating the impact of serine
phosphorylation at positions 434/463.  Biophysical journal 2007,
93(2):586-596.
35. Lommel S, Benesch S, Rohde M, Wehland J, Rottner K: Entero-
haemorrhagic and enteropathogenic Escherichia coli use dif-
ferent mechanisms for actin pedestal formation that
converge on N-WASP.  Cellular microbiology 2004, 6(3):243-254.
36. Patel A, Cummings N, Batchelor M, Hill PJ, Dubois T, Mellits KH,
Frankel G, Connerton I: Host protein interactions with enter-
opathogenic Escherichia coli (EPEC): 14-3-3tau binds Tir and
has a role in EPEC-induced actin polymerization.  Cellular
microbiology 2006, 8(1):55-71.
37. Kenny B, Warawa J: Enteropathogenic Escherichia coli (EPEC)
Tir receptor molecule does not undergo full modification
when introduced into host cells by EPEC-independent mech-
anisms.  Infect Immun 2001, 69(3):1444-1453.
38. Hayward RD, Leong JM, Koronakis V, Campellone KG: Exploiting
pathogenic Escherichia coli to model transmembrane recep-
tor signalling.  Nature reviews 2006, 4(5):358-370.
39. Ayala I, Baldassarre M, Giacchetti G, Caldieri G, Tete S, Luini A, Buc-
cione R: Multiple regulatory inputs converge on cortactin to
control invadopodia biogenesis and extracellular matrix deg-
radation.  Journal of cell science 2008, 121(Pt 3):369-378.
40. Bommarius B, Maxwell D, Swimm A, Leung S, Corbett A, Bornmann
W, Kalman D: Enteropathogenic Escherichia coli Tir is an
SH2/3 ligand that recruits and activates tyrosine kinases
required for pedestal formation.  Molecular microbiology 2007,
63(6):1748-1768.
41. Tehrani S, Tomasevic N, Weed S, Sakowicz R, Cooper JA: Src phos-
phorylation of cortactin enhances actin assembly.  Proceedings
of the National Academy of Sciences of the United States of America 2007,
104(29):11933-11938.
42. Okamura H, Resh MD: p80/85 cortactin associates with the Src
SH2 domain and colocalizes with v-Src in transformed cells.
The Journal of biological chemistry 1995, 270(44):26613-26618.
43. Alto NM, Weflen AW, Rardin MJ, Yarar D, Lazar CS, Tonikian R,
Koller A, Taylor SS, Boone C, Sidhu SS, et al.: The type III effector
EspF coordinates membrane trafficking by the spatiotempo-
ral activation of two eukaryotic signaling pathways.  The Jour-
nal of cell biology 2007, 178(7):1265-1278.
44. Martinez-Quiles N, Rohatgi R, Anton IM, Medina M, Saville SP, Miki H,
Yamaguchi H, Takenawa T, Hartwig JH, Geha RS, et al.: WIP regu-
lates N-WASP-mediated actin polymerization and filopo-
dium formation.  Nature cell biology 2001, 3(5):484-491.Page 14 of 14
(page number not for citation purposes)
  
 
 
Cortactin, an oncoprotein targeted by pathogens during infection  
E. Nieto-Pelegrín
1
, E. Meiler
1
, and N. Martínez-Quiles
1, 2
 
1 Department of Microbiology, Facultad de Farmacia, Universidad Complutense de Madrid, Avda de la Complutense s/n, 
28040 Madrid, Spain.  
2 Corresponding author: narcisaquiles@farm.ucm.es 
1. Introduction 
Cell motility and locomotion are important for many cellular functions. The cell skeleton or cytoskeleton remodels itself 
during multiple cellular tasks. For example, the actin cortical cytoskeleton undergoes significant changes during 
endocytosis, cell migration, adhesion and bacterial invasion [1]. 
 The cytoskeleton is made up of actin, intermediate and tubulin filaments. There is crosstalk among these constituents, 
allowing then to behave as a complex network. We are just beginning to understand some of the aspects of this network 
and to flesh out the broad strokes of how it is regulated. We are confronted by great biological complexity, so we must 
try to simplify it in order to understand it. Thus, it would contribute to our knowledge of the cytoskeleton as a whole if 
we focus on some details of a particular protein that helps to orchestrate some of these changes. This review focuses on 
cortactin, a protein that has emerged as an important convergence node in the regulation of the cytoskeleton during 
numerous biological tasks. More than to give an exhaustive review, our intention is to give a general vision of the best 
known aspects of this protein, while highlighting with a personal view some more controversial aspects that may 
require further studies. We recommend some recent reviews of cortactin that complement the present one [2,3]. 
2. From the first studies of cortactin to the present 
Cortactin was originally described as a protein located at the cell cortex and as a substrate of the Src kinase [4]. At 
nearly the same time, it was identified as the product of the CTTN gene (formerly EMS1), located in a chromosomal 
region, 11q13, frequently amplified in different human carcinomas [5]. Today, cortactin is considered an oncoprotein 
and a bona fide invadopodia marker. Invadopodia are actin-rich protrusions of the cell membrane that penetrate the 
extracellular matrix and degrade it, mainly through the accumulation and action of metalloproteinases [6,7]. At the same 
time, cortactin is a preferential target for bacterial and viral pathogens that subvert the cytoskeleton to their own benefit. 
For this reason, it has been called ‘the Achilles’ heel of the actin cytoskeleton’ [8]. 
3. Cortactin is an important node in the regulation of the actin cellular network 
Cortactin is a modular protein that participates in many signals that converge on the alteration of the actin cytoskeleton. 
Actin polymerization occurs when the globular monomeric form (G-actin) ensembles into a filamentous form (F-actin). 
The initial formation of a dimeric or a trimeric nucleus is unstable, and it is promoted and controlled by proteins that 
facilitate the process. One such protein is the Arp2/3 complex, which comprises two subunits, called actin-related 
proteins 2 and 3, as well as five other subunits. This complex is able to add a ‘branch’ to the side of a preexisting 
filament, giving rise to branched filaments with a characteristic 70-degree angle [1]. 
 Cortactin has an N-terminal acidic motif (NTA) that directly binds and activates the Arp2/3 complex, thereby 
behaving as a nucleation-promoting factor (NPF). The NTA domain is followed by a six and a half repeats of amino 
acids that bind to F-actin, binding that is required for cortactin activity [3]. However cortactin is a weak activator of the 
Arp2/3 complex in vitro, which raises the question of whether wild-type (WT) cortactin is active or whether it requires 
some post-translational modification to be fully active. Indeed, although cortactin has a predicted molecular weight of 
approximately 65 kDa, it migrates as an 80/85 kDa doublet in SDS-PAGE. To add to the complexity, cortactin is 
expressed as several isoforms that differ in the number of repeats, which seems to be related to the location of these 
isoforms to cell-cell contacts in epithelial cells [9]. In particular, a detailed analysis of cortactin expression is needed for 
immunological cells, since in most situations it is assumed that a paralog protein HS1 plays the role of cortactin. We 
favor the hypothesis that the pattern of expression of cortactin is similar to that of N-WASP/WASP (see next 
paragraph). Clearly, we do not understand some basic aspects of cortactin expression and post-translational 
modification. 
 There is another way in which cortactin can promote actin nucleation: its SH3 terminal domain binds directly and 
activates the neural Wiskott-Aldrich syndrome protein (N-WASP) [10, 11]. The first described activators of the Arp2/3 
complex were the WASP family of proteins. The representative member of the family, WASP, which is expressed 
exclusively in the immune system, is mutated in the immune deficiency called Wiskott-Aldrich syndrome (WAS). N-
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WASP is more ubiquitous than WASP and is coexpressed with this protein in some cell types, such as macrophages and 
dendritic cells. The mechanism by which these proteins promote actin polymerization (NPFs class I) differs from that of 
cortactin: they bind G-actin and activate the Arp2/3 complex through a verprolin cofilin acidic (VCA) domain [10]. 
4. Cellular location of cortactin 
Following various stimuli such as growth factor stimulation, binding and integrin engagement, cortactin translocates 
from a perinuclear/Golgi location to areas of cytoskeleton remodeling, such as lamellipodia at the leading edge [3]. The 
molecular mechanism of this translocation is still unknown. More recently, cortactin has been detected in the nucleus, 
where it has been proposed to participate in the separation of the centrosomes in preparation for mitosis [12]. Again the 
details of this translocation remain to be elucidated. 
5. Post-translational modifications of cortactin 
5.1 Cortactin phosphorylation 
As previously mentioned, cortactin is traditionally known as a substrate of Src kinase. Until the past decade, that was 
the only known cortactin post-translational modification of cortactin. In the murine protein the major phosphorylation 
sites are tyrosines 421, 466 and 482. It is assumed that Src phosphorylation of cortactin stimulates cortactin activity. 
More recent data, however, paint a more complicated picture of the effect of Src-mediated phosphorylation of native 
cortactin [3]. 
 In addition to Src kinase, one study has indicated that extracellular response-activated kinase (Erk) phosphorylates 
cortactin on serines 405 and 418 [13]. Long forgotten, this report came to light again in view of the action of cortactin 
on N-WASP activity, which we discuss later in this review. 
 In a comprehensive and meritorious effort, the Cell Migration Consortium mapped cortactin phosphorylation sites 
[14] describing 17 new ones. This gives us a more realistic perspective on the complexity of the regulation of this 
protein. Most of these sites are serines and threonines. 
 At the present it is known that cortactin is phosphorylated by various kinases, including Fer, Abelson and related 
kinases (Abl/Arg), p21-activated kinases (Paks) [15], and protein kinase D (PKD) [3]. In contrast, protein-tyrosine 
phosphatase 1B (PTP1B) is the sole phosphatase known to act on cortactin [16,17]. The physiological importance of 
cortactin dephosphorylation has probably been misrepresented due to the scarce data on the subject. 
5.2 Cortactin acetylation 
Recently, regulation of cortactin by reversible lysine acetylation has been described [18]. It can be acetylated by the 
acetyltransferase PCAF and p300, and deacetylated by histone deacetylase 6 (HDAC6) and SIRT1. According to this 
study, 11 lysines can be acetylated. When acetylated, the molecule loses two otherwise positively charged patches of 
lysines, most of which are located in the area of the repeats. Consequently, the ability of cortactin to bind F-actin 
diminishes. The authors of that study proposed that acetylation of cortactin inactivates the protein. However, it is very 
important to address the consequences of this acetylation on cortactin activity using in vitro actin polymerization assays 
and an acetylation mimic cortactin mutant. In this way, some important conclusions might be drawn about the activity 
of the protein and the effect of the acetylation on cortactin structure.  
 This regulation has already been implicated in quality control (QC) autophagy, a mechanism that, under 
physiological conditions, is important for removal of protein aggregates and turnover of organelles, such as 
mitochondria. HDAC6 recruits and deacetylates cortactin, which promotes the F-actin remodelling required for the 
fusion of autophagosome and lysosome and subsequent substrate degradation [19]. 
6. Cortactin as a cytoskeletal switch 
Apart from its intrinsic activity, cortactin can activate the WASP/N-WASP family of nucleators, which establishes a 
functional connection between the two main families of proteins capable of activating the Arp2/3 complex.  
 It was shown that cortactin binds and activates N-WASP through its SH3 terminal domain. However, full-length 
cortactin was less potent than the isolated SH3 domain in activating N-WASP, which suggests that cortactin, at least in 
vitro, is in a closed conformation that masks the SH3 domain. The interaction between cortactin and N-WASP was 
studied using in vitro actin polymerization assays involving both phosphomimetic mutants and non-phosphorylatable 
mutants of cortactin, as well as recombinant cortactin phosphorylated in vitro. Erk-mediated serine phosphorylation of 
cortactin opens the molecule, and allows the cortactin SH3 to interact with N-WASP. This interaction is terminated by 
Src-mediated tyrosine phosphorylation of cortactin. These findings led to the proposal of an ‘on/off switching’ 
mechanism called the ‘S-Y Swicth’ model, in which phosphorylation of cortactin by Erk and Src kinases controls the 
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ability of cortactin to activate N-WASP. Thus, cortactin binds and activates N-WASP only when phosphorylated at 
serines 405 and 418. The phosphorylation of cortactin by Src at tyrosines 421, 466 and 482 terminates this interaction 
(Fig. 1) [11]. 
 
 
Figure 1. Coupled cortactin-N-WASP activation according to the ‘S-Y Switch’ model proposed by Martinez-Quiles et al (2004). 
 
 
 The most easily testable prediction of the ‘S-Y Switch’ model is the understanding that cortactin can be regulated by 
a conformational change. The structure of cortactin has been resolved by circular dicroism, chemical crosslinking and 
X-ray scattering. These results showed that cortactin adopts a closed globular conformation through interaction between 
the cortactin SH3 domain and the repeats region [20]. These results are in agreement with our proposed ‘S-Y Switch’ 
model and contradict a previous description of cortactin as a thin elongated monomer [21]. It would be very important 
to use structural techniques to asses how Src-mediated phosphorylation of cortactin affects its structure and activity. As 
mentioned above, it seems that the in vitro effect of this phosphorylation is different from that of Erk phosphorylation, 
which seems to open the molecule and liberate the SH3 domain.  
 Immediately after Erk- and Src-mediated phosphorylation was shown to regulate cortactin, these findings were tested 
in different in vivo settings because of their repercussions on the fields of cellular motility and molecular microbiology 
[8, 22]. In a clear relation to the ‘S-Y Switch’ model, studies examined the effects of different serine and tyrosine 
phospho-mutations in cortactin on lamellipodial protrusion, actin assembly within cells, and focal adhesion dynamics. 
Cortactin mutants mimicking serine phosphorylation appeared to affect predominantly actin polymerization, whereas 
mutation of tyrosine residues altered turnover of focal adhesions [23]. 
 The ‘S-Y Switch’ model was also tested in different settings [24, 25], and phosphorylation of cortactin not only by 
Erk and Src but also by Pak was shown to be important for invadopodia formation, where ‘a fine balance between 
different phosphorylation events induces subtle changes in structure to calibrate cortactin function during invadopodia 
formation’ [24].  
 Finally, the importance of studying the different states of cortactin phosphorylation during bacterial invasion has 
been highlighted [8]. Under the new prism of the ‘S-Y Switch’ model, our group decided to assess the contribution of 
cortactin to actin polymerization during pedestal formation by enteropathogenic Escherichia coli (EPEC). We chose 
EPEC as a model system in order to analyze signaling to the actin cytoskeleton across the plasma membrane in response 
to external stimuli. 
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7. Cortactin and bacterial pathogens 
7.1 Role of cortactin in pedestal formation by EPEC and EHEC 
Numerous pathogens have evolved mechanisms to subvert for their own benefit the cellular regulatory complexes that 
control actin polymerization. Among such bacteria, enteropathogenic Escherichia coli (EPEC) and enterohemorrhagic 
E. coli (EHEC) are non-invasive pathogens. EPEC are responsible for severe diarrhoea and EHEC can cause bloody 
diarrhoea, haemorrhagic colitis and haemolytic uremic syndrome. Both food-borne pathogens are an important cause of 
infant mortality in developing countries. These bacteria colonize the intestinal epithelium through the formation of 
attaching and effacing (AE) lesions, which are characterized by a localized loss of microvilli, close adherence of 
bacteria to the host cell membrane and the generation of filamentous (F)-actin-rich structures beneath these bacteria 
called pedestals [26,27]. 
 To generate these actin pedestals both pathogens translocate their bacterial effectors into the mammalian cell using a 
type III secretion system (TIIISS). Translocated intimin receptor (Tir) is a translocated receptor that inserts into the 
plasma membrane with a hairpin loop topology. The extracellular domain binds to the bacterial outer membrane protein 
intimin inducing clustering of Tir. Tyrosine 474 in the C-terminal cytoplasmic domain is phosphorylated. This 
phosphotyrosine recruits the SH2 domain-containing mammalian adapter proteins Nck1 and Nck2 (hereafter referred to 
collectively as Nck). Nck recruits and is thought to activate N-WASP, which in turns binds and activates the Arp2/3 
complex to promote actin polymerization [28]. 
 For many years this has been the only pathway considered both necessary and sufficient for actin polymerization. 
When our research group as new comers to the field, examine the literature on this pathway, several questions occur to 
us. When does the phosphorylation of Tir occur? After the insertion in the membrane or is it a necessary step for 
insertion? Does it occur before or after clustering? If we extrapolated from signaling in immune receptors, we would 
expect the clustering to precede the phosphorylation. A more general question is, why, ultimately, do these bacteria 
form pedestals? This is an intriguing question because bacteria also adhere without them. Are pedestals made for the 
sole purpose of strengthening bacterial adhesion? If so, why are then many other proteins recruited to pedestals, 
including cortactin [29,30]? What is the reason for recruiting two activators of the Arp2/3 complex, when one (N-
WASP) is sufficient [31]? 
 It is known that cortactin localizes to actin pedestals, and that overexpression of truncated forms of the protein blocks 
pedestal formation [31]. This indicates that cortactin is an important player whose role should be reconsidered in view 
of its newly described capacity to directly activate both the Arp2/3 complex [21] and N-WASP [11]. Greater 
importance for cortactin is also suggested by the recently proposed ‘S-Y Switch’ model of regulation [11]. Indeed, 
using a very similar approach two research groups [32, 33] examined the effect of serine and tyrosine phospho-mimic 
and non-phosphorylatable mutants of cortactin on pedestal formation. Both studies concluded that tyrosine 
phosphorylation inhibits pedestal formation. However, the Erk phospho-mimic mutant had no effect on pedestal 
formation, in contrast to the inhibitory effect of the corresponding non-phosphorylatable mutant [33]. Therefore it 
seems that serine phosphorylation of cortactin is needed for pedestal formation, whereas tyrosine phosphorylation 
inhibits it. 
 A very important finding reported independently by both groups is that EPEC infection induces tyrosine 
phosphorylation of cortactin [32, 33]; this phosphorylation is abolished in N-WASP-deficient cells [33] but not in Nck-
deficient cells (our own unpublished results). Therefore cortactin tyrosine-phosphorylation depends on the presence of 
N-WASP, more than on the presence of the pedestal itself, because pedestals do not form in the absence of either N-
WASP or Nck. On the contrary, serine phosphorylation of cortactin does not require N-WASP. Moreover, the N-
terminal domain of cortactin directly binds the N-terminal part of Tir in vitro [33, 32], in a tyrosine and serine 
phosphorylation independent manner [32, 33]. More importantly, the interaction between cortactin and TirEPEC promotes 
Arp2/3 complex-mediated actin polymerization by activating cortactin [33].  
 We propose a model of cortactin action on pedestals induced by EPEC (Fig. 2) [33]. Taking into account that 
cortactin binds and activates N-WASP though its SH3 domain, and that this activation by cortactin is regulated by 
tyrosine and serine phosphorylation of cortactin, we proposed that cortactin binds Tir through the N-terminus and N-
WASP through the SH3 domain. In this situation, cortactin phosphorylated on serine would bind both Tir and N-
WASP, whereas cortactin phosphorylated on tyrosine would bind only Tir. In other words, cortactin may act on the Tir-
Nck-N-WASP pathway by controlling a possible cycling activity of N-WASP that may underlie pedestal motility (Fig. 
2) [33]. 
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Figure 2. Proposed model of the coordinated actions of cortactin and N-WASP during EPEC infection. Modified from Cell Commun 
Signal. 2009 May 6; 7:11. 
 
 
 Current research on pedestal signaling to trigger actin polymerization shows an increasingly complicated picture: no 
longer is there a reassuringly linear Tir-Nck-N-WASP pathway. EspF is another translocated effector of both EPEC and 
EHEC that seems to participate in pedestal formation. EspF contains several C-terminal repeats, each of which 
possesses a segment for N-WASP binding and a proline-rich sequence. The latter is recognized by sorting nexin 9 
(SNX9), a protein that contains an SH3 domain and a highly conserved Bin-Amphysin-Rvs (BAR) domain that binds 
and deforms membranes inwardly. The role of EspF-SNX9 interaction is intuitively difficult to understand because 
pedestals are structures that protrude [34]. The implication of cortactin in this recently described and apparently 
secondary pathway has not been addressed. Therefore it would be very interesting to test whether cortactin contributes 
to actin assembly through EspF. 
 Despite the high homology between the Tir proteins from EPEC and EHEC strains, the latter lack tyrosine 474 which 
has ‘forced’ the development of a distinct mechanism to promote actin synthesis in EHEC. In this pathotype, TirEHEC 
does not require Nck for actin assembly. Two groups reported that the effector encoded within prophage U, EspFu [35], 
also known as Tir cytoskeleton coupling protein, Tccp [36], is able to recruit and to activate N-WASP. EspFu is 
recruited to sites of bacterial attachment, and this recruitment depends on the NPY458 (Asn-Pro-Tyr458) motif located in 
the C-terminal domain of TirEHEC. It is unclear how the motif recruits EspFu, since EspFu does not bind directly to it. 
 Interestingly, this motif is homologous to tyrosine 454 on TirEPEC, which is responsible for a minor Nck-independent 
pathway whose physiological importance is uncertain. This raises the possibility that both EPEC and EHEC use a 
common Nck-independent pathway for actin polymerization. How can it be that what is an inefficient mechanism in 
EPEC has turned into the major mechanism in EHEC? The expression of EspFu by EHEC has converted this otherwise 
secondary pathway into the principal one. The picture gets even more complicated when we consider that EHEC 
express both EspFu and EspF effectors which share 25% sequence identity and 35% similarity. 
 As another example of bacterial molecular mimicry, EspFu is able to activate N-WASP by disrupting the 
intramolecular interaction that maintains N-WASP in a closed conformation [37]. Although WIP is known to keep N-
WASP in a closed conformation [38], the role of WIP in modulating the effect of EspFu on N-WASP has not been 
addressed. 
7.1.1 Cortactin as the ‘missing link’ in EHEC 
Although N-WASP and EspFu complex with Tir neither protein binds Tir directly. An important area of investigation in 
EHEC signaling to actin is the search for the ‘missing link’ that bridges Tir and N-WASP. Cortactin has been suggested 
as an appropriate candidate [39]. Cortactin binds both TirEHEC, and EspFu simultaneously: the C-terminal SH3 domain 
of cortactin is responsible for binding EspFu [39]. Subsequently, in in vitro organ cultures (IVOC) of human terminal 
ileal tissue, it was shown that cortactin is recruited to the site of EHEC adhesion independently of EspFu and N-WASP. 
This suggests that cortactin plays a more important role during infection of mucosal surfaces in vivo than has been 
observed using in vitro cultured cells [40]. 
 Interestingly, at early stages of infection, EHEC induces the tyrosine phosphorylation of cortactin, after which it is 
rapidly dephosphorylated [40]. The authors proposed a model where at early stages of infection cortactin binds Tir and 
EspFu. Soon thereafter, cortactin is tyrosine-dephosphorylated and released from EspFu. Finally this liberated cortactin 
helps to activate N-WASP, promoting actin polymerization through the Arp2/3 complex [40] (Fig. 3).  
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 Various other proposed ‘missing links’ has been proposed, such as the 53KDa insulin receptor substrate (IRSp53) 
and insulin receptor tyrosine kinase substrate (IRTKS), which are homologous to each other [41-43]. Both contain 
inverse-BAR (I-BAR) domains that deform PI(4,5)P(2)-rich membranes outwardly, mainly through electrostatic 
interactions [44]. We should also take into account that TirEPEC phosphorylated on tyrosine 454 forms complexes with 
an active phosphatidylinositol 3-kinase (PI3K), probably to stimulate the production of PI(3,4,5)P(3) beneath EPEC 
attachment sites [45]. If we extrapolate this mechanism to the tyrosine 458 of EHEC, we can speculate that IRSp53 is 
implicated in the deformation of the membrane, which in turn is coupled to actin remodeling through a process 
involving the WAVE family of proteins [46]. Although researchers that advocate for these missing links tend to 
underestimate the contribution of cortactin, we think that both IRSp53/IRTKs and cortactin might participate in the 
process, and that contradictory views arise from the incompleteness of the data at presently known. To be sure, we 
could propose many different models to support various views of the signaling process and of the identity of the missing 
link in EHEC. However, we believe that when doing research on signal transduction it is important to keep an open 
mind [47] and to interpreter incomplete findings cautiously. Dogmas are sustained until knowledge abrogates them, and 
one example is the finding that a recently described category of EPEC forms intracellular pedestals [48]. 
 
Figure 3. Signaling during pedestal formation by EPEC and EHEC 
 
7.2 Cortactin phosphorylation during the invasion of other pathogens 
During Chlamydia trachomatis infection, pathways involving Abl kinase or platelet-derived growth factor receptor 
(PDGFR) are activated, leading to tyrosine phosphorylation of cortactin. Tyrosine phosphorylation of cortactin likely 
participates in the remodelling of actin cytoeskeleton in order to internalize bacteria. Phospho-cortactin is also recruited 
to the site of bacterial entry [49]. There are many other examples where bacteria control cortactin phosphorylation as 
part of a complex mechanism of entry, such as Shigella [8]. Many other pathogens will be shown to alter not only 
cortactin tyrosine phosphorylation but many other post-translational modifications. 
7.2.1 Cortactin as a bacterial target for acetylation 
To block the immune response, the acetyltranferase YopJ, an effector of Yersinia species, acetylates the critical serine 
or threonine of the activation loop of a MAP kinase, impeding its subsequent activation by phosphorylation [50]. 
 It would be very interesting to test whether Yersinia also inhibits cortactin by acetylating it. In addition to 
deacetylating cortactin, HDAC6 deacetylates alpha-tubulin and this is required for invasion by uropathogenic 
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Escherichia coli (UPEC) [51]. Future studies will probably establish many situations in which acetilation/deacetilation 
is subverted by pathogens [52]. 
7.2.2. Cortactin and the innate immune response to Candida 
Immature dendritic cells (DC) express C-type lectins that recognize fungi. A newly described type of protrusion, named 
fungipod, has been implicated in the recognition of Candida parapsilosis. Fungipods are dynamic structures that 
contain clathrin, actin and cortactin. They may promote yeast phagocytosis by DCs [53]. 
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Cortactin Tyrosine Phosphorylation Promotes Its
Deacetylation and Inhibits Cell Spreading
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Abstract
Background: Cortactin is a classical Src kinase substrate that participates in actin cytoskeletal dynamics by activating the
Arp2/3 complex and interacting with other regulatory proteins, including FAK. Cortactin has various domains that may
contribute to the assembly of different protein platforms to achieve process specificity. Though the protein is known to be
regulated by post-translational modifications such as phosphorylation and acetylation, how tyrosine phosphorylation
regulates cortactin activity is poorly understood. Since the basal level of tyrosine phosphorylation is low, this question must
be studied using stimulated cell cultures, which are physiologically relevant but unreliable and difficult to work with. In fact,
their unreliability may be the cause of some contradictory findings about the dynamics of tyrosine phosphorylation of
cortactin in different processes.
Methodology/Principal Findings: In the present study, we try to overcome these problems by using a Functional
Interaction Trap (FIT) system, which involves cotransfecting cells with a kinase (Src) and a target protein (cortactin), both of
which are fused to complementary leucine-zipper domains. The FIT system allowed us to control precisely the tyrosine
phosphorylation of cortactin and explore its relationship with cortactin acetylation.
Conclusions/Significance: Using this system, we provide definitive evidence that a competition exists between acetylation
and tyrosine phosphorylation of cortactin and that phosphorylation inhibits cell spreading. We confirmed the results from
the FIT system by examining endogenous cortactin in different cell types. Furthermore, we demonstrate that cell spreading
promotes the association of cortactin and FAK and that tyrosine phosphorylation of cortactin disrupts this interaction,
which may explain how it inhibits cell spreading.
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Introduction
The actin cytoskeleton remodels to accomplish many cellular
processes and therefore undergoes significant changes during cell
migration, adhesion, endocytosis and bacterial invasion [1]. The
cortactin protein has emerged as an important node in the
network regulating the actin cytoskeleton during numerous
biological processes [2,3]. It was originally described as a substrate
of Src kinase located primarily at the cell cortex [4]. Almost
simultaneously, cortactin was cloned as the product of the CTTN
gene (formerly EMS1), located in chromosomal region 11q13,
which is frequently amplified in different human carcinomas [5].
Today, cortactin is considered an oncoprotein and a bona fide
invadopodial marker [6].
Cortactin is a modular protein that contains an N-terminal
acidic (NTA) domain with a 20DDW22 motif that directly binds
and activates the Arp2/3 complex. The NTA domain is followed
by six and a half amino acid ‘repeats’ that bind to F-actin and
define the actin-binding region (ABR) [7]. Since cortactin only
weakly activates the Arp2/3 complex in vitro [8], it is unclear
whether cortactin requires post-translational modifications to be
fully active. The ABR is followed by a helical, proline-rich region,
followed in turn by a C-terminal Src homology (SH3) domain.
Cortactin binds several proteins through its SH3 domain, such as
WIP [9] and neural Wiskott-Aldrich syndrome protein (N-WASP)
[10,11].
Cortactin regulation is very complex [12]. Although tradition-
ally studied as a substrate of Src family kinases (SFKs) [4], it can
also be phosphorylated by other tyrosine kinases such as Fer [13]
and Abl/Arg [14]. The effects of tyrosine phosphorylation on
cortactin structure and function remain largely unknown. This
phosphorylation was shown to decrease cortactin binding to F-
actin [15], and this binding is required for cortactin activation of
the Arp2/3 complex [16]. This phosphorylation is also required
for inducing bone metastasis of breast cancer cells in nude mice
[17], and it appears to be involved in bacterial invasion of cells,
such as for the adhesion of enteropathogenic Escherichia coli (EPEC)
[18]. Protein phosphatase 1B (PTB-1B) dephosphorylates tyrosine
421 in cortactin [19], suggesting reversible regulation. The data
seem to indicate that tyrosine phosphorylation of cortactin is
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tightly controlled, but the details of this regulation are far from
clear. Tyrosine phosphorylation-dephosphorylation of cortactin
may regulate its ability to form complexes with other proteins
[20,21].
Cortactin is also the target of serine-threonine kinases, including
ERK [22] and Pak [23,24]. In fact, phosphoproteomic analysis has
revealed numerous phosphorylation sites, most of which are
serines and threonines [25].
Cortactin promotes actin polimerization through two pathways:
directly, by activating the Arp2/3 complex; and indirectly, when
the SH3 domain binds and activates N-WASP [10]. In vitro,
cortactin binds and activates N-WASP only when phosphorylated
on serines by ERK, whereas phosphorylation by Src at tyrosines
421, 466 and 482 terminates cortactin activation of N-WASP,
which suggests that phosphorylation indeed affects cortactin
structure. Based on studies by our group [10] and others [22],
we proposed a model in which serine/tyrosine phosphorylation
controls the accessibility of the SH3 domain of cortactin [10]. This
model was subsequently named the ‘S-Y Switch’ model [26], and
its most easily testable prediction is that cortactin can be regulated
by a conformational change. The structure of unmodified
cortactin [27] reveals a closed, globular conformation achieved
mainly through interactions between the SH3 domain and ABR
region.
Studies with mutant forms of cortactin have been carried out to
understand the functional consequences of serine and tyrosine
phosphorylation. Indeed it has been proposed that different
cortactin phosphoforms have distinct cellular functions: in this
proposal, tyrosine-phosphocortactin mainly regulates focal adhe-
sion turnover, whereas serine-phosphocortactin controls actin
polimerization [28]. More recently, antibodies specific for
phospho-serine have been used to show that serine phosphoryla-
tion of cortactin is essential for lamellipodial persistence [29].
Adding another layer of complexity to cortactin regulation,
studies have shown that the protein is also regulated by reversible
acetylation. The protein can be acetylated by histone acetyltrans-
ferase p300/CBP-associated factor (PCAF) and deacetylated
mainly by Histone Deacetylase 6 (HDAC6). Acetylated cortactin
has a reduced capacity to bind F-actin [30].
Although numerous studies of cortactin have suggested a
complex network of regulatory post-translational modifications,
they have been unable to indicate definitively how Src-mediated
phosphorylation affects cortactin structure and activity, and how
this phosphorylation relates to other post-translational modifica-
tions. These difficulties may reflect the low basal level of phospho-
tyrosine cortactin in most cell types, which makes cell culture-
based studies of cortactin challenging. Here we attempt to
overcome this problem using the Functional Interaction Trap
(FIT) system [31,32]. The FIT system involves fusing a kinase and
a substrate of interest to complementary leucine zippers;
cotransfection with the two expression vectors allows for specific
and efficient phosphorylation of the substrate.
Methods
Cells, reagents and antibodies (Abs)
The following cell lines were obtained from the American Type
Culture Collection (ATCC): human epithelial HeLa cells; mouse
fibroblasts deficient in Src, Yes, and Fyn kinase (Src2/2, Yes2/2,
Fyn2/2; abbreviated SYF); and SYF fibroblasts rescued for Src
(Src+/+, Yes2/2, Fyn2/2; abbreviated Rsrc). Wild-type (WT) and
HDAC6-deficient MEFs immortalized by p53 gene deletion [33]
were obtained from Dr. Tso-Pang Yao (Department of Pharma-
cology and Cancer Biology, Duke University). Cells were grown in
Iscove’s modified Dulbecco’s medium (IMDM) supplemented with
10% fetal bovine serum (FBS) and antibiotics. The deacetylase
inhibitor Trichostatin A (TSA) from Streptomyces sp was purchased
from Sigma. The selective Src-family kinase inhibitor PP2 was
purchased from Calbiochem.
The following commercial Abs were purchased from Millipore:
mouse cortactin 4F11 MoAb; mouse Src GD11 MoAb; mouse
myc 4A6 MoAb; Platinum phospho-tyrosine (for WB), which is a
mixture of two generic phosphotyrosine Abs: PY20 and 4G10;
vinculin MoAb; and FAK 2A7 MoAb (for IPs). For immunopre-
cipitations (IPs), we used phosphotyrosine MoAb and for FAK
WB, the Ab from Cell Signaling. Mouse actin C4 MoAb was from
MP Biomedicals, and rabbit cortactin MoAb was from Novus
Biologicals. The rabbit cortactin polyclonal Ab (Applied Biological
Materials) was raised against an unphosphorylated peptide around
tyrosine 466. This Ab recognizes both unphosphorylated and
tyrosine-phosphorylated cortactin. Rabbit phosphocortactin Y466
polyclonal Abs were obtained from Santa Cruz Biotechnology and
from Abcam (data not shown). Myc (A14) Ab was from Santa
Cruz. pY421 cortactin Ab was from Abcam. Rabbit Ab against
acetyl-cortactin was initially obtained from Dr. Edward Seto (H.
Lee Moffitt Cancer Center and Research Institute, Tampa,
Florida) and subsequently from Millipore.
IRDye 800CW-labeled goat rabbit and mouse secondary Abs
(Fisher Scientific) were used to give green signal. IRDye 680CW-
labeled goat rabbit Ab (Fisher Scientific) and Alexa 680-labeled
goat mouse Ab (Invitrogen) were used to give red signal. All
secondary Abs were purchased at a concentration of 1 mg/ml and
used at 1:5,000 dilution.
Constructs
All FIT constructs used, including MycCortactin, were a
generous donation of Dr. Bruce J. Mayer (Connecticut Health
Center, CT, USA). Cortactin with mutations of all three tyrosines
that can be phosphorylated by Src (Y421/466/482F, referred to as
the 3F mutant) was produced using the QuikChange site-directed
mutagenesis kit (Stratagene). Mutations were produced sequen-
tially: first the 421F mutant was generated, and then this was used
as template to mutate Y466 and Y482 (primer sequences available
upon request). After verifying the sequence, the insert was
subcloned into an empty ZipB vector. WT GFP-cortactin and
3F-GFP constructs were previously described [10].
Cell transfection and Western blotting (WB)
For transfection, plasmid DNAs were purified with endotoxin-
free, transfection-grade JetStar 2.0 Midi columns (Genomed) as
per the manufacturer’s instructions. Cell transfections were carried
out using Lipofectamine 2000 (Invitrogen) or Fugene HD
transfection reagent (Roche). Briefly, cells were grown to 60–
75% confluence for Lipofectamine transfections or to 50–60%
confluence for Fugene transfections in 6-well plates using 2 mg of
the indicated plasmids per well. Transfections were incubated for
approximately 20 h in medium containing 10% FBS but no
antibiotics.
WB was carried out on cells from a single well or, when
necessary, from a 100-mm plate. Cells were washed once with cold
Dulbecco’s phosphate-buffered saline (D-PBS) with calcium and
magnesium (Invitrogen) and scraped into 300 ml 26 Laemmli
buffer. Samples were homogenized by three passages through a
syringe with a 25-gauge needle and then centrifuged at 21,0006g
for 5 min at 4uC. Samples were resolved by 10% SDS-PAGE and
transferred to nitrocellulose membranes (Amersham) using a
BioRad transfer system. Membranes were blocked for 1 h with
Odyssey blocking buffer and incubated overnight with primary Ab
Acetylation versus Phosphorylation of Cortactin
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in blocking buffer containing 0.1% Tween 20. Membranes were
washed 4 times for 5 min with PBS containing 0.1% Tween 20,
then incubated for 1 h with the appropriate secondary antibody,
and washed as before. Membranes were scanned with the Odyssey
infrared system (Lycor, Fisher Scientific) using the red (700 nm)
and green (800 nm) channels. When required, membranes were
stripped using Odyssey stripping buffer according to the
manufacturer’s instructions. When significantly different intensities
were observed between the two color signals, we performed
sequential Ab incubations. After stripping membranes, we
incubated them with secondary Ab alone and scanned them to
confirm the efficiency of stripping before incubating them with
another primary Ab.
Quantification of the bands was performed on the scanned
images using the Odyssey Scan band tool. The results were
analyzed by the two-tailed Student’s t test and displayed
graphically using GraphPad Prism software (version 5.0).
Pervanadate treatment
Pervanadate solution was prepared by mixing 1 mM Na3VO4
with 1% H2O2 (both from Sigma), diluting two-fold with IMDM
medium and used for 30 min at 37uC and 5% CO2.
Immunoprecipitation (IP) experiments
Cells were grown on 150-mm plates and transfected as
described above with 20 mg of each plasmid. After transfection
cells were washed once with D-PBS and scraped into 700 ml
modified RIPA buffer [50 mM Tris-HCl (pH 7.4), 150 mM NaCl,
15% glycerol, 2 mM EDTA, 0.1% SDS, 1% Triton X-100, 1 mM
Na3VO4, 10 mM NaF, 1 mM PMSF, protease inhibitor cocktail
(Amersham), phosphatase inhibitor (PhosSTOP, Roche)]. When
indicated, TSA was added to the RIPA buffer at a final
concentration of 400 ng/ml to detect cortactin acetylation [30],
except in the case of lysates from WT or HDAC6-deficient cells.
Magnetic mouse or protein G Dynabeads (30 ml/IP, Invitrogen)
were washed and blocked with PBS containing 0.1% BSA for
10 min, then incubated 1 h with 4 mg Ab per IP. After one wash
with PBS-0.1% BSA, the beads were added to 200–300 ml cell
lysate and incubated with rotation at 4uC for 4 h. The beads were
washed 3 times with the help of a magnet (Invitrogen) and 200 ml
lysis buffer diluted 1:10 in PBS supplemented with TSA, except in
the case of lysates from WT or HDAC6-deficient cells, when TSA
was omitted. The beads were resuspended in 40 ml 26 Laemmli
buffer and processed for SDS-PAGE or frozen at 280uC until
further analysis.
Pull-down (PD) experiments
GST and the GST-cortactin SH3 domain were produced in
BL21 E. coli, purified and coupled to GSH-beads [10]. The
proteins were added to 200 ml cell lysate and incubated for 3 h
with tumbling at 4uC. Pull-downs were washed twice with 200 ml
lysis buffer diluted 1:10 in PBS.
Immunofluorescence microscopy
Cells were fixed for 20 min at room temperature with 4%
formalin (Sigma) and permeabilized with 0.1% Triton X-100 for
5 min. After three washes with PBS, cells were blocked with 2%
BSA in PBS for 10 min, stained at room temperature (RT) with
the appropriate primary Ab for 1 h, washed 3 times with PBS, and
finally incubated 1 h with secondary Ab. Actin cytoskeleton was
visualized with 1 mg/ml tetramethyl-rhodamine-isothiocyanate
(TRITC)-phalloidin (Sigma) or a 1:25 dilution of Alexa Fluor
350-phalloidin (Invitrogen). The secondary Abs (Invitrogen) were
Alexa Fluor 405-labelled mouse (blue), Alexa Fluor 488-labeled
mouse and -rabbit (green), and Alexa 568-labeled rabbit (red).
Counting was done using a Nikon Eclipse TE 200-U
fluorescence microscope equipped with a Hamamatsu camera.
Images were processed with Adobe Photoshop. Confocal micros-
copy was performed at the Parque Cientı´fico de Madrid
microscopy facility with a Leica Confocal SP2/DMEIR2, using
Leica software (version 2.61).
Spreading experiments
Cells were transfected for 20 h, trypsinized and washed once
with trypsin inhibitor at 0.5 mg/ml (Sigma). For immunofluores-
cence studies, 2.56105 cells per time point were replated on 4
coverslips previously treated with 30 mg/ml fibronectin (Calbio-
chem) in each well of a 6-well plate. After fixation they were
processed for immunofluorescence. For FAK pull-down and IP
experiments, transfections were carried out in 150-mm plates, and
cultures were trypsinized 20 h later. For each condition, 2.56106
trypsinized cells were kept in suspension or replated on
fibronectin-treated 100-mm plates.
Results
Efficient tyrosine phosphorylation of cortactin by Src in
cells transfected with the FIT system
To specifically phosphorylate cortactin in cells with Src kinase,
we used the FIT system (Fig. 1, schematic cartoon). HA-tagged Src
kinase lacking the SH2 and SH3 domains was expressed with a C-
terminal leucine zipper from the Leucine-ZipA vector (ZipAHA-
DSrc), while myc-tagged cortactin was expressed with an N-
terminal leucine zipper from the Leucine-ZipB vector (ZipBMyc-
Cortactin) (Fig. 1, lane 5). As controls, we transfected different
vector combinations (Fig. 1A) and left cells untransfected (lane 9).
We performed these transfections in SYF fibroblasts, which lack
the three SFKs (Src, Yes, Fyn) predominant for that cell type [34].
We also performed these transfections in control cells reconstituted
with Src (Rsrc cells).
WB of cell lysates was carried out using the Odyssey two-color
infrared scanning system. Src targets tyrosines 421, 466, and 482
of mouse cortactin [35]. We observed strong tyrosine phosphor-
ylation of transfected cortactin using a phospho-specific Ab against
tyrosine 466 (pY466 Ab). Simultaneously we detected both
endogenous cortactin, migrating at 80–85 kDa, and transfected
cortactin using the 4F11 mouse MoAb (Fig. 1A). We next merged
the images to show that the phosphorylated band superimposes on
the transfected cortactin band, and that the mobility of both bands
was slightly lower than that of unphosphorylated cortactin. Actin
was detected as a loading control. Similar results were obtained
with a different cortactin pY466 Ab (data not shown). Using the
FIT system, we found no appreciable differences in the levels of
cortactin phosphorylation between SYF and Rsrc cells.
To analyze how efficiently the FIT system generated phosphor-
ylated cortactin, we transfected truncated Src kinase and cortactin
without the ZipA or ZipB domains, respectively (Fig. 1A, lines 4
and 8). The results show that cotransfection of Src and cortactin
increases tyrosine phosphorylation of cortactin, and that the
phosphorylation level is much higher when the leucine zipper
domains are used, in agreement with previous studies using the
FIT system [32].
We also analyzed the phosphorylation of position 421 using a
pY421 Ab (Fig. 1B). The results in Fig. 1A and 1B indicate that the
FIT system allows efficient phosphorylation of cortactin on
tyrosines 421 and 466. In subsequent experiments, we used the
pY466 Ab because it gave a stronger signal than the pY421 Ab.
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To specifically detect transfected cortactin, we performed WB
with mouse myc 4A6 MoAb and rabbit cortactin MoAb. Fig. S1A
shows that transfected cortactin is recognized equally well by both
Abs. This was further confirmed by the superposition of bands
generated with the 4F11 Ab and the rabbit cortactin MoAb (data
not shown). These results show that endogenous and transfected
ZipBMyc-Cortactin can be detected by either MoAb, though the
signal intensity was greater with the rabbit MoAb.
As a control for the transfections we blotted with antibodies
against the HA tag to detect both HA-DSrc (Fig. S1B, lanes 1, 4
and 8) and ZipAHA-DSrc (lanes 2 and 5). We confirmed the
genotype of the SYF and Rsrc cells by blotting with Src MoAb
GD11 (Fig. S1B).
Substrate specificity of Src kinase in the FIT system
To determine whether cortactin is the primary Src substrate
phosphorylated in cells transfected with the FIT system, we
analyzed the cell lysates by WB using mouse MoAbs against
generic phospho-tyrosine (Platinum Ab: 4G10+PY20) (Fig. S2).
The same membrane was also incubated with rabbit cortactin
MoAb. We observed a strong phospho-tyrosine band that
comigrated with transfected cortactin (lane 5, asterisk). When
Src kinase is activated, it is phosphorylated on tyrosines, which
explains why we observed in lanes 2 and 5 a band of slightly higher
molecular weight than actin that corresponds to ZipAHA-DSrc.
Similarly, we observed Src kinase in the reconstituted Rsrc cells.
These results demonstrate that the major phospho-protein in our
lysates is transfected ZipBMyc-Cortactin that is tyrosine-phos-
phorylated by ZipAHA-DSrc (lane 5, asterisk).
As a second control of phosphorylation specificity, we analyzed
whether the Src substrate paxillin [36] is phosphorylated by our
transfected Src kinase. We performed WB using a phospho-
paxillin (p-paxillin) Ab. In Fig. 2A we show the most relevant
transfections (lanes 4 and 5) from two FIT experiments (FIT8 and
FIT9), after blotting with p-paxillin Ab. As an internal control, we
treated both cell types with pervanadate, a generic phosphatase
inhibitor that induced a strong signal for p-paxillin. While
untreated cell lysates did not show detectable paxillin phosphor-
ylation, lysates of treated cells did. Thus we can conclude that our
transfected cells express a basal level of phospho-paxillin.
Positional specificity of Src kinase in the FIT system
Src phosphorylates tyrosines 421, 466 and 482 in mouse
cortactin [35]. After detecting cortactin phosphorylation at
positions 421 and 466, we wanted to exclude the possibility of
phosphorylation at other tyrosines. For this purpose we used a
non-phosphorylatable mutant in which the three major residues
targeted by Src kinase were replaced by phenylalanine (3F). We
carried out our experiments in HeLa cells because the experiments
described above showed similar results in SYF and Rsrc cells, and
HeLa cells are easier to handle and widely used.
We cotransfected cells with ZipAHA-DSrc and either ZipBMyc-
Cortactin or ZipBMyc-Cortactin 3F, and performed WB using
Abs against generic phospho-tyrosine and cortactin. Cortactin was
phosphorylated on tyrosines, while the 3F mutant was not (Fig. 2B,
lanes 4 and 5), indicating that cortactin is phosphorylated
specifically on the expected tyrosines.
Relationship between tyrosine phosphorylation and
acetylation of cortactin
Cortactin is acetylated mainly in the cortactin repeat region,
and this modification decreases the ability of cortactin to bind F-
actin [30]. Because cortactin phosphorylation by Src has a similar
effect [15], we wanted to analyze whether a relationship exists
between the two post-translational modifications.
Figure 1. Efficient tyrosine phosphorylation of cortactin by Src in cells using the FIT system. SYF and Rsrc cells were transfected with
different combinations of Src and cortactin FIT fusion vectors (lanes 1–8) or left untransfected (lane 9). Cell lysates were blotted for actin as a loading
control and with different Abs, then blotted with the respective conjugated secondary antibodies and finally visualized with the Odyssey system. The
lysates were blotted with (A) pY466 or (B) with pY421 cortactin Abs. In both cases, we observed a clear specific phosphorylation band (in green)
when ZipA-HA-DSrc and ZipB-MycCortactin were cotransfected (transfection 5), and this band superimposes (asterisks) on the cortactin band
detected with the 4F11 MoAb (in red). Sizes of the molecular weight markers (denoted M) are shown in kDa. A schematic cartoon of the FIT system is
shown.
doi:10.1371/journal.pone.0033662.g001
Acetylation versus Phosphorylation of Cortactin
PLoS ONE | www.plosone.org 4 March 2012 | Volume 7 | Issue 3 | e33662
For this purpose, we decided to use HeLa cells because cortactin
acetylation was previously detected in this cell type [30]. Cells
were transfected with empty vectors (Fig. 3, lane 1), with
ZipBMyc-Cortactin plus HA empty vector (lane 2), or with
ZipBMyc-Cortactin together with HA-DSrc (lane 3) or ZipAHA-
DSrc (lane 4). Transfected cells were left untreated or treated with
Trichostatin A (TSA), a deacetylase inhibitor previously used to
prevent deacetylation of cortactin [30]. WB experiments were
performed to confirm tyrosine phosphorylation of cortactin using
the pY466 Ab (Fig. S3A). As expected, cortactin was strongly
phosphorylated when ZipBMyc-Cortactin was cotransfected with
ZipAHA-DSrc (lane 4), and the phosphorylation signal was much
lower when ZipBMyc-Cortactin was cotransfected with HA-DSrc
(lane 3).
To analyze whether phospho-cortactin was simultaneously
acetylated, we performed IPs of transfected cortactin using a
myc MoAb, followed by WB with an Ab specific for acetyl-
cortactin (Fig. 3A). The results show that cortactin was efficiently
immunoprecipitated in all samples, while it was undetectable in
the isotype control IP (Fig. 3A, right panels). Acetyl-cortactin was
nearly undetectable in the sample in which cortactin was strongly
phosphorylated (lane 4), whereas it was clearly detectable when
cortactin was not phosphorylated (lane 2). Treating cells with TSA
increased the apparent level of acetyl-cortactin, suggesting that it
prevents the deacetylation of cortactin as previously described
[30].
In addition to checking cortactin phosphorylation in the lysates
used to perform the IPs (Fig. S3A), we wanted to check the
phosphorylation status in the immunoprecipitates (Fig. 3A). The
membrane was gently stripped until the green acetyl signal was lost
and then reprobed with pY466 Ab and myc MoAb. As expected,
the myc immunoprecipitates showed cortactin phosphorylation
mainly when ZipAHA-DSrc and ZipBMyc-Cortactin were cotrans-
fected (lane 4). When transfected alone, ZipBMyc-Cortactin was not
detectably phosphorylated, yet it presented a strong acetylation
signal (Fig. 3A, lane 2). The results suggest that acetylation and
phosphorylation of cortactin occur antagonistically.
To confirm these results separate IPs were carried out in parallel
with myc MoAb and generic phospho-tyrosine MoAb (pTyr
MoAb) (Fig. 3B). To simplify the experiment we used only TSA-
treated cells and the most relevant vector combinations: empty
vectors (lane 1), empty HA-vector and ZypBMyc-Cortactin (lane
2), and ZipAHA-DSrc and ZipBMyc-Cortactin (lane 3). IP with
pTyr MoAb was performed only in the cotransfection of ZipAHA-
DSrc and ZipBMyc-Cortactin, where cortactin should be
phosphorylated. Again, we observed that tyrosine-phosphorylated
cortactin was not acetylated and vice versa. Thus no signal for
acetylation was detected in the phospho-tyrosine IP, which pulled
down only tyrosine-phosphorylated cortactin. In contrast, a very
faint acetylation signal was detected in the myc IP, which pulled
down primarily phosphorylated cortactin but also a small fraction
of unphosphorylated protein. We found a statistically significant
difference in acetylation signal between unphosphorylated cortac-
tin (transfection 2) and tyrosine-phosphorylated protein (transfec-
tion 3; Fig. 3B).
To verify these results with tyrosine-phosphocortactin by a
different approach we performed IPs with the pY466 cortactin Ab
(Fig. S3B) using the same vector combinations as above (Fig. 3B).
The immunoprecipitates and lysates were blotted with cortactin
4F11 MoAb, which detects both transfected and endogenous
cortactin in lysates. Tyrosine-phosphorylated cortactin was
efficiently immunoprecipitated when ZipAHA-DSrc and ZipB-
Myc-Cortactin were cotransfected (lane 3). WB with acetyl-
cortactin Ab revealed that pY466 immunoprecipitates did not
contain acetylated cortactin, which is consistent with previous
results (Fig. 3A, B). These results indicate that the two
modifications did not occur simultaneously, suggesting that a
competition exists between phosphorylation and acetylation of
cortactin.
To exclude any non-specific effects due to the fusion tag and to
further characterize how these two post-translational modifications
relate to each other, we performed transfections using GFP-tagged
cortactin constructs (Fig. 4). We transfected HeLa cells with empty
vector and a vector encoding GFP-WT cortactin or GFP-3F
cortactin, and we blotted the lysates with acetyl-cortactin Ab. We
observed that WT and GFP-3F cortactin were acetylated (Fig. 4A)
and found no statistically significant difference in acetylation level
between the two constructs (data not shown). This indicates that
Figure 2. Specificity of tyrosine phosphorylation in the FIT
system. (A) Detection of the phosphorylation status of paxillin,
another Src kinase substrate. SYF and Rsrc cells were transfected with
FIT fusion vectors and the most relevant lysates (4 and 5) from two
different experiments (FIT 8 and 9) were analyzed by WB with a rabbit
Ab against phospho-paxillin (in green) and with a MoAb against actin
(in red). As controls, cells were left untreated or treated with
pervanadate (PV), a potent phosphatase inhibitor that induces the
phosphorylation of paxillin. Rsrc cells showed a higher basal level of
phospho-paxillin than did SYF cells, though in both cell lines, this basal
level was enhanced by treatment with PV. The FIT system did not
increase the basal level of phospho-paxillin. (B) Tyrosine phosphoryla-
tion of cortactin occurs on the expected tyrosines (Y421, Y466 and
Y482). HeLa cell lysates were transfected with ZipA-HA-DSrc and ZipB-
MycCortactin (lane 4) or with ZipA-HA-DSrc and ZipB-MycCortactin with
the triple mutation Y421/466/482F (3F) (lane 5). Several control
cotransfections were done (lanes 1–3). WB with generic pTyr MoAb
demonstrated that only ZipB-Myc WT cortactin, and not the 3F mutant,
was phosphorylated (in green). Cortactin was detected with a rabbit
MoAb (in red). Actin is shown as a loading control.
doi:10.1371/journal.pone.0033662.g002
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phosphorylation of cortactin at positions 421, 466 and 482 is not
required for cortactin acetylation.
We next examined the effects of pervanadate (PV) and TSA on
GFP-cortactin; these compounds induce phosphorylation and
acetylation, respectively (Fig. 4B). Lysates of cells transfected with
GFP-cortactin were left untreated or treated with PV or TSA, and
subjected to WB with the acetyl-cortactin Ab first, followed by
gentle stripping and then reprobing with the pY466 cortactin Ab.
As a transfection control, lysates were also blotted with GFP
MoAb. Treating lysates with TSA increased the amount of acetyl-
cortactin over basal levels. However, we cannot determine
whether it simultaneously decreased the level of phospho-cortactin
because the basal level of the phospho-protein is undetectable. In
contrast, PV strongly induced tyrosine phosphorylation of
cortactin, and this was accompanied by a decrease in the level
of acetyl-cortactin, such that the ratio of the two forms of cortactin
differed significantly from basal conditions (Fig. 4B). These results
indicate that induction of tyrosine phosphorylation of cortactin
decreases its acetylation.
Analysis of the acetylation and phosphorylation status of
endogenous cortactin
The experiments described so far established that acetylation
and phosphorylation of transfected cortactin are mutually
exclusive events. We next analyzed whether the same relationship
holds for endogenous cortactin (Figs. 5, 6). First we performed
experiments in WT and HDAC6-deficient mouse embryonic
fibroblasts (MEFs), because HDAC6 is the major cortactin
deacetylase in cells [30]. IPs using 4F11 MoAb were blotted with
acetyl-cortactin Ab, then the membranes were stripped and
blotted with pY466 Ab (Fig. 5A). IPs from HDAC6-deficient cell
lysates using 4F11 MoAb showed a significantly higher basal level
of acetylated cortactin than did IPs from WT cell lysates. In
addition, the ratio of the acetyl:pY466 signals was significantly
higher in the HDAC6-deficient cells. These results indicate that
the lack of HDAC6 deacetylase significantly increases the
acetyl:pY466 cortactin ratio and that HDAC6-deficient cells are
a valuable reagent to characterize how acetylation and tyrosine
phosphorylation of cortactin relate to each other. Consequently,
we performed cortactin IPs using the acetyl-cortactin Ab and
blotted them with pY466 Ab and 4F11 MoAb. No signal was
detected by pY466 Ab in the immunoprecipitates in which
cortactin was detectable with the 4F11 MoAb (Fig. 5B). To
confirm this result, acetyl-cortactin immunoprecipitates were
analyzed using generic pTyr mouse MoAb or cortactin rabbit
MoAb on separate membranes. Similar results were obtained (Fig.
S4). We confirmed the HDAC6-deficient phenotype of the MEFs
by WB with HDAC6 Ab (Fig. 5C). These results show that
Figure 3. Analysis of acetylation and tyrosine phosphorylation of transfected cortactin. (A) Lysates from various transfection
combinations (lanes 1–4), treated or not with the deacetylase inhibitor Trichostatin A (TSA), were used to perform IPs using a myc MoAb that were
examined by WB first with acetyl-cortactin Ab (in green) and second with myc MoAb (in red). The merge of both images is shown. After the
membrane was gently stripped to remove the acetyl signal, it was blotted with pY466 Ab. The isotype control IP (Ctrl.) is also shown. (B) TSA-treated
cell lysates from various transfection combinations (lanes 1–3) were subjected to parallel IP experiments with the myc MoAb and the generic pTyr
MoAb. The IPs were blotted first with acetyl-cortactin Ab, and second with the myc MoAb; then the membranes were stripped and reprobed with
pY466 Ab and myc MoAb. The asterisks denote non-specific bands. Quantification of the signals from cortactin immunoprecipitates showed a
statistically significant inverse relationship between acetylation and tyrosine phosphorylation signals. a.u.: arbitrary units. *, p,0.05; **, p,0.01.
doi:10.1371/journal.pone.0033662.g003
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endogenous acetylated cortactin is not tyrosine-phosphorylated in
WT or HDAC6-deficient cells.
We next examined cortactin acetylation in SYF and Rsrc
MEFs, because they represent cell types with different levels of
tyrosine-phosphorylated cortactin (Fig. 6). Separate IPs were
carried out in parallel using 4F11 and pTyr MoAb and blotted first
with rabbit acetyl-cortactin Ab. Then the blot was stripped and
reprobed with pY466 cortactin Ab. To detect immunoprecipitated
cortactin the membrane was stripped again and reprobed with a
cortactin Ab (Fig. 6A). We detected acetyl-cortactin in immuno-
precipitates prepared from SYF and Rsrc cell lysates using
cortactin 4F11 MoAb. Parallel IPs performed with the pTyr
MoAb showed that endogenous tyrosine-phosphorylated cortactin
was present only in Rsrc cell lysates, as expected. Furthermore,
this cortactin fraction was not acetylated (see asterisks, Fig. 6A).
We quantified three independent experiments and found that
4F11 immunoprecipitates from SYF and Rsrc cells differed
significantly in the ratio of acetyl:pY466 cortactin (Fig. 6A). These
results indicate that when most of the immunoprecipitated
cortactin is tyrosine-phosphorylated, then is not concomitantly
acetylated.
To confirm these results, we performed IPs from SYF and Rsrc
cell lysates with pY466 cortactin Ab (Fig. 6B). The immunopre-
cipitates were blotted with acetyl-cortactin Ab and cortactin 4F11
MoAb, gently stripped, and then reprobed with pY466 cortactin
antibody (Fig. 6B). As detected in Fig. 6A, tyrosine-phosphorylated
cortactin was immunoprecipitated only from Rsrc cell lysates.
More importantly, cortactin phosphorylated on Y466 was not
acetylated (Fig. 6B). Again as detected in Fig. 6A, when cortactin
was immunoprecipitated with a generic antibody such as 4F11
MoAb, the immunoprecipitates contained both acetylated and
tyrosine-phosphorylated cortactin. On the contrary, when cortac-
tin was immunoprecipitated with a generic phospho-tyrosine
MoAb or a specific pY466-cortactin Ab, only tyrosine-phosphor-
ylated cortactin was immunoprecipitated and it was not acetylated.
Together these results demonstrate that the majority of endoge-
nous cortactin is acetylated or tyrosine-phosphorylated, consistent
with the results obtained with transfected cortactin.
Analysis of cortactin acetylation and tyrosine
phosphorylation during cell spreading
We performed FIT transfections of SYF and Rsrc cells to
visualize the location of nonphosphorylated cortactin (transfection
2) and phosphorylated protein (transfection 3). As negative
controls, we left cells untransfected and we transfected them with
empty vectors (Fig. S5 and data not shown). We visualized cell
morphology with TRICT-phalloidin (Fig. S5). We also examined
high-magnification images to study cell morphology in detail. We
detected cortactin expression using myc MoAb and cortactin
phosphorylation using pY466 Ab. As in the IPs (Fig. 6), the level of
endogenous cortactin that was tyrosine-phosphorylated in SYF
cells under our experimental conditions was nearly undetectable;
the level of phosphorylation was similar to that observed in cells
transfected only with cortactin (transfection 2, TF2). Cotransfec-
tion of cortactin and Src kinase in the FIT system (TF3) increased
the level of phospho-cortactin in cells, and this level was easier to
observe in SYF cells because of their null background level. In SYF
cells, cortactin localized to the cell periphery and around the
nucleus, as previously described for endogenous cortactin [7].
In contrast to SYF cells, untransfected Rsrc cells showed, as
expected, a detectable level of tyrosine-phosphorylated cortactin
(data not shown), as did Rsrc cells transfected in the TF2
experiment. Some cells showed clusters of actin and phospho-
cortactin (arrows, Fig. S5). Images from TF3 showed that Rsrc
cells were somewhat more retracted and detached than their TF2
counterparts. These results demonstrate that transfected and
endogenous tyrosine-phosphorylated cortactin show similar local-
ization, and suggest a role for phospho-cortactin in cell adhesion.
To test this hypothesis, we examined the spreading of
transfected SYF and Rsrc cells on fibronectin (Fig. 7). Fig. 7A
shows representative spread and non-spread SYF and Rsrc cells
Figure 4. Analysis of acetylation and tyrosine phosphorylation of transfected GFP-cortactin. (A) Tyrosine phosphorylation of cortactin is
not required for acetylation of the protein. HeLa cells were transfected with vectors encoding GFP fused with WT cortactin or the Y421/466/482F non-
phosphorylatable cortactin mutant (3F). Lysates were blotted with acetyl-cortactin Ab and GFP MoAb. Transfected cortactin was acetylated and no
statistically significant difference was found in acetylation level between WT and 3F transfectants (data not shown). (B) Tyrosine phosphorylation of
cortactin decreases acetylation of the protein. HeLa cells were transfected with a vector encoding GFP fused with WT cortactin. Transfectants were
left untreated (-) or treated with pervanadate (PV), a generic phosphatase inhibitor, or with Thrichostatin A (TSA), a deacetylase inhibitor. Lysates were
blotted with acetyl-cortactin Ab and with GFP MoAb. After stripping, the membrane was incubated with pY466 cortactin, which was merged with the
GFP cortactin signal. The ratio of acetyl:pY466 cortactin is shown for untreated (-) and PV-treated cells. a.u.: arbitrary units. **, p,0.01.
doi:10.1371/journal.pone.0033662.g004
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transfected with ZipB-MycCortactin and empty HA vector (TF2)
or ZipB-MycCortactin and ZipAHA-DSrc (TF3). We counted 100
transfected cells and classified then as spread or non-spread for two
different time points under three transfection conditions [TF1
(empty vectors), TF2 (cortactin) and TF3 (tyrosine-phosphorylated
cortactin)]. In TF3 we counted only transfected cells that also
showed significant phosphorylation signal. Quantification of the
results showed that at 1 h after replating, cells overexpressing
cortactin (TF2) showed significantly more cell spreading than did
TF1 or TF3 cells. More importantly, expression of tyrosine-
phosphorylated cortactin (TF3) significantly inhibited cell spread-
ing compared to TF1 or cortactin-transfected cells (TF2). This
pattern of spreading was also observed at 3 h after replating.
Analysis of cells that did not spread confirmed that cortactin favors
spreading, while tyrosine-phosphorylated cortactin inhibits it.
Indeed, at 6 and 18 h after replating, most Rsrc cells in TF3
were detached (data not shown). Similar results were found in SYF
cells, although the differences among the three transfection
conditions did not reach statistical significance. These results
suggest that cortactin expression favors cell spreading, while
cortactin phosphorylation counteracts this effect (Fig. 7A).
To further understand the role of tyrosine phosphorylation of
cortactin and explore how it relates to cortactin acetylation during
cell spreading, we analyzed the spreading of Rsrc cells on
fibronectin in the presence and absence of PP2, a widely used
Src family kinase inhibitor (Fig. 7B). Untreated cells were plated
and allowed to spread for 1 and 3 h. Cells on a third plate were
allowed to spread for 1 h and then they were cultured for 2 h in
the medium containing 10 mM PP2. Cell lysates were subjected to
IPs with cortactin 4F11 MoAb or isotype control Ab. The
membranes were first blotted with acetyl-cortactin Ab, the acetyl
signal was stripped, and then the membranes were reprobed with
pY466 cortactin Ab and 4F11 cortactin MoAb. We observed that
PP2 treatment nearly abolished cortactin tyrosine phosphorylation
(right panel IPs, Fig. 7B) and increased the intensity of the acetyl-
cortactin signal (left panel IPs). Quantification of three indepen-
dent experiments showed that treatments with PP2 significantly
increased the ratio of acetyl:pY466 cortactin. These results
indicate that inhibition of tyrosine phosphorylation of cortactin
during cell spreading induces cortactin acetylation.
To characterize how cell spreading is altered by tyrosine
phosphorylation of cortactin, we stained focal adhesions using
vinculin as a marker (Fig. 8). We performed FIT transfections of
SYF and Rsrc cells as before and allowed them to spread on FN
for 3 hours (Fig. 8). We visualized focal adhesions by immunoflu-
orescence staining with vinculin MoAb and detected expressed
protein using myc Ab in cells transfected with empty vectors (TF1)
or in cells overexpressing unphosphorylated cortactin (TF2) or
tyrosine-phosphorylated cortactin (TF3). We observed that cells
overexpressing tyrosine-phosphorylated cortactin (TF3) showed
markedly fewer focal adhesions than under the TF1 and TF2
conditions, and these differences were more apparent in Rsrc cells
(Fig. 8) than in SYF cells. Many cells in TF3 had an elongated
morphology, in agreement with previous observations (Fig. 7).
Cell spreading induces the interaction of cortactin with
focal adhesion kinase (FAK), and this interaction is lost
upon tyrosine phosphorylation of cortactin
To understand how tyrosine phosphorylation of cortactin may
affect the formation of focal adhesions, we focused on a recently
described cortactin partner, focal adhesion kinase (FAK) [37],
which plays important roles in focal adhesion dynamics [38].
We examined the spreading of HeLa cells on fibronectin, and in
parallel left them in suspension as a negative control (Fig. 9). Since
Figure 5. Analysis of acetylation and tyrosine phosphorylation of endogenous cortactin in WT and HDAC6-deficient MEFs. (A)
Isotype control (Ctrl.) and 4F11 immunoprecipitates from cell lysates of WT and HDAC6-deficient MEFs (H) were blotted first with acetyl-cortactin Ab
(in green) and second with the 4F11 cortactin MoAb (in red). The merge of both images is shown. After gentle stripping to remove the acetyl signal,
the membrane was blotted with pY466 Ab and 4F11 MoAb. Quantification and statistical analysis of three independent 4F11 immunoprecipitates and
the ratio of acetyl:pY466 cortactin signals are shown. a.u.: arbitrary units. *, p,0.05. (B) Immunoprecipitates obtained with acetyl-cortactin Ab were
blotted with pY466 Ab and 4F11. The phosphorylation signal did not coincide with acetylated cortactin. (C) Blotting of WT and HDAC6-deficient cell
lysates with HDAC6 Ab is shown as a control of cell phenotype.
doi:10.1371/journal.pone.0033662.g005
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previous work has shown that WT cortactin interacts with FAK,
while cortactin lacking the SH3 domain does not [37], we
performed pull-down experiments on the lysates using recombi-
nant purified cortactin SH3 domain fused to GST (GST-SH3) or
GST alone as a negative control (Fig. 9A). We found that cortactin
SH3 domain was able to pull down much more FAK from the
lysates of spread cells than from lysates of suspended cells. Similar
results where obtained with Rsrc lysates (data not shown). These
results indicate that focal adhesion formation during cell spreading
induces cortactin-FAK association (Fig. 9B).
To confirm the cortactin-FAK interaction during cell spreading
and to determine whether it is affected by tyrosine phosphoryla-
tion of cortactin, we performed IPs from cell lysates overexpressing
cortactin (TF2) or tyrosine-phosphorylated cortactin (TF3)
(Fig. 9C). We immunoprecipitated FAK using a FAK mouse
MoAb. The immunoprecitates were blotted sequentially, first with
myc Ab and secondly with FAK Ab, and lastly with pY466
cortactin Ab. Interestingly, we observed that FAK immunopre-
cipitated cortactin but not tyrosine-phosphorylated cortactin (see
asterisk, Fig. 9C). This result implies that FAK is associated with
cortactin, but not when it is tyrosine-phosphorylated.
Discussion
Cortactin phosphorylation is predicted to have important
physiological consequences [26] that are not yet fully understood.
Although cortactin is a classical Src kinase substrate, the functional
consequences of its tyrosine phosphorylation remain unclear. The
low basal level of tyrosine-phosphorylated cortactin, and poor
reproducibility of results when stimulating cell cultures with
growth factors such as EGF and PDGF, have made it challenging
to understand how tyrosine phosphorylation regulates cortactin
activity. To avoid these problems, we used the FIT system to study
the effect of Src-mediated phosphorylation of cortactin in cells. In
this system, a leucine zipper motif, consisting of a pair of
complementary amphipathic helices [39], is added to both Src and
its substrate, in this case cortactin.
Src kinase targets tyrosines 421, 466 and 482 of murine
cortactin [35]. Src family kinases (SFKs) are composed of
separable modules that include SH2 and SH3 domains [34].
Different systems have been used to study SFK substrates and
signal transduction pathways. The hemopoietic cell Src kinase
(Hck) was reengineered by substituting the SH2 and SH3 domains
with a PDZ domain to alter the kinase’s substrate specificity [40].
In another study, a temperature-sensitive vSrc mutant was found
to increase tyrosine phosphorylation of cortactin [41]. The FIT
system has been used successfully to force efficient phosphorylation
of desired substrates in cells [31], including Src-mediated
phosphorylation of paxillin, p130Cas and cortactin [32].
In the present study, we set up the FIT system and
simultaneously detected levels of total cortactin and tyrosine-
phosphorylated protein, both transfected and endogenous, using
two commercial Abs against phospho-Y466 and the 4F11 MoAb
(Fig. 1A). Transfected cortactin was also detected using a rabbit
cortactin MoAb and a MoAb to recognize the myc tag on our
cortactin constructs. Western blots were visualized with the
Odyssey scanning system, which allowed unambiguous double
labeling of cortactin and phospho-cortactin. We performed these
experiments in SYF and Rsrc fibroblasts to exclude any
contribution from endogenous Src kinases. When cells were
cotransfected with Src and cortactin, both fused to leucine zipper
interaction motifs, we observed a strong phosphorylation signal at
positions 421 and 466 that superimposed on the transfected
cortactin band (Fig. 1A, B).
We next performed various analyses to determine the
phosphorylation specificity of our FIT system. We determined
that cortactin is the major phosphoprotein in our samples, based
on experiments using two generic phospho-tyrosine MoAbs (Fig.
S2). We also showed that our FIT system is specific to cortactin:
the transfections did not affect the phosphorylation status of
paxillin, a known Src substrate (Fig. 2A). Finally, using the non-
phosphorylatable triple cortactin mutant Y421/466/482F (3F), we
verified that Src-mediated phosphorylation of cortactin occurs at
the expected tyrosines (Fig. 2B).
Like phosphorylation, acetylation regulates numerous cellular
functions. In fact, many proteins related to cytoskeletal dynamics
are regulated by acetylation, such as Arp2/3, tubulin, cofilin and
coronin [42]. Cortactin is regulated by reversible acetylation that
occurs mainly in the ABR of the protein [30], and this acetylation
was recently confirmed by ‘‘acetylome’’ analysis [42]. Acetylation
of lysines in the ABR was shown to reduce binding to F-actin,
which inhibits cell migration [30].
Like cortactin acetylation, Src-mediated phosphorylation of
cortactin decreases its binding to F-actin [15]. This binding is
required to activate the Arp2/3 complex [16]. We hypothesized
that the two modifications are interrelated since they have similar
effects on cortactin function, and we explored this idea in the
present study. Using the FIT system, we overexpressed phosphor-
ylated or unphosphorylated cortactin in cells, immunoprecipitated
the protein, and performed WB experiments with Abs against
Figure 6. Analysis of acetylation and tyrosine phosphorylation
of endogenous cortactin in SYF and Rsrc MEFs. Cell lysates of SYF
and Rsrc MEFs were subjected to IPs using (A) isotype control Ab (Ctrl),
4F11 MoAb and generic phospho-tyrosine (pTyr) MoAb. These IPs were
performed in parallel by probing first with acetyl-cortactin Ab (in
green), after a gentle stripping, with pY466 and at last, the membrane
was stripped and reprobed with cortactin Ab. Statistical analysis of the
ratio of acetyl:pY466 cortactin signals is shown for 4F11 immunopre-
cipitates. a.u.: arbitrary units. **, p,0.01. Asterisks denote evidence that
pTyr immunoprecipitates from Rsrc cell lysates contain phospho-
cortactin but not acetyl-cortactin. (B) IPs with pY466 and isotype
control Abs were probed with acetyl-cortactin Ab and 4F11 cortactin
MoAb, and reprobed, after gentle stripping, with pY466 Ab and 4F11
MoAb.
doi:10.1371/journal.pone.0033662.g006
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Figure 7. Tyrosine phosphorylation of cortactin affects cell spreading. (A) SYF and Rsrc cells were transfected for 20 h with empty vectors
(not shown), ZipB-MycCortactin and empty vector (TF2), or ZipB-MycCortactin and ZipA-HADSrc (TF3). Cells were then trypsinized, replated on
fibronectin-treated coverslips, and fixed at 1 and 3 h. Pictures were taken in a confocal microscope at 6006magnification. Immunofluorescence
staining was done using myc MoAb (in green), pY466 cortactin Ab (in red) and Alexa Fluor 350-phalloidin (in blue). For each experimental condition, a
representative image of a non-spread and spread cell is shown. * Denotes that spreading of Rsrc cells is incomplete. Images were merged using Leica
software. Scale bars are shown. A total of 100 transfected cells were quantified and classified into two categories: spread or non-spread. Statistical
analysis from 7 independent experiments at 1 and 3 h after replating Rsrc cells is shown for tranfections TF1 (empty vectors), TF2 (cortactin) and TF3
(phosphorylated cortactin). *, p,0.05; **, p,0.01; ***, p,0.001. (B) Inhibition of cortactin phosphorylation increases its acetylation during cell
spreading. Rsrc cells were replated on fibronectin (FN)-coated coverslips and allowed to spread for 1 or 3 h. A third plate was allowed to spread for
1 h and then treated with PP2 for 2 h. The lysates were subjected to IPs using isotype control (Ctrl.) MoAb or 4F11 MoAb and were blotted first with
acetyl-cortactin Ab and second with anti 4F11 MoAb. After gentle stripping, the membrane was incubated with pY466 cortactin Ab and 4F11 MoAb.
Quantification of the ratio of acetyl:pY466 cortactin signals indicated a significantly higher ratio after PP2 treatment. a.u.: arbitrary units. **, p,0.01.
doi:10.1371/journal.pone.0033662.g007
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acetyl-cortactin and pY466-cortactin (Fig. 3). To be sure of our
results, we performed the IPs using a myc MoAb, and then again
using a generic phospho-tyrosine MoAb (Fig. 3A, B) and pY466
cortactin Ab (Fig. S3). The first set of IPs brought down
phosphorylated and unphosphorylated cortactin, whereas the
second set brought down only phosphorylated cortactin. Blotting
with pY466 Ab detected cortactin phosphorylation mainly in the
sample transfected with Zip-cortactin and Zip-Src. These
experiments show that acetylation and phosphorylation of
cortactin are mutually exclusive: acetylated cortactin is not
phosphorylated and vice versa (Fig. 3). Another major finding of
our study is that when WT cortactin is expressed in transfected
cells, at least some of it is acetylated (Figs. 3 and 4) and therefore
predicted to be inactive [30].
To determine whether the competition observed between
acetylation and phosphorylation of transfected cortactin also holds
for the endogenous protein, we carried out experiments in two cell
types. The first was WT and HDAC6-deficient MEFs. HDAC6 is
the major deacetylase acting on cortactin [30]. As expected, we
found the HDAC6-deficient cells to have a significantly higher
basal level of acetylated cortactin than did WT cells, as previously
described using siRNA techniques [30]. More importantly, we
confirmed in both cell types our finding of a competition between
acetylation and tyrosine phosphorylation. We did this in two types
of IP experiments, one using the 4F11 MoAb and the other using
an Ab against acetyl-cortactin (Fig. 5). In the latter IPs, acetyl-
cortactin did not show detectable tyrosine phosphorylation, as
assessed by either pY466 cortactin Ab or generic pTyr MoAb (Fig.
S4). These two IP experiments were repeated on endogenous
cortactin in a second cell type, SYF cells, for which Rsrc cells
served as control (Fig. 6). Since SYF and Rsrc cells have different
levels of tyrosine-phosphorylated cortactin, we performed IPs with
4F11, pTyr Ab and pY466 Ab. As in WT and HDAC6 deficient
MEFs, endogenous tyrosine-phosphorylated cortactin was not
acetylated.
A major conclusion of our work is that phosphorylation of
cortactin has important repercussions on cell spreading, extending
the insights of a previous study showing that cortactin mutants
mimicking tyrosine phosphorylation affect focal adhesion turnover
[28]. Using the FIT system to control tyrosine phosphorylation of
cortactin, we analyzed the effect of phosphorylating cortactin on
cell location (Fig. S5) and cell spreading (Fig. 7). We found that
phosphorylated and unphosphorylated cortactin expressed
through transient transfection has an intracellular distribution
similar to that of endogenous protein [12]. More importantly,
phosphorylation affects cell spreading: cortactin expression
facilitated cell adhesion, while tyrosine phosphorylation inhibited
it. This phenotype was more noticeable in Rsrc cells, which
express Src, than in SYF cells, which do not contain the major
SFKs expressed in fibroblasts (Src, Yes and Fyn). This difference
between the cell lines is understandable given that many proteins
besides cortactin participate in cell adhesion, and many of them
are regulated by Src-mediated phosphorylation [43].
In an effort to understand the molecular mechanism underlying
the inhibitory effect of tyrosine phosphorylated cortactin on cell
spreading, we hypothesized that this post-translational modifica-
tion would affect the binding of cortactin SH3 domain to
interacting proteins that function in cell spreading. One obvious
candidate was FAK [37]. Our results in the present study
demonstrate that in vivo, as previously proposed in vitro [10],
tyrosine phosphorylation of cortactin prevents the SH3 domain
from interacting with FAK and potentially other proteins as well.
While we were preparing this manuscript for submission,
researchers reported that a tyrosine phosphorylation-mimicking
mutant of cortactin no longer binds FAK and promotes cell
motility [44]. This result is comparable to our results obtained with
cortactin mutants and with the endogenous protein after
Figure 8. Tyrosine phosphorylation of cortactin affects focal adhesion formation: staining for vinculin. SYF and Rsrc cells were
transfected with empty vectors, with ZipB-MycCortactin and empty vector (TF2) or with ZipB-MycCortactin and ZipA-HADSrc (TF3). Cells were fixed
and visualized by immunofluorescence using vinculin MoAb (in green) and myc Ab (in red). Photographs were taken using a Nikon Eclipse TE 200-U
fluorescence microscope equipped with a Hamamatsu camera. Images were processed with Adobe Photoshop. A scale bar is shown.
doi:10.1371/journal.pone.0033662.g008
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Helicobacter infection [37]. In the present study, we used not mutant
forms of cortactin but the phosphorylated form of the WT protein
to demonstrate directly that phosphorylation inhibits cortactin
binding to FAK and cell spreading. Our results point to a
significant role for tyrosine phosphorylation of cortactin in
regulating cell adhesion to fibronectin. This further suggests the
possibility that cortactin and its phosphorylation contribute to
integrin signaling.
Model
We propose a model for the ‘sequential’ activation of cortactin
(Fig. 10). The major tyrosines targeted by Src are located in the
proline-rich region at the C-terminus of the protein. Cortactin has
a closed, globular conformation, achieved mainly through
interactions among the SH3 domain, the ABR and helical region
[27]. This agrees with previous studies showing that in unmodified
cortactin, the SH3 domain is masked [10,22]. Since acetylated
cortactin has also been proposed to be inactive [30], we
hypothesize that acetylated cortactin has a closed conformation
as well.
Based on our observation that acetylation and tyrosine
phosphorylation are not present simultaneously, we propose that
in acetylated cortactin, the tyrosines targeted by Src are hidden.
Analysis of the tertiary structure of cortactin suggests that both
acetyl and phosphate groups can be close to each other in space
[45], which may explain why one process excludes the other.
Acetylation of the e-amino group of lysines has already been
suggested to ‘‘rival’’ phosphorylation in some cases [46]. Some
examples of phosphorylation-acetylation switches in the regulation
of proteins are already known. For example, Signal Transducers
and Activators of Transcription 1 (STAT1) is activated by
phosphorylation and inactivated by acetylation [47]. We further
propose that upon appropriate stimulation, such as focal adhesion
formation during cell spreading, cortactin is deacetylated, mainly
by HDAC6, which like cortactin can translocate to the cell
periphery [48]. This deacetylated status would be maintained by
rapid Src-mediated tyrosine phosphorylation, although we cannot
exclude the possibility that other post-translational modifications
contribute to inhibiting reacetylation. In essence, we propose that
tyrosine-phosphorylated cortactin is a ‘pre-activation state’. At the
present moment we do not know whether this species has an open
or closed configuration; this will require high-resolution structural
analysis.
Figure 9. Tyrosine phosphorylation of cortactin terminates its interaction with focal adhesion kinase (FAK) during cell spreading.
(A) Coomassie staining of purified GST and GST-cortactin SH3 domain was scanned in the Odyssey system. (B) HeLa cells were detached with trypsin-
EDTA, washed with trypsin inhibitor and kept in suspension (susp.) or allowed to spread for 3 h on fibronectin (FN)-treated 100-mm plates. RIPA cell
lysates were used for pull-down experiments with GST or GST-SH3, which were analyzed by SDS-PAGE and WB with focal adhesion kinase (FAK) Ab,
followed by labeling with a 800CW-conjugated goat rabbit Ab. (C) HeLa cells were transfected with ZipB-MycCortactin and empty vector (TF2) or with
ZipB-MycCortactin and ZipA-HADSrc (TF3). After 20 h cells were detached with trypsin-EDTA, washed with trypsin inhibitor and allowed to spread on
FN-coated 100-mm plates for 3 h. Cell lysates were subjected to immunoprecipitation with FAK MoAb. The immunoprecipitates were subjected to
WB and probed in three steps: (1) with myc Ab to detect transfected cortactin, followed by a 680CW-labeled goat mouseAb (red); (2) with FAK Ab,
followed by a 800CW-labeled goat rabbit Ab (green); and (3) with pY466 cortactin Ab, followed by a 800CW-labeled goat rabbit Ab. Transfected
cortactin was immunoprecipitated by FAK (asterisk) only when the protein was not tyrosine-phosphorylated.
doi:10.1371/journal.pone.0033662.g009
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Supporting Information
Figure S1 Western-blotting controls for the transfec-
tions of the FIT vectors. (A) To detect our transfected protein,
lysates were analyzed by WB with a rabbit cortactin MoAb and a
mouse myc MoAb. Both MoAbs recognize transfected cortactin.
(B) Transfection and cell phenotype controls were performed by
WB with HA Ab (in green), and myc and Src MoAbs (in red).
(TIF)
Figure S2 Specificity of the FIT system as detected with
phosphotyrosine generic antibodies. SYF and Rsrc cells
were transfected with different combinations of Src and cortactin
FIT fusion vectors (lanes 1–8) or left untransfected (lane 9). The
cell lysates were blotted for actin as a loading control, and with a
mixture of two generic phosphotyrosine MoAbs: 4G10 and PY20
(Platinum). The major tyrosine-phosphorylated band observed in
our lysates corresponded to cortactin detected with rabbit
cortactin MoAb (in red) in the lysates cotransfected with ZipA-
HA-DSrc and ZipB-MycCortactin (lane 5, asterisks).
(TIF)
Figure S3 Analysis of acetylation and tyrosine phos-
phorylation of transfected cortactin. (A) Lysates from
various transfection combinations (lanes 1–4), treated or not with
the deacetylase inhibitor Trichostatin A (TSA), were blotted using
pY466 cortactin Ab (pY466) (in green) and 4F11 MoAb (in red) to
analyze the phosphorylation of transfected cortactin. (B) TSA-
treated cell lysates from various transfection combinations (lanes
1–3) were subjected to IP experiments with the pY466 Ab or
isotype control Ab (Ctrl.). The IPs were blotted first with acetyl-
cortactin Ab, and second with the cortactin 4F11 MoAb; then the
membrane was stripped and reprobed with pY466 Ab and with
cortactin 4F11 MoAb. The asterisk denotes nonspecific bands.
(TIF)
Figure S4 Analysis of acetylation and tyrosine phos-
phorylation of endogenous cortactin in WT and HDAC6-
deficient MEFs. Immunoprecipitates obtained with acetyl-
cortactin Ab were blotted with phospho-tyrosine generic mouse
MoAb (pTyr) and cortactin rabbit MoAb. There was not
phosphorylation signal to coincide with acetylated cortactin.
(TIF)
Figure S5 Localization of tyrosine-phosphorylated cor-
tactin. SYF and Rsrc cells were transfected with empty vectors
(not shown), with ZipB-MycCortactin and empty vector (TF2) or
with ZipB-MycCortactin and ZipA-HADSrc (TF3). Cells were
fixed and visualized by immunofluorescence using myc MoAb (in
blue), pY466 cortactin Ab (in green) and TRITC-phalloidin to
label actin cytoskeleton (in red). Pictures were taken on a confocal
microscope at 6006 magnification. Images were merged and a
zoomed view was generated using Leica software. Scale bars are
shown. Some cells showed clusters of actin and phospho-cortactin
(arrows).
(TIF)
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